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ABSTRACT 
 
 This thesis discloses catalytic, enantioselective dipolar cycloadditions to deliver new 
nitrogen-containing heterocycles and formal hydroarylations of olefins that have previously not 
been possible. 
 Catalytic, enantioselective, dearomative cycloadditions of stabilized, α-substituted 
azomethine ylides with 3-nitroindoles occur in the presence of a catalytic complex generated 
from Cu(OTf)2 and (R)-Difluorphos.  These reactions set four contiguous stereocenters, two of 
which are fully substituted.  Overcoming the barrier of breaking aromaticity, this catalyst system 
delivers pyrrolo[3, 4b]indoles with exo´-selectivity in moderate-to-good yields (39-85%) with 
high diastereoselectivity (up to 98 : 1 : 1 dr) and enantioselectivity (up to 96% ee). 
Catalytic, enantioselective, dipolar cycloadditions of highly reactive nitrile imines with 
methyleneindolinones occur in the presence of a catalyst generated from Mg(NTf2)2 and a chiral 
aminoindanol-derived bisoxazoline ligand.  The catalyst system designed overcomes a rapid 
competing background reaction to deliver spiro[pyrazolin-3,3′-oxindoles] in up to 98% yield and 
99% ee. 
Conjugate additions of arylboronic acids to challenging 2-alkylchromones occur in 
aqueous medium in the presence of a catalyst system generated from Pd(TFA)2 and 1,10-
phenanthroline.  This system overcomes the problem of competing protodeboronation and biaryl-
forming reactions to deliver 2-alkyl-2-aryl-chromanones in up to 90% yield, providing a new and 
effective means of generating a fully substituted carbon center.   
In all of these projects, effective catalyst design principles were established to overcome 
challenges that made these types of reactions previously impossible.  
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CHAPTER 1 
ARENES AND HETEROARENES AS 2 π-ELECTRON REACTION PARTNERS IN 
CATALYTIC, ASYMMETRIC, DEAROMATIVE CYCLOADDITIONS: A REVIEW  
 
General Introduction 
Dearomative cycloadditions of arenes and heteroarenes offer the potential to generate 
novel polycyclic systems in a rapid and elegant manner.  As 2 π-electron partners in catalytic, 
enantioselective cycloadditions, aromatic systems are challenging substrates due to the high 
energy barrier of breaking aromaticity.1  In recent years, the potential synthetic utility of 
asymmetric cycloadditions with arenes as 2 π-electron partners has led to increased 
investigations into these types of reactions, which are the focus of this review.  Aromatic 
compounds as 4 π-electron partners have been explored in catalytic, asymmetric synthesis.2  The 
electron-rich nature of these species renders them effective as dienes in many reactions.3  A 
recent review included reports of such dienes as 4 π-electron partners,4 and these reactions are 
not included here.  This review is organized by reaction type, and includes catalytic, 
enantioselective dearomative cycloadditions via carbenoid species, chiral Lewis acid catalysis, 
cascade reactions involving allylic substitution, chiral phosphoric acid catalysis, and iminium ion 
organocatalysis.  
Enantioselective dearomative cycloadditions via carbenoid species 
 In 2003, Reiser and coworkers reported the first catalytic, asymmetric cyclopropanations 
of aromatic compounds via metal carbenoid species (Scheme 1).5  These cyclopropanations took 
place in the presence of chiral catalysts formed from copper (II) and bisoxazoline ligands.  
Methylfuran-2-carboxylate 1a reacted smoothly in the presence of the 4/Cu(OTf)2 to deliver 
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cyclopropanated furan 3a in 36% yield and 91% ee (Scheme 1a).  Methylfuran-3-carboxylate 1b 
reacted with 2 in the presence of the catalyst to furnish 3b in 19% yield and 40% ee (Scheme 1a).  
The investigators propose a hydrogen-bonding interaction between the amino-moiety of 4 and 
the carbonyl group of the ester in 1a that allows for the delivery of high enantioselectivity in 
product 3a.  This hydrogen-bonding interaction is likely absent in the interaction of 1b with the 
catalyst, leading to a lack of facial discrimination, and thus, low enantioenrichment.  The 
reaction of N-Boc pyrrole 5, which lacks sterically accessible hydrogen-bond acceptors, in the 
presence of 8/Cu(OTf)2 delivered 7 in only 52% yield and 46% ee, lending further evidence of 
the requirement for secondary interactions between the catalyst complex and the substrate to 
achieve high enantioenrichment under these conditions. 
 
Scheme 1.  Copper-catalyzed enantioselective cyclopropanations of furans and pyrroles with 
carbenes formed from diazoacetates 
 
 Davies and coworkers designed a more generalized system for cyclopropanations of 
furans and pyrroles that employed rhodium prolinate catalyst Rh2(S-DOSP)4 (Scheme 2).
6  This 
catalyst system did not require a chelating substituent on the ring and delivered both mono-and 
di- cyclopropanation products.  Furan 9 reacted with donor-acceptor carbene precursor 10 to 
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deliver monocyclopropanated furan 11 in 61% yield and 92% ee and di-cyclopropanated 12 in 
8% yield and 93% ee (Scheme 2a).  In the presence of excess carbene precursor 10, 12 was the 
major product, isolated in 68% yield and 96% ee (Scheme 2a). The reaction of neat N-Boc 
pyrrole 5 delivered cyclopropane product 13 in 54% yield and 79% ee, and di-cyclopropanated 
14 in 34% yield and 92% ee (Scheme 2b).  Interestingly, the reactions yielded cyclopropanated 
furans 11 and 12 and cyclopropanated pyrroles 13 and 14 with opposite absolute 
stereochemistry, despite the reactions occurring in the presence of the same enantiomer of the 
catalyst.   
 
Scheme 2.  Rhodium-catalyzed enantioselective cyclopropanations of furans and pyrroles with 
carbenes formed from diazo precursors 
 
 When the authors extended this methodology to include benzofurans 15a and 15b as 
substrates, the system delivered cyclopropanation of the benzofuran C2-C3 with moderate-to-
good yield and high enantioenrichment (Scheme 3).  The reaction of 15a with 10 furnished 16a 
in 61% yield and 96% ee, while the reaction of 15b with 10 delivered 16b in 81% yield and 97% 
ee (Scheme 3a).  However, the reaction of 2-methylbenzofuran 17 with 10 yielded product 18 
with di-cyclopropanation of the benzenoid ring and no cyclopropanation of the C2-C3 bond 
(Scheme 3b).  Not surprisingly, higher temperatures were detrimental to the enantioenrichment 
of the product, as the reaction delivered 18 as a single diastereomer in 47% yield and 51% ee at 
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room temperature, and 49% yield and only 32% ee at 69 °C (Scheme 3b).  Reactions of 2-
methylindole 19a and 3-methylindole 19b also resulted in only benzenoid ring cyclopropanation 
products, although in higher enantioenrichment than the product from the reaction of benzofuran 
substrate 17 (Scheme 3c).  
 
Scheme 3.  Reactions of benzofurans and indoles with carbene precursor 10 in the presence of 
Rh2(S-DOSP)4 
 In 2012, the Boysen group reported catalytic, enantioselective cyclopropanations that 
selectively cyclopropanated the C2-C3 bonds of N-acylated indoles.7  The transformation 
employed ethyldiazoacetate 2 as a carbene precursor and a copper (I) complex of 3-O-Ac 
glucobox ligand 23 as a catalyst.  At -10 °C, N-acetyl-3-methylindole 21 reacted with 2 in the 
presence of the catalyst to deliver exo-22 and endo-22 in 29% combined yield, with >99:1 
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exo:endo-selectivity and 70% ee observed in exo-22 (Scheme 4a).  The reaction of N-Boc-3-
methylindole 24 with 2 resulted in an increase in enantioenrichment to 96% ee, observed upon 
derivatization of cyclopropanated indole 25 to product 27 by Boc-deprotection and ring opening, 
followed by lactone formation (Scheme 4b).  The enantioenrichment and diastereomeric ratio of 
products 25 could not be directly observed due to the presence of carbene homocoupling 
products.  27 was easily transformed to the natural product (-)-Desoxyeseroline 28 (Scheme 4b).  
Scheme 4.  Reactions of N-acyl-3-methylindoles with 2 in the presence of a Cu(I)-3-O-Ac 
glucobox catalyst 
 
In 2010, Davies reported rhodium-catalyzed cyclopentannulations of N-methylindoles 
with phenylvinyldiazoacetates in the presence of Rh2(R-DOSP)4.
8  N-methylindole 29 reacted 
smoothly with (E)-phenylvinyldiazoacetate 30 in the presence of the rhodium catalyst to afford 
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regioisomeric endo-31 and exo-31 in a roughly 4:1 ratio (Scheme 5a).  This formation of a 
mixture of regioisomers was unsurprising as vinylcarbenoids can be electrophilic at either the 
carbenoid or vinylogous sites.9  In order to gain insight into the reaction mechanism, the authors 
carried out reactions of 1,2-disubstituted indoles 32 and 1,3-disubstituted indoles 34 with 
phenylvinyldiazoacetates in the presence of Rh2(S-DOSP)4. The [3+2]-cycloadditions of 1,2-
disubstituted indoles 32 with phenylvinyldiazoacetates occurred with endo-diastereoselectivity 
and high enantioselectivity, and fusion of the indole C3-position to the ester terminus of the vinyl 
carbenoid (Scheme 5b).  In contrast to the regioselectivity and diastereoselectivity observed with 
Scheme 5.  Cyclopentannulations of N-methylindoles with phenylvinyldiazoacetates in 
the presence of Rh2(DOSP)4 
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1,2-disubstituted indoles, the reaction conditions applied to 1,3-dimethylindole 34 resulted in 
exo-selectivity and fusion of the indole C3 with the arene terminus of the vinyl carbenoid (Scheme 
5c). 
It is probable that the observed opposite regiochemical outcomes depending on the 
utilization of 1,2-disubstituted indoles 32 or 1,3-dimethylindole 34 arise from the approach of the 
indole to the carbenoid that places the C2- or C3- alkyl group of the indole distal to the prolinate 
ligand of the rhodium complex (Scheme 6).  The diastereochemical outcome is likely to be 
dictated by the conformation of the vinyl carbenoid prior to ring closure: the reaction manifold to 
deliver endo-33 likely involves an s-trans configured rhodium carbenoid species (Scheme 6a), 
while the pathway to exo-35 likely involves an s-cis configured rhodium carbenoid species 
(Scheme 6b).  It is well established that reactions of N-alkylindoles with rhodium carbenoids 
proceed via zwitterionic intermediates with the positive charge stabilized by the electron-rich 
Scheme 6.  Proposed reaction mechanisms of indole cyclopentannulations with rhodium 
vinyl carbenoids in the presence of a rhodium catalyst 
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indole and the negative charge stabilized by the rhodium,10 making it reasonable to propose I-1 
and I-2 as intermediates in the reaction pathways that lead to endo-33 and exo-35.  It is also 
possible that the vinyl group orientation takes place in intermediates I-1 and I-2 prior to 
cyclization.  Further mechanistic insight is required to determine at what point the rhodium vinyl 
carbenoid assumes the proper orientation to subsequently arrive at I-1 or I-2. 
Rhodium carbenoids are also useful intermediates in catalytic, enantioselective, 
dearomative cycloadditions of carbonyl ylides.  A report from the Hashimoto group 
demonstrates the use of diazodiketoesters as cyclic carbonyl ylide precursors in rhodium-
catalyzed enantioselective, dearomative cycloadditions with indole dipolarophiles.11  
Decomposition of the diazo moiety in 36 to a rhodium carbene, followed by nucleophilic attack 
of the carbene by the carbonyl oxygen results in a metallated cyclic carbonyl ylide (shown in T-
1), which subsequently undergoes [3+2] cycloaddition with the indole C2-C3 bond (Scheme 7).  
These transformations employed chiral rhodium catalysts C1-C3 on the basis of previous 
work.12  Reactions of carbonyl ylides derived from precursors 36 with indoles delivered 
cycloadducts exo-37 with excellent enantioenrichment and diastereoselectivity (Scheme 7).  
Screening of catalysts revealed that the use of C2 and C3 as catalysts led to slightly diminished 
Scheme 7.  Rhodium-catalyzed carbonyl ylide cycloadditions with indole dipolarophiles 
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yields and enantioselectivities.  The resulting mixture of exo and endo diastereomers 39 afforded 
by the reaction in the presence of an achiral rhodium catalyst highlights the necessity of a chiral 
rhodium catalyst for high diastereoselectivity (Scheme 8).  Although the role of the phthalimido 
groups in the bridging ligands of the dirhodium (II) catalysts C1-C3 in diastereselection is not 
entirely clear as of this writing, previous work demonstrates the importance of these groups in 
this context.12-13 
 
Scheme 8.  Reaction of a 6-membered cyclic carbonyl ylide with N-methylindole in the presence 
of an achiral rhodium catalyst 
 
The established catalyst system was effective in cycloadditions of 6-membered cyclic 
carbonyl ylides.  Reactions of indoles 40 with carbonyl ylides derived from precursor 41 in the 
presence of C1 delivered indoline products 42 in up to 86% yield and 99% ee, with >99% exo 
selectivity (Scheme 9).  The system did not perform as well, however, with 5-membered cyclic 
carbonyl ylides: reactions of N-methylindole with 5-membered cyclic carbonyl ylides derived 
from precursors 43 resulted in overall lower yields and enantioselectivities compared to reactions 
carried out with 6-membered cyclic carbonyl ylides.  Reactions of carbonyl ylides derived from 
gem-dimethyl substituted precursors 43 with N-methylindole resulted in high exo:endo 
selectivity, but low enantioenrichment in products 44 (Table 1, entries 1-3).  The reaction 
required a spirocyclopropane backbone on precursor 43, as well as higher temperatures, in order 
to deliver synthetically useful diastereo- and enantioselectivity in the product mixture (entry 5).  
These results suggest that 1) the rhodium catalyst is still bound to the carbonyl ylide at higher 
temperatures, since the carbonyl ylide detached from the catalyst would be achiral;13d,14  and 2) 
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immediate trapping of the rhodium-bound carbonyl ylide by the indole is required for high yield, 
diastereoselectivity, and enantioselectivity. 
 
Scheme 9. Rhodium-catalyzed cycloadditions of 6-membered cyclic carbonyl ylides with N-
methylindoles 
 
 
Table 1.  Rhodium-catalyzed cycloadditions of 5-membered cyclic carbonyl ylides with 
 
Entry R Temp (°C) Yield (%) exo:endo ee exo (%) ee endo 
(%) 
1 Me 23 40 >99:1 50  
2 Me 60 84 >99:1 61  
3 Me 80 80 >99:1 59  
4 -CH2CH2- 23 69 87:13 82 2 
5 -CH2CH2- 60 88 92:8 92 2 
 
In a recent revisiting of rhodium catalyzed cycloadditions of cyclic carbonyl ylides with 
indole dipolarophiles, Suga and coworkers approached rhodium-catalyzed cycloadditions of 
cyclic carbonyl ylides with indoles from the standpoint of a Lewis acid/rhodium dual activation 
approach, where the rhodium catalyst drove the formation of the carbonyl ylide, and a chiral 
Lewis acid catalyst guided the approach of the indole dipolarophile to the dipole (Scheme 10).15  
Although this approach with 5-membered cyclic carbonyl ylides still did not deliver synthetically 
useful enantioenrichment, this catalyst system was notable in that it favored endo-46 with the 
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proper choice of Lewis acid.  This Lewis acid/rhodium dual activation approach thus 
complements the previous work by Hashimoto which favors exo selectivity in reactions of  5-
membered cyclic carbonyl ylides with indoles.11 
 
Scheme 10.   Lewis acid/rhodium dual activation strategy for cycloadditions of cyclic carbonyl 
ylides with indole dipolarophiles 
 
In 2013 the Davies group reported rhodium-catalyzed dearomative cycloadditions where 
1,2,3-triazoles functioned as rhodium-carbenoid precursors.16 A serendipitous discovery 
(Scheme 11) opened the door for the synthesis of pyrroloindolines via cycloadditions of N-
alkylindoles with rhodium carbenoid imines.16  1,3-dimethylindole 47 reacted with triazole 50 in 
the presence of Rh2(oct)4 to yield aldehyde 48 as expected after hydrolysis of the resultant N-
sulfonylimine.  However, the corresponding reaction of 47 with triazole 51 yielded unexpected 
pyrrolo[2, 3b]indole 49. 
12 
 
 
Scheme 11.  Serendipitous discovery of cycloadditions of indoles with rhodium carbenoid imines 
to deliver pyrroloindolines 
 
The formation of unexpected 49 led the authors to explore reactions of 4-arylsubstituted 
triazoles with indoles.  1,3-disubstituted indoles 53 reacted with triazoles 54 in the presence of 
Rh2(S-PTAD)4 to deliver products 55 in up to quantitative yield and 95% ee (Scheme 12).  While 
the reaction tolerated of a wide range of functional groups on the aryl ring of the triazole and on 
the indole, it was intolerant of bulky groups (TBS, Bn) or electron-withdrawing groups (Ts, 
CO2Me, Boc) on the indole nitrogen, as well as bulky substituents at the 1-position of the 
triazole.  The formation of a pyrroloindoline product, coupled with the failure of the reaction in 
polar solvents, led the authors to propose a reaction mechanism that involved an initial 
cyclopropanation of the C2-C3 bond of the indole to form cyclopropane intermediate I-6 
followed by ring opening and recombination via intermediate I-7 to form product 56 (Scheme 
13).   
13 
 
 
Scheme 12.  Formal cycloadditions of rhodium carbenoid imines with 1,3-dialkylindoles 
 
 
Scheme 13.  Proposed mechanistic pathways of pyrroloindoline formation in cycloadditions of 
rhodium carbenoid imines with indoles 
 
Recently, Bandini and coworkers17 reported enantioselective gold-catalyzed [2+2] 
cycloadditions of alleneamides with indoles.  Previous reactions of N-unsubstituted indoles with 
alleneamides delivered C-3 allylated products 59 (Scheme 14a) with no cycloadducts observed.18 
An electron-withdrawing group on the indole nitrogen rendered the indole C-2 position in I-8 
more electrophilic and an electron-rich phosphine made the gold center more nucleophilic, 
allowing for protodeauration to be outpaced by ring closure to deliver of indoline cyclobutanes 
60 in good yields and high enantioselectivities (Scheme 14b).  These reactions tolerated a wide 
range of substituents and occurred with perfect diastereoselectivity and Z-alkene selectivity.  C2-
C3 annulated indoles and 2,3-dialkylated indoles were effective dienophiles in these [2+2]-
14 
 
 
cycloadditions, with representative examples shown in Scheme 15.  A 5-bromo substituent on 
the indole decreased the overall yield, but with no erosion in enantioselectivity (63c).  
Replacement of the indole N-Boc substituent with an N-CBz resulted in a lower but satisfactory 
yield (63d).  Finally, the reaction carried out with an N-unsubstituted indole resulted in only 8% 
yield, highlighting the requirement for substitution at the indole nitrogen (63e).  The exclusive Z-
geometry of the alkene can likely be attributed to a ring closure that occurs simultaneously with 
deauration (Scheme 16, path a). 
 
Scheme 14.  Gold-catalyzed reactions of indoles with allenamides to deliver C-3 allylated 
indoles and indoline-cyclobutanes 
 
 
Scheme 15.  Gold-catalyzed [2+2]-cycloadditions of indoles with alleneamides 
15 
 
 
 
Scheme 16. Proposed catalytic cycle for gold-catalyzed [2+2]-cycloadditions of indoles with 
alleneamides 
Enantioselective dearomative cycloadditions catalyzed by chiral Lewis acids 
 Chiral Lewis acid catalysts provide directional activation with the intention of favoring a 
certain stereochemical outcome as well as the advantage of a well-defined coordination 
environment around the metal center.19 With these attributes in mind, they have been studied as 
catalysts in enantioselective, dearomative cycloadditions.  Selected examples are reviewed herein 
where Lewis acids activate reagents to allow dearomative cycloadditions to occur with high 
enantioselectivity.  
 Donor-acceptor epoxides and donor-acceptor cyclopropanes have been used as 
annulation partners in dearomatizing cycloadditions with indoles.  From the reaction of 3-
methylindole 64 with oxiranyl dicarboxylate 65 in the presence of the complex generated from 
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Ni(ClO4)2 and bisoxazoline ligand 67, Zhang and coworkers isolated furo[3, 4b]indole 66 in 72% 
yield with 19% ee and >20:1 dr (Scheme 17a).20  Feng and coworkers created a more suitable 
catalyst for cycloadditions of oxiranyl dicarboxylate 65 with indoles 68 where a complex derived 
from Ni(ClO4)2 and chiral N, N´-dioxide ligand 70 was operative.
21  In this case, addition of 
LiNTf2 to the reaction led to a more Lewis acidic nickel (II) species generated upon ion 
exchange.22  The reaction carried out with 1,3-dialkylindoles 68 in the presence of the nickel 
catalyst furnished cycloadducts 69 in up to 98% yield, >95:5 dr, and up to 91% ee (Scheme 17b).  
Unsurprisingly, reactions of oxiranyl dicarboxylates bearing electron-neutral and electron-
withdrawing aryl groups were not suitable carbonyl ylide precursors in this chemistry.  The Tang 
group developed cycloadditions of donor acceptor cyclopropanes 72 with N-benzyl substituted 
indoles 71, catalyzed by the complex of Cu(OTf)2 and bisoxazoline ligand 74, to deliver 
cyclopenta-fused indolines 73 in up to 98% yield, >50:1 dr, and 96% ee (Scheme 17c).23  In the 
presence of this catalyst, fused tricyclic indole 75 underwent cycloaddition with donor-acceptor 
cyclopropane 76 to generate 77, the core structure of Borreverine, in 96% yield and 95% ee as a 
single diastereomer (Scheme 18).  In addition to the rhodium-catalyzed cyclopentannulations 
developed by Davies,8 the cycloadditions developed by Tang provide another route for the 
enantioselective synthesis of cyclopenta-fused indolines. 
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Scheme 17.  Lewis acid-catalyzed cycloadditions of indoles with donor-acceptor cyclopropanes 
 
Scheme 18.  Application of Tang method23 to the synthesis of Borreverine core 
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 Cycloadditions of azomethine ylides with aromatic dipolarophiles are another promising 
route to the rapid generation of polycyclic architectures.24  Gribble and coworkers initially 
reported cycloadditions of highly reactive, unstabilized azomethine ylides with 2- and 3-
nitroindoles to generate racemic pyrroloindolines.25  More recently, Chataingner, Piettre and 
coworkers demonstrated that racemic cycloadditions of unstabilized azomethine ylides were 
possible with a broad scope of electron-deficient aromatic dipolarophiles.26  In 2014, Arai and 
coworkers reported the first catalytic, enantioselective reactions of azomethine ylides with 3-
nitroindoles to deliver pyrrolo[3, 4b]indoles.27   Reactions of glycine-derived imino esters 79 
with 3-nitroindoles 78 in the presence of the complex of Cu(OTf)2 and PyBidine ligand 81  
afforded pyrroloindolines exo´-80 with high yield, diastereoselectivity, and enantioselectivity 
(Scheme 19a).  Our group concurrently reported cycloadditions of azomethine ylides generated 
from α-substituted imino esters 82 with 3-nitroindoles 78.28  These reactions occurred in the 
presence of a Cu(OTf)2/(R)-Difluorphos complex to deliver cycloadducts exo´-83 in up to 85% 
yield, 98:1:1 exo´:exo:endo diastereoselectivity, and up to 96% ee (Scheme 19b).  Interestingly, 
we observed in the cycloaddition of 3-nitro-N-tosylindole 84 with 85 in the presence of the 
copper catalyst the initial formation of a significant amount of endo-85, which epimerized to 
exo´-85 as the reaction progressed.  At two hours of reaction time, the observed exo´:exo:endo 
ratio was 69:5:26 (Scheme 20).  After 6 hours, the ratio observed was 77:9:14, and at 16 hours it 
was 93:3:4 (Scheme 20).  In the absence of the copper complex, the exo´:exo:endo remained 
approximately 60:10:30 throughout the entire course of the reaction, demonstrating that little 
epimerization occurs in the absence of the copper catalyst.  The epimerization likely occurs via a 
retro-Mannich/Mannich reaction manifold.29   
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Scheme 19.  Copper-catalyzed azomethine ylide cycloadditions with 3-nitroindoles 
 
Scheme 20.  Evolution of diastereoselectivity over time in copper-catalyzed cycloadditions of 
azomethine ylides with 3-nitroindoles 
 In 2010, the Reisman group reported catalytic, enantioselective, dearomative formal 
[3+2] cycloadditions of indoles 87 with 2-amidoacrylates 88 in the presence of a Sn/(R)-BINOL 
catalytic complex to deliver diastereomeric mixtures of pyrrolo[2, 3b]indoles exo-89 and endo-
89 (Scheme 21).30  The authors propose a stepwise reaction mechanism where a chiral Lewis 
acid activates the acrylate carbonyl toward conjugate addition by the indole, generating 
intermediate I-12.  Iminium ion trapping and enolate protonation then deliver cycloadducts exo-
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89 and endo-89, both with high enantioenrichment.  Notably, the reaction pathways to form exo-
89 and endo-89 operate on opposite faces of the indole, leading to opposite absolute 
stereochemistry at the carbons where the 5-membered rings are fused. 
 
Scheme 21.  (R)-BINOL/SnCl4 catalyzed formal cycloadditions of 2-amidoacrylates with indoles 
 A report from Chai discloses copper-catalyzed enantioselective cycloadditions of 2-aryl-
N-tosyl aziridines with indoles via kinetic resolutions of 2-aryl-N-tosylaziridines, generating 
enantioenriched pyrrolo[2, 3b]indoles.31  Copper(I) complexes of (R)-XylBINAP preferentially 
catalyzed the reaction of S-91 with indoles 90 to deliver pyrrolo[2, 3b]indoles 92 in up to 98% 
yield with >20:1 dr and up to 99% ee (Scheme 22).  The reaction scope encompassed a broad 
array of aziridines, and it was notable that aziridines with electron-deficient aryl groups reacted 
sluggishly to give low yields of cycloadducts. 
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Scheme 22.  Catalytic, enantioselective cycloadditions of N-tosylaziridines with indoles via 
kinetic resolution 
 Recent work demonstrates that chiral Lewis acids are effective as enantioselective 
catalysts in dearomative Diels-Alder reactions where arenes function as dienophiles.  Reports 
from the groups of Larianov32 and Wang33 disclose inverse electron-demand Diels-Alder 
reactions where heterodienes are generated in situ via dehydrohalogenation of heterodiene 
precursors.  Chiral Lewis acids control the approach of the aromatic dienophiles to the dienes, 
resulting in highly enantioenriched products (Scheme 23).  Larianov reported enantioselective 
Diels-Alder reactions between 1,3-dialkylsubstituted indoles 93 and transient nitrosoalkene 
species I-13, generated in situ from chlorooxime 94 (Scheme 23a).32  The reactions occurred in 
the presence of a complex generated from CuOTf and (DM)-BINAP 96 to afford cycloadducts 
95 in up to 85% yield, >20:1 dr, and up to 96% ee.  The authors report that the catalyst is very 
sensitive to the presence of chloride ions, necessitating the use of silver carbonate, which 
functions as a base and a sequestering agent for chloride ions generated by the 
dehydrohalogenation process.  A PBr3-catalyzed Beckman rearrangement of oxazine products 
97a and 97b proceeded smoothly to deliver pyrrolo[2, 3b]indoles 98a and 98b (Scheme 23b), 
providing an additional route to pyrroloindoline scaffolds.  Wang’s group demonstrated that 
azadienes I-14, generated in situ from hydrazones 100, reacted smoothly with 1,3-dialkyl 
substituted indoles 99 in the presence of Cu(I) and Phosferrox ligand 102 to deliver 
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terahydropyridazine products 102 in high yields with good enantio- and diastereoselectivity 
(Scheme 23c).33 
 
Scheme 23.  Lewis acid-catalyzed enantioselective dearomative Diels-Alder reactions with 
indole dienophiles 
 Yuan and coworkers recently reported organocatalyzed34 and chiral Lewis acid-
catalyzed35 cycloadditions of 3-isothiocyanatooxindoles 103 with 3-nitroindoles 104 to generate 
enantioenriched polycyclic spirooxindoles 105 (Table 2).  Organocatalyzed reactions of 103 with 
104 occurred in the presence of chiral bifunctional organocatalyst 106.  The authors propose that 
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the substrate-catalyst diastereomeric transition state that delivers enantioenrichment is achieved 
via a hydrogen bonding interaction between the thioamide N-H of 106 and the nitro-group of 
104.  This hydrogen-bonding interaction also activates the indole for the Michael addition of the 
enolate of 103 to the C2 position of the indole, which is followed by cyclization.  As shown in 
Table 2, the organocatalyzed process was extremely sensitive to the nature of the N-protecting 
groups of 103 and 104.  Reactions of 103 and 104 in the presence of Zn(OTf)2 and 
diphenylamine-linked-bisoxazoline ligand 107 were much less sensitive to the nature of the N-
protecting groups of 103 and 104, as this catalyst could deliver high diastereo- and 
enatnioselectivity with a broader array of substrates (Table 2).   
Table 2.  Comparison of organocatalyzed and Lewis-acid catalyzed cycloadditions of 3-
isothiocyanato oxindoles with 3-nitroindoles 
 
R4, R2 Conditions A Conditions B 
R4 = Ts, Bs; R2 = Me 82:18->99:1 dr, 59-96% ee 93:7-99:1 dr, 91-99% ee 
R4 = Ms, Ns, CBz, Boc, 
CO2Et,; R
2 = Me 
50:50-91:9 dr, 31-83% ee >99:1 dr, 98-99% ee 
R4 = Ts; R2 = Et, Bn, Ph 79:21-86:14 dr, 36-40% ee 85:15->99:1 dr, 92-98% ee 
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Enantioselective dearomative cycloadditions via cascade reactions involving allylic 
substitution 
 Dearomative cycloadditions via cascade reactions involving allylic substitution rely on 
the in situ formation of a species that contains an electrophilic metal-allyl functionality and a 
nucleophilic moiety. This species can react with a 2π-electron reaction partner in an 
asynchronous process.36  In 2014, the Trost group reported palladium-catalyzed 
trimethylenemethane (TMM) cycloadditions with nitroarenes (Scheme 24).37  Under the 
palladium-catalyzed conditions, the TMM unit generated in situ from silyl acetate 109 includes 
an electrophilic palladium allyl complex and a negatively charged nucleophilic site.36  
Phosphoramidite ligands 111-113 were suitable ligands for this transformation.  This method is 
notable in that it not only provides another means for catalytic, enantioselective dearomative 
Scheme 24.  Palladium-catalyzed trimethylenemethane cycloadditions with arenes           
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cyclopentannulations of indoles, it also overcomes the problem of rearomatization by the 
extrusion of nitrous acid, observed previously in TMM cycloadditions with nitroarenes.38   
 The You lab recently reported a dearomative cycloaddition cascade reaction involving 
the attack of cycloalkyl-fused indoles 114 on a palladium-allyl species generated from 2-
(hydroxymethyl)allyl methyl carbonate 115  to form tetracyclic products 116 (Scheme 25).39  
Indoles with fused cyclopentane rings reacted smoothly at room temperature in the presence of a 
Pd0 catalyst and ligand 117 to yield tetracyclic products 116a in 75-99% yield and 92-97% ee 
Scheme 25.  Palladium-catalyzed cycloadditions of 2-(hydroxymethyl)allyl methyl carbonates 
with indoles 
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(Scheme 25a).  Reactions of 5-Ph substituted and 4,6-Me2-substituted indoles 114  required 
higher temperatures and less sterically congested ligand 118 to deliver acceptable yields and 
enantioselectivities in products 116b (Scheme 25b).  In addition to higher temperatures, the 
reactions of indoles 114 bearing fused cyclohexane rings required higher catalyst loading to 
deliver products 116c (Scheme 25c). 
Enantioselective dearomative cycloadditions catalyzed by chiral phosphoric acids 
 Chiral phosphoric acids have the advantages of stability in the presence of oxygen and 
water, long term stability, and convenience due to the fact that they are single component 
catalysts.40  In addition, most chiral phosphoric acids have pKa values between 2 and 4,
41 
allowing facile protonation of substrates and the formation of tight ion pairs with substrates.  
These advantages make them promising as catalysts in enantioselective dearomative 
cycloadditions.   
In 2013 Zhu and Sun reported catalytic, asymmetric, multi-component aza-Diels Alder 
reactions with indole dienophiles in the presence of a chiral phosphoric acid catalyst to deliver 
complex polycyclic indoles (Scheme 26).42  Aryl aldehydes 121 and anilines 122 condensed to 
form arylidenealdehydes that functioned as aza-dienes in Diels-Alder reactions with indoles 120 
(see T-2 in Scheme 26) in the presence of chiral phosphoric acid 124.  Given the good 
performance of ethers as directing groups in previously reported enantioselective chiral 
phosphoric acid-catalyzed reactions,43 the authors placed various ethers at the ortho-position of 
arenes 121.  Simple alkyl ethers allowed the reaction to take place efficiently to deliver products 
123a in high yields but with low enantioenrichment (Scheme 26a).  However, an oxetane group 
in the ortho-position led to the formation of products 123b with good-to-excellent 
enantioselectivities through a pathway that included oxetane desymmetrization.  In addition, the 
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importance of the free indole N-H was clear: when the reaction was run with a protected indole 
nitrogen, the yield was less than 20%.  This reaction is notable in that it sets four stereocenters 
with high enantioenrichment. 
 
Scheme 26.  Chiral phosphoric acid-catalyzed multi-component dearomative aza-Diels-Alder 
reactions with indole dienophiles 
 Zhang and coworkers reported enantioselective [3+2] couplings of quinone monoacetals 
and quinone monoimines with indoles in the presence of chiral phosphoric acid catalysts.44  After 
initial attempts with Lewis acids delivered low yields and no enantioselectivity, they discovered 
that chiral phosphoric acid 128 catalyzed the coupling of 3-methylindole 125 with quinone 
monoacetal 126 to furnish benzofuro[2, 3b]indole 127 in 72% yield and 33% ee (Scheme 27a).44a  
Reactions of quinone monimines 130 with indoles 129 in the presence of the catalyst delivered 
annulated indole products 131 with yields and enantioselectivities of up to 99% (Scheme 27b).44b  
It should be noted that a methyl group ortho to the imine moiety in monoimine 130 resulted in no 
reaction in the presence of the catalyst, and the reaction carried out with N-Boc or N-Cbz 
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substituted imines led only to decomposition of the imines and no desired reaction, leaving areas 
for further development of this chemistry.   
 
Scheme 27.  Chiral phosphoric acid-catalyzed cyclizations of quinone monoacetals and quinone 
monoimines with indoles 
Enantioselective dearomative cycloadditions via iminium ion catalysis 
 Catalysts bearing chiral amine moieties are ubiquitous as alternatives to metal catalysts in 
enantioselective transformations.45  You and coworkers developed asymmetric, dearomative 
formal [4+2] cycloadditions of 2,3-disubstituted indoles with methyl vinyl ketone catalyzed by a 
quinine-based primary amine catalyst (Scheme 28).46  Methyl vinyl ketone 133 interacts with 
amine catalyst 135 to form an α,β-unsaturated iminum ion, which is attacked from the 3-position 
of indoles 132, forming cationic intermediate I-15 (Scheme 28a).  The enamine formed 
undergoes ring closure, followed by hydrolysis.  After conjugate addition of a second equivalent 
of methyl vinyl ketone 133 by the indoline N-H, the reaction affords products 134 in up to 98% 
yield and 98% ee (Scheme 28a).  Oxidation with PDC to the amide, followed by dithiol 
protection of the carbonyls, hydrolysis and global deprotection provided free indole N-H product 
138 with perfect enantioretention (Scheme 28b).  
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Scheme 28.  Organocatalytic enantioselective formal [4+2] cycloaddition of 2,3-disubstituted 
indoles with methyl vinyl ketone 
Jørgensen and coworkers recently reported enantioselective formal [4+2] cycloadditions 
via enamine catalysis.47  Dienals 140 condense with the pyrrolidine N-H of catalyst 142 to form  
trienamine species that react with nitroarenes 139 as shown in transition state T-3 (Scheme 29).  
Transition state T-3 leads to intermediate I-16, which undergoes base-promoted denitration, 
followed by hydrolysis to deliver products 141 in 51-87% yield and 49-90% ee.  Notably, 
reactions of 6-substituted dienals with arenes under these conditions result in very high 
enantioenrichment (Scheme 29, bottom).  The authors propose that the catalyst plays three roles 
in the reaction: 1) hydrogen bonding with the nitro group to lower the LUMO of the indole C2-
C3; 2) control of facial selectivity, and 3) assisting in the base-promoted dinitration process.  The 
reaction with 3-nitrobenzothiophene dienophiles under these conditions is exceptional, as 
dienophiles of this type have previously required temperatures of up to 180 °C in order to react.48 
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Scheme 29.  Catalytic, enantioselective, Diels-Alder reactions with indole dipolarophiles via 
trienamine catalysis 
Enantioselective dearomative cycloadditions: conclusions and outlook 
 Although many robust methods for catalytic, enantioselective dearomative cycloadditions 
have been reported, this region of chemical space remains open for further exploration.  
Currently, most arenes employed as 2 π-electron partners in catalytic, enantioselective 
dearomative cycloadditions are heteroarenes, which have lower aromatic stabilization energies 
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relative to benzene.49  Cycloadditions involving non-heteroarenes as 2 π-electron partners remain 
a challenge. 
 Another problem that remains to be solved is that currently, there exists no catalytic 
system in the realm of catalytic, dearomative cycloadditions that encompasses an arene scope 
containing both electron-poor and electron-rich 2 π-electron aromatic partners.  Currently, every 
reported method either employs 2 π-electron partners with solely electron-donating groups or 
solely electron-withdrawing groups.  Additionally, although there are reports of racemic 
dearomative cycloadditions betaine dipoles with arenes,50 there exist no reports of catalytic, 
enantioselective reactions of these highly reactive dipoles with arenes. 
 To date, the field of catalytic, enantioselective cycloadditions with arenes as 2 π-electron 
partners is still in its infancy.  Catalytic, enantioselective, dearomative cycloadditions offer the 
potential to construct polycyclic systems in a streamlined and elegant fashion, and thus, these 
reactions will continue to attract much investigation in the years to come. 
Thesis Organization 
 This thesis is comprised of 5 chapters.  Chapter 1 is a review of catalytic, 
enantioselective, dearomative cycloadditions where arenes and heteroarenes are 2 π-electron 
partners.  Chapter 2 is a modification of an article published in Organic Chemistry Frontiers in 
2016.  It discloses the first example of catalytic, enantioselective, dearomative cycloadditions of 
stabilized α-substituted azomethine ylides (derived from imino esters of α-substituted amino 
acids) with 3-nitroindoles to furnish pyrrolo[3, 4b] indoles in high yield, enantioselectivity, and 
diastereoselectivity.  Dr. Arkady Ellern, crystallographer in the Iowa State University 
Department of Chemistry, collected the data for the crystal structure reported.  The author of this 
thesis was responsible for the remainder of the research discussed.  Chapter 3 is a modification 
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of an article published in Organic and Biomolecular Chemistry in 2013.  In this manuscript, 
catalytic, enantioselective cycloadditions of nitrile imines with methyleneindolinines are 
explored.  These reactions were catalyzed by a magnesium-bisoxazoline complex and delivered 
spiro[pyrazolin-3,3′-oxindoles] in high yield and enantioenrichment.  Kelsie Pugh, an 
undergraduate in the Stanley lab at the time, was responsible for a portion of the synthesis of 
methyleneindolinones and the purification of a portion of the spiro[pyrazolin-3,3′-oxindoles].  
Dr. Michael Slade, a postdoctoral fellow in the Stanley lab at the time, was responsible for the 
synthesis of dipoles and the testing of these dipoles in the reaction, as well as the dipole 
competition reactions.  Dr. Arkady Ellern, crystallographer in the Iowa State University 
Department of Chemistry, collected the data for the crystal structure reported.  The author of this 
thesis was responsible for methyleneindolinone synthesis, ligand synthesis, screening of 
conditions, the dipolarophile scope, and the dipolarophile competition reactions.  Chapter 4 is a 
manuscript that has been submitted for publication in Tetrahedron Letters.  It discusses the first 
example of palladium-catalyzed conjugate additions of arylboronic acids to 2-substituted 
chromones.  The reaction described occurs in aqueous medium overcomes competing 
protodeboronation and biaryl forming reactions to deliver substituted flavanones in up to 90% 
yield.  The author of this thesis was responsible for the entirety of the research disclosed.  
Chapter 5 is a summary of the key conclusions drawn from each of the other chapters. 
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CHAPTER 2 
ENANTIOSELECTIVE DEAROMATIVE [3+2] CYCLOADDITIONS OF INDOLES WITH 
AZOMETHINE YLIDES DERIVED FROM ALANINE IMINO ESTERS 
Modified from a paper published in Organic Chemistry Frontiersa 
Anthony L. Gerten and Levi M. Stanley* 
Abstract 
Catalytic, enantioselective [3 + 2] cycloadditions of azomethine ylides derived from 
alanine imino esters with 3-nitroindoles are reported. The dearomative cycloaddition reactions 
occur in the presence of a catalyst generated in situ from Cu(OTf)2 and (R)-Difluorphos to 
form exo′-pyrroloindoline cycloadducts and establish four contiguous stereogenic centers, two of 
which are fully substituted. The exo′-pyrroloindoline products are formed in moderate-to-good 
yields (39–85%) with high diastereoselectivities (up to 98 : 1 : 1 dr) and enantioselectivities (up 
to 96% ee). 
Introduction 
The development of dearomatization reactions offers the potential to rapidly generate 
molecular complexity and new molecular frameworks.1  In recent years, [2+2],2 [3+2],3 [4+2],4 
and [5+2]5 dearomative cycloadditions have emerged as promising strategies to construct 
polycyclic carbocycles and heterocycles from arenes and heteroarenes.  Despite the steady 
development of new dearomative cycloaddition reactions, examples of catalytic, enantioselective 
dearomative cycloadditions are rare.2b,3b,3c,3f,3i   
Among the promising classes of dearomative cycloadditions for further development are 
intermolecular [3+2] cycloadditions of nitrogen-containing 1,3-dipoles with arenes and 
heteroarenes.  In particular, cycloadditions of azomethine ylides with arenes and heteroarenes 
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have emerged as a viable approach to generate polycyclic nitrogen heterocycles.6  Gribble and 
co-workers initially reported cycloadditions of unstabilized azomethine ylides with 2- and 3-
nitroindoles to form racemic pyrroloindolines.7  More recently, Chatainger, Piettre, and co-
workers showed that cycloadditions of unstabilized azomethine ylides with electron-deficient 
arenes and heteroarenes form a wide variety of racemic, polycyclic cycloadducts in good-to-
excellent yields.8 
We initially discovered reactivity with glycine-derived iminoesters (Scheme 1a). 
However, during the course of our studies, Awata and Arai reported the first catalytic, 
enantioselective dearomative cycloadditions of stabilized azomethine ylides with 3-nitroindoles 
Scheme 1.  Enantioselective cycloadditions of glycine and alanine-derived azomethine 
ylides with 3-nitroindoles 
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(Scheme 1b).9  Cycloadditions of a wide range of azomethine ylides derived from glycine imino 
esters occur with excellent enantioselectivity and nearly perfect exo´-selectivity when reactions 
are run in the presence of a complex prepared from Cu(OTf)2 and a chiral PyBidine ligand.  
However, catalytic, enantioselective dearomative cycloadditions of azomethine ylides derived 
from alanine iminoesters have not been reported.  Herein, we report the first examples of 
diastereo- and enantioselective dearomative cycloadditions of alanine-derived azomethine ylides 
with 3-nitroindoles.  These reactions generate pyrroloindolines with four contiguous stereogenic 
centers, two of which are fully substituted (Scheme 1c).  
Enantioselective dearomative [3+2] cycloadditions of indoles with azomethine ylides 
derived from alanine imino esters: identification of reaction conditions 
To identify a diastereo- and enantioselective catalyst for dearomative cycloadditions of 
alanine-derived azomethine ylides, we evaluated the model reaction of N-tosyl-3-nitroindole 1a 
with racemic 2a (Table 1).  Initially, we found that Lewis acid complexes of chiral bisphosphine 
ligands (R)-BINAP, (R)-Segphos, (R)-Difluorphos (10 mol%) catalyzed the cycloadditions of 1a 
with 2a.  These reactions formed a diastereomeric mixture of cycloadducts 3a with exo´-3a 
generated as the major diastereomer (entries 1-4).  The reaction of 1a with 2a occurred with the 
highest diastereoselectivity (93 : 3 : 4 exo´-3a : exo-3a : endo-3a) with the copper(II) triflate 
complex of (R)-Difluorphos as catalyst (entry 4).10  The cycloadduct exo´-3a was isolated in 73% 
yield with 86% ee.  The high enantioselectivity and diastereoselectivity observed for the model 
reaction led us to explore additional reaction parameters using the combination of Cu(OTf)2 and 
(R)-Difluorphos as catalyst. 
By lowering the reaction temperature to 0 °C and -20 °C, we observed higher 
enantioselectivity for exo´-3a (92-93% ee) with lower diastereoselectivity (entries 5 and 6).  For  
40 
 
 
example, the reaction of 1a with 2a forms a 41 : 15 : 44 mixture of exo´: exo : endo  
diastereomers when the reaction is carried out at -20°C.  The endo selectivity of the reaction 
carried out at -20 °C led us to postulate that the model cycloaddition is endo-selective, but 
epimerization of endo-3a to exo´-3a occurs at higher temperatures through a retro-
Mannich/Mannich addition pathway and leads to the observed exo´-selectivity.11 
Entry Ligand Temp 
(°C) 
Equiv. 
2a 
dr (exo´:exo:endo) Yield (exo´-
3a) (%) 
ee 
(exo´-3a) 
(%)  
1a L1 rt 1.0 52:9:39 37 29 
2 L1 rt 1.0 66:13:21 39 64 
3 L2 rt 1.0 79:9:12 60 82 
4 L3 rt 1.0 93:3:4 73 86 
5 L3 0 1.0 73:9:18 51 92 
6 L3 -20 1.0 41:15:44 34 93 
7 L3 rt 1.0 71:11:18 58 76 
8 L3 rt 1.2 93:3:4 75 89 
9 L3 rt 1.5 92:3:5 78 88 
10 L3 rt 2.0 92:3:5 72 90 
aAgClO4 used instead of Cu(OTf)2, and NEt3 used as base instead of DBU. 
 
Table 1.  Identification of catalysts and reaction conditions for the cycloaddition of 1a and 2a.   
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Lowering the loading of the copper catalyst also proved detrimental to the diastereo- and 
enantioselectivity of the model reaction.  The reaction of 1a with 2a in the presence of 5 mol%  
of the copper catalyst formed 3a as a 71 : 11 : 18 mixture of exo´: exo : endo diastereomers with 
exo´-3a isolated in 76% ee (entry 7).  The decrease in enantioselectivity and diastereoselectivity 
observed at lower catalyst loading suggests: (1) the rate of uncatalyzed background reaction is 
likely competitive with the rate of the catalyzed process; and (2) the copper complex may 
catalyze the epimerization of endo-3a to exo´-3a. 
Varying the concentration of iminoester 2a has minimal impact on the yield and 
selectivity of the model reaction (compare entries 4 and 8-10).  The diastereoselectivity remains 
essentially unchanged when varying the amounts of imino ester 2a from 1.0-2.0 equivalents.  
However, a slight excess (1.2 equivalents, entry 8) of 2a leads to a modest increase in 
enantioselectivity, but this trend does not hold when the concentration of 2a is further increased 
(entries 9 and 10). 
To develop a better understanding of the rates of the catalyzed reaction and the 
uncatalyzed reaction and the evolution of diastereoselectivity over time, we conducted 
cycloadditions of 1a and 2a in the presence and absence of copper catalyst and monitored the 
yield and diastereoselectivity over time (Table 2).  The catalyzed reaction of 1a with 2a occurs to 
approximately 90% conversion after 2 h (entry 1) and is complete after 6 h (entry 3), while the 
uncatalyzed reaction occurs to approximately 50% and 80% conversion over the same time 
periods (entries 2 and 4).  Although the uncatalyzed background reaction is slower than the 
catalyzed process, this data shows that the rate of uncatalyzed cycloaddition is sufficient to 
negativiely impact the enantioselectivity of the cycloadditions and likely explains the poor 
enantioselectivity observed when the catalyst loading is lowered. 
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Entry Cu(II) 
catalyst 
Time (h) dr 
(exo´:exo:endo) 
NMR Yield 
(%)a 
ee (exo´-3b) 
(%) 
1 Yes 2 69:5:26 84 (91) 87 
2 No 2 59:6:35 49 (52) -- 
3 Yes 6 77:9:14 99 (99) 90 
4 No 6 60:10:30 78 (82) -- 
5 Yes 16 93:3:4 99 (99) 89 
Table 2.  Evolution of Stereoselectivity in Catalyzed versus Uncatalyzed Reactions of 1a with 2b  
aDetermined by 1H NMR spectroscopy of the crude reaction mixture using dibromomethane as 
the internal standard.  Conversion of 1a is listed in parentheses. 
 
The evolution of diastereoselectivity over time is greatly influenced by the presence or 
absence of the copper catalyst.  The uncatalyzed model reaction forms a 59 : 6 : 35 ratio of exo´: 
exo : endo diastereomers after 2 h, and this ratio does not change significantly over an additional 
4 h (Table 2, entries 2 and 4).  In contrast, the diastereoselectivity of the copper-catalyzed 
cycloaddition changes markedly with reaction time.  The catalyzed reaction forms a 69 : 5 : 26 
ratio of exo´: exo : endo diastereomers after 2 h (entry 1); a ratio that is similar to that observed 
in the uncatalyzed reaction.  However, the diastereomeric ratio improves to 77 : 9 : 14 (entry 3) 
after 6 h and to 93 : 3 : 4 (entry 5) after 16 h.  The dramatic decrease in the amount of endo-3a 
and increase in the amount of exo´-3a indicates that the complex generated from Cu(OTf)2 and 
L3 catalyzes the epimerization of endo-3a to exo´-3a which leads to high exo´ selectivity of the 
cycloaddition reaction. 
 
Enantioselective dearomative [3+2] cycloadditions of indoles with azomethine ylides 
derived from alanine imino esters: scope of alanine-derived imino esters 
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With a practical set of reaction conditions and a diastereoselective and enantioselective 
catalyst identified, we evaluated cycloadditions of N-tosyl-3-nitroindole 1a with a variety of 
iminoesters 2b-2l derived from alanine methyl ester and an array of aromatic aldehydes.  Results 
of these reactions are summarized in Table 3. In general, cycloadditions of 1a with imino esters 
containing 4-substitutued aryl groups occur to form exo´-3 in >70% yield with >90% ee and 
greater than 90 : 7 : 3 exo´: exo : endo diastereoselectivity (entries 1-5).  The notable exceptions 
to these typical yields and selectivities include the reactions of imino esters 2b (Ar = 4-F3CC6H4) 
and 2c (Ar = 4-ClC6H4).  The cycloaddition of 2b with 1a occurs in high yield with excellent 
diastereoselectivity (entry 1).  However, exo´-3b is isolated with 80% ee, possibly due to a faster 
rate of uncatalyzed background reaction with an azomethine ylide containing an electron-
withdrawing 4-trifluoromethyl group on the arene moiety.  This hypothesis is supported by a 
positive correlation between enantioselectivity of the reaction and increasing electron-donating 
ability of the substituents at the 4-position on the aryl ring of the dipoles.  The cycloaddition of 
2c with 1a forms exo´-3c in 70% yield with 88% ee, but the reaction occurs with modest 
diastereoselectivity (entry 2).  Notably, the reaction of electron-rich imino ester 2g, containing a 
3,4,5-trimethoxyphenyl moiety, with 1a affords 3g  in only 32% ee (entry 6). This result suggests 
that the azomethine ylide generated from imino ester 2g binds very tightly to the copper catalyst. 
A tightly bound copper catalyst slows catalytic turnover and allows the racemic background 
reaction to become more competitive with the catalyzed process. 
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Entry rac-2 (Ar) exo´-3 dr 
(exo´:exo:endo) 
Yield exo´-3 
(%) 
ee exo´-3 
(%) 
1 2b (4-F3CC6H4) 3b >98:1:1 83 80 
2 2c (4-ClC6H4) 3c 78:5:17 70 88 
3 2d (4-BrC6H4) 3d 95:4:1 78 90 
4 2e (4-H3CC6H4) 3e 90:7:3 76 91 
5 2f (4-MeOC6H4) 3f 95:4:1 71 96 
6 2g (3,4,5-MeOC6H4) 3g 65:13:22 39 32 
7 2h (3-MeOC6H4) 3h 89:8:3 72 89 
8 2i (3-BrC6H4) 3i 69:8:23 40 80 
9 2j (2-MeOC6H4) 3j 74:7:19 39 82 
10 2k (2-FC6H4) 3k 67:5:27 51 87 
11 2l (2-ClC6H4) 3l 88:8:4 85 79 
 
Cycloadditions of imino esters 2h-2l containing 2- and 3-substituted aryl groups with 1a 
generally occur with slightly lower yields and selectivities (entries 7-11) than imino esters 2b-2f.  
While the cycloaddition of 3-MeO-substituted imino ester 2h occurs to form exo´-3h in high 
yield with high diastereo- and enantioselectivity (entry 7), the cycloaddition of 3-Br-substituted 
imino ester 2i formed exo´-3i in only 40% yield with modest diastereoselectivity, likely due to a 
relatively slow epimerization of endo-3i to exo´-3i, and slightly lower enantioselectivity (entry 
8).  Cycloadditions of 2-MeO-, 2-F, and 2-Cl-substituted imino esters 2j-l formed exo´-3j-l in 
39-85% yield with 79-87% ee and with diastereoselectivities ranging from 67 : 5 : 27 to 88 : 8 : 4 
exo´: exo : endo (entries 9-11). 
The absolute configuration of exo´-3f was determined after treatment with HBr to form 
exo´-3f·HBr in >99% yield (Scheme 2).  The absolute configuration of exo´-3f·HBr was 
determined to be (1S, 3R, 3aS, 8bS) by X-ray crystallographic analysis. 
Table 3.  Scope of dearomative cycloadditions of indole 1a with iminoesters 2b-l 
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Scheme 2.  Determination of the absolute stereochemistry of exo´-3f. 
 
Enantioselective dearomative [3+2] cycloadditions of indoles with azomethine ylides 
derived from alanine imino esters: additional substrate scope 
Although our studies focused on reactions of N-tosyl-3-nitroindole 1a with imino esters 
derived from alanine methyl ester, we have also demonstrated that cycloadditions involving an 
imino ester derived from alanine isopropyl ester and N-tosyl-5-bromo-3-nitroindole occur in high 
yields with excellent stereoselectivity (Table 4, entry 1, Scheme 3).  For example, the reaction of 
N-tosyl-3-nitroindole 1a with imino ester 2m derived from alanine isopropyl ester occurs with 
93 : 7 exo´: exo diastereoselectivity and forms pyrroloindoline exo´-3m in 71% yield with 94% 
ee (Table 4, entry 1).  The endo diastereomer was not observed after the 18 h reaction time. 
However, reactions of phenylalanine-derived 2n and leucine-derived 2o with 1a in the presence 
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of the catalyst resulted in lower enantio- and diastereoselectivity.  These reactions delivered 
exo´-3n in 67% yield, 48 : 25 : 27 exo´ : exo : endo diastereomeric ratio and 36% ee, and exo´-3o 
in 71% yield, 72 : 19 : 9 exo´ : exo : endo diastereomeric ratio and 30% ee (entries 2-3).  In these 
cases, it is likely that increased steric bulk lowers the binding constant of the catalyst to the 
imino ester, allowing for a competitive racemic background reaction.  The cycloaddition of 
imino ester 2a with N-tosyl-5-bromo-3-nitroindole 1b occurs with nearly perfect exo´ selectivity 
(>98 : 1 : 1 exo´ : exo : endo, Scheme 3).  Pyrroloindoline exo´-3p was isolated in 79% yield and 
91% ee. 
Table 2.  Dearomative cycloadditions of 1a with imino esters 2m-o   
 
Entry rac-2 (R1, R2) exo´-3 dr 
(exo´:exo:endo) 
Yield exo´-3 
(%) 
ee exo´-3 
(%) 
1 2m (R1=Me, R2=i-Pr) 3m 93:7:0 71 94 
2 2n (R1=Bn, R2=Me) 3n 48:25:27 67a 36 
3 2o (R1=i-Bu, R2=Me) 3o 72:19:9 71b 30 
a 
 Isolated in 46 : 24 : 30 exo : exo : endo diastereomeric ratio. b Isolated in 75 : 20 : 0 exo : exo : 
endo ratio. 
 
 
Scheme 3.  Reaction of 1b with rac-2a 
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Enantioselective dearomative [3+2] cycloadditions of indoles with azomethine ylides 
derived from alanine imino esters: effects of single enantiomer dipoles on reaction 
outcomes 
 To our knowledge, no experiment has been carried out to determine whether or not single 
enantiomer α-substituted imino esters with opposite absolute stereochemistry react differently 
with dipolarophiles in the presence of the same single enantiomer catalyst in azomethine ylide 
cycloadditions.  The dearth of information available on this topic prompted us to subject single 
enantiomer imino esters to our reaction conditions to determine whether or not the starting 
absolute stereochemistry of the imino ester impacts the yield, enantioselectivity, and 
diastereoselectivity of the reaction.  Interestingly, D-2a and DL-2a reacted similarly with 1a in the 
presence of the copper catalyst to deliver exo´-3a with high yield, diastereoselectivity, and 
enantioselectivity (Table 5, entries 2-3).  However, the reaction of L-2a with 1a in the presence 
of the catalyst afforded exo´-3a with 93:3:4 exo´: exo : endo selectivity and 80% yield, but only 
58% ee (entry 1). The differences in enantioselectivity depending on the absolute 
stereochemistry of the dipole may arise from differences in equilibrium between each enantiomer 
of the iminoester and metallodipole I-1 (Scheme 4).  When iminoester D-2a is subjected to the 
reaction conditions, it is likely that the equilibrium between the iminoester and metallodipole I-1 
lies in favor of the metallodipole, and the majority of the iminoester thus moves through the 
catalyzed pathway, resulting in high enantioenrichment in exo'-3a.  In the case of L-2a, the 
equilibrium between the iminoester and metallodipole I-1 lies in favor of the iminoester, and the 
racemic background reaction thus becomes competitive with the catalyzed process, leading to 
lower enantioselectivity in exo'-3a.  The high enantioselectivity in the reaction of DL-2a with 1a 
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could be the result of a positive nonlinear effect or the involvement of already formed 
enantioenriched product as part of the active catalytic species.12 
Table 5.  Effects of Dipole 2a Stereochemistry on Reaction Outcomes 
 
Entry 
2a 
Configuration 
dr 
(exo´:exo:endo) 
Yield (%) % ee (exo') 
1 L 93:3:4 80 58 
2 D 94:4:1 72 82 
3 DL 93:3:4 75 89 
 
 
 
Scheme 4.  Possible pathways for formation of exo´-3a from D-2a and L-2a 
   
Enantioselective dearomative [3+2] cycloadditions of indoles with azomethine ylides 
derived from alanine imino esters: conclusion 
In summary, we have developed the first catalytic, enantioselective dearomative 
cycloadditions of alanine-derived imino esters with 3-nitroindoles.  These exo´-selective 
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dearomative cycloadditions form a variety of highly enantioenriched pyrroloindolines with four 
contiguous stereogenic centers, two of which are fully substituted, when the reactions are 
conducted in the presence of a catalyst generated from Cu(OTf)2 and (R)-Difluorphos.  The high 
diastereoselectivities observed favoring the formation of the exo´-cycloadduct result from a 
Cu(OTf)2/(R)-Difluorphos-catalyzed epimerization of the endo-cycloadduct to the exo´-
cycloadduct during the course of the reaction.  Studies to develop new catalytic, enantioselective 
dearomative cycloadditions with additional classes of aromatic and heterearomatic 
dipolarophiles are ongoing in our laboratory. 
Experimental details 
General experimental details 
All air-sensitive procedures were conducted under inert atmosphere in a nitrogen-filled 
dry box or by standard Schlenk techniques. All reactions were performed under an atmosphere of 
nitrogen unless otherwise stated. All glassware for moisture sensitive reactions was dried at 140 
°C in an oven. THF and CH2Cl2 were degassed by purging with argon for 45 minutes and dried 
with a solvent purification system by passing through a one-meter column of activated alumina. 
Flash column chromatography was performed on Fisher brand silica gel 60 (230-400 mesh) or 
Silicylce Siala-P silica gel or on a Teledyne Isco CombiFlash Rf automated chromatography 
system with RediSep Rf Gold normal-phase silica columns.  Products of reactions were 
visualized on TLC plates under UV light. 
HRMS (ESI) analysis was performed at the Iowa State University Chemical 
Instrumentation Facility on an Agilent 6540 QTOF spectrometer. Optical rotations were 
measured on an Atago AP-300 automatic polarimeter. HPLC analyses were carried out on a 
Water Alliance HPLC system with an e2695 Separations Module and a 2489 (UV/Vis) dual 
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wavelength detector. NMR spectra were acquired on Varian MR-400 and Bruker Avance III 600 
spectrometers at the Iowa State University Chemical Instrumentation Facility. 1H and 13C NMR 
chemical shifts are reported in ppm relative to residual CHCl3 in CDCl3 (7.26 ppm for 
1H and 
77.23 ppm for 13C). 19F NMR shifts are reported in ppm relative to trifluoroacetic acid as an 
external standard (F3CCO2H = -76.55 ppm). 
Materials 
Benzaldehyde, 4-chlorobenzaldehyde, 4-methylbenzaldehyde, 4-methoxybenzaldehyde, 
3-methoxybenzaldehyde, 2-methoxybenzaldehyde, 2-chlorobenzaldehyde, 3,4,5-
trimethoxybenzaldehyde and DL-phenylalanine were purchased from Sigma-Aldrich and used 
without further purification. 4-Trifluoromethylbenzaldehyde, 4-bromobenzaldehyde, 3-
bromobenzaldehyde, and 2-fluorobenzaldehyde were purchased from Oakwood Chemical 
Company and used without further purification. DL-alanine, D-alanine methyl ester hydrochloride, 
L-alanine methyl ester hydrochloride, and DL-leucine were purchased from AK Scientific and 
used without further purification. Amino acid methyl ester hydrochlorides were prepared by 
bubbling HCl gas through a methanolic solution of the amino acid followed by removal of the 
volatiles under reduced pressure to furnish the amine hydrochloride.  DL-alanine isopropyl ester 
hydrochloride was prepared by bubbling HCl gas through a solution of DL-alanine in isopropanol 
followed by removal of the volatiles under reduced pressure to furnish the required amine 
hydrochloride.  Tosyl chloride and indole were purchased from Sigma-Aldrich and used without 
further purification.  5-bromoindole was purchased from Frontier Scientific and used without 
further purification. 5-Bromo-N-tosylindole was prepared according to a literature procedure.13 
3-Nitro-N-tosylindole 1a was prepared according to a literature procedure.14  Cu(OTf)2, rac-
BINAP, (R)-BINAP (2,2’-bis(diphenylphosphino)-1,1’-binaphthalene), (R)-segphos ((R)-(+)-
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5,5´-Bis(diphenylphosphino)-4,4´ -bi-1,3-benzodioxole), and (R)-Difluorphos ((R)-(-)-5,5’-
Bis(diphenylphosphino)-2,2,2´,2´-tetrafluoro-4,4´-bi-1,3-benzodioxole) were purchased from 
Strem Chemicals and used without further purification. 
 
Synthesis of 5-bromo-3-nitro-N-tosylindole 1b9,15 
 
 
5-Bromo-N-tosylindole (2.30 g, 6.57 mmol, 1.00 equiv) was added to a round bottom 
flask and suspended in 32 ml of acetic anhydride.  A solution of 1.3 mL of 70% nitric acid and 
13 mL of acetic anhydride was added dropwise over 30 minutes to the suspension of 5-bromo-3-
nitroindole at -78 °C.  The solution was warmed to 0 °C and maintained at this temperature for 4 
h.  The reaction was quenched with water and extracted with dichloromethane (3x).  The 
combined organic layer was washed with brine.  The organic layer was dried over MgSO4, 
filtered, and concentrated under reduced pressure to yield crude 5-bromo-3-nitro-N-tosylindole 
1b.  Crude 1b  was recrystallized fr om 1:1 hexane:dichloromethane to yield 5-bromo-3-nitro-1-
tosylindole 1b (1.35 g, 3.41 mmol, 52%). 1H NMR (CDCl3, 600 MHz) δ 2.41 (s, 3H), 7.34(d, J 
= 8.0 Hz, 2H), 7.57 (dd, J = 9.0, 1.4 Hz, 1H), 7.83-7.90 (m, 3H), 8.40 (d, J = 1.4 Hz, 1H), 8.54 
(s, 1H) 13C NMR (CDCl3, 151 MHz) δ 22.0, 115.3, 120.1, 123.5, 124.2, 127.66, 127.67, 128.8, 
130.2, 130.9, 132.5, 133.8, 147.3. 
General procedure for synthesis of imino esters rac-2a-f, rac-2h-o  
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To a suspension of DL-amino acid methyl ester hydrochloride or DL-alanine isopropyl 
ester hydrochloride (1.2 equiv), sodium carbonate (1.5 equiv), and a small amount of magnesium 
sulfate in methanol (0.36 M solution with respect to the amine hydrochloride) was added the 
appropriate aldehyde (1 equiv).  The reaction mixture was stirred for 12 h at room temperature.  
The reaction mixture was then filtered through celite into a separatory funnel.  The mixture was 
extracted into diethyl ether.  The ether layer was washed with water (2x) and brine (2x).  The 
organic layer was dried over magnesium sulfate, filtered, and concentrated under reduced 
pressure to afford imino esters rac-2a-2o, which were used without further purification.  NMR 
spectra match reported NMR data for known imino esters 2a,16 2b,17 2c,16 2d,17 2e,17 2f,17 2j,18 
2k,17 2l,19 2m,19-20 2n,16 and 2o.16 
Methyl (E)-2-((3-methoxybenzylidene)amino)propanoate (rac-2h): 
Prepared according to the general procedure from DL-alanine methyl ester 
hydrochloride (1.00 g, 7.17 mmol) and 3-methoxybenzaldehyde (0.72 mL, 5.9 
mmol) to yield rac-2h as a yellow oil in 87% yield (1.13 g, 5.12 mmol).  1H 
NMR (CDCl3, 600 MHz) δ 1.52 (d, J = 6.8 Hz, 3H), 3.72 (s, 3H), 3.81 (s, 3H), 
4.14 (q, J = 6.8 Hz, 1H), 6.97 (d, J = 7.8 Hz, 1H), 7.24-7.33 (m, 2H), 7.37 (s, 1H), 8.26 (s, 1H) 
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13C NMR (CDCl3, 151 MHz) δ 19.4, 52.1, 55.3, 67.9, 111.9, 117.9, 121.8, 129.5, 137.2, 159.9, 
162.9, 172.9. HRMS (ESI) calcd. for C12H16NO3
+ [M+H]+ 222.1125, found 222.1130. 
 
Methyl (E)-2-((3-bromobenzylidene)amino)propanoate (rac-2i): Prepared 
according to the general procedure from DL-alanine methyl ester hydrochloride 
(1.00 g, 7.17 mmol) and 3-bromobenzaldehyde (0.70 mL, 6.0 mmol) to yield rac-
2i as a yellow oil in 91% yield (1.46 g, 5.40 mmol). 1H NMR (CDCl3, 600 MHz) 
δ 1.56 (d, J = 6.8 Hz, 3H), 3.78 (s, 3H), 4.20 (q, J = 6.8 Hz, 1H), 7.31 (dd, J = 
7.6, 7.2 Hz, 1H), 7.58 (d, J = 7.6 Hz, 1H), 7.67 (d, J = 7.2 Hz, 1H), 8.00 (s, 1H), 8.28 (s, 1H).  
13C NMR (CDCl3, 151 MHz)  δ 19.6, 52.5, 68.0, 123.1, 127.5, 130.3, 131.1, 134.2, 137.8, 161.6, 
172.9.  HRMS (ESI) calcd. for C11H13BrNO2
+ [M+H]+ 270.0124, found 270.0126. 
Synthesis of Methyl (E)-2-((3,4,5-trimethoxybenzylidene)amino)propanoate rac-2g 
 
To a suspension of 3,4,5-trimethoxybenzaldehyde (1.00 g, 5.09 mmol, 1 equiv) and DL-
alanine methyl ester hydrochloride (0.854 g, 6.12 mmol, 1.2 equiv) in CH2Cl2 (10.75 ml) was 
added triethylamine (0.853 ml, 6.12 mmol, 1.2 equiv) and a small amount of magnesium sulfate.  
The reaction mixture was stirred at room temperature until judged by TLC to be complete.  The 
reaction mixture was then filtered through celite into and concentrated.  The reaction mixture 
was then extracted into diethyl ether.  The ether layer was washed with water (2x) and brine (1x).  
The organic layer was filtered and concentrated under reduced pressure to furnish rac-2g as a 
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yellow oil in 74% yield (1.06 g, 3.76 mmol).  1H NMR (CDCl3, 600 MHz) δ 1.49 (d, J = 6.8 Hz, 
3H), 3.71 (s, 3H), 3.84 (s, 3H), 3.87 (q, J = 6.8 Hz), 6.98 (s, 2H), 8.18 (s, 1H).  13C NMR 
(CDCl3, 151 MHz)  δ 19.5, 52.3, 56.4, 61.0, 67.9, 105.6, 131.4, 140.8, 153.5, 162.7, 173.1. 
General procedure for synthesis of racemic pyrroloindolines exo-3a-p 
 
 
 
In a nitrogen-filled dry-box, Cu(OTf)2 (7.2 mg, 0.020 mmol, 0.10 equiv), (rac)-BINAP 
(12.5 mg, 0.0200 mmol, 0.100 equiv), and the appropriate indole 1a or 1b (0.200 mmol, 1.00 
equiv) were added to a 1-dram vial.  In a second 1-dram vial, a 0.48 M solution of the 
appropriate imino ester rac-2a-2o in THF was prepared. Both vials were sealed with a 
PTFE/silicone-lined septum cap and removed from the dry-box.  The mixture of Cu(OTf)2, R-
BINAP, and the indole was suspended in THF (0.5 mL) and allowed to stir  for 1 h at room 
temperature.  DBU (40 L of a 1 M solution in THF, 0.040 mmol, 0.20 equiv) and the 
appropriate iminoester (0.50 mL of a 0.48M solution in THF, 0.24 mmol, 1.2 equiv) were then 
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added to the vial containing the mixture of Lewis acid and dipolarophile.  The reaction mixture 
was allowed to stir overnight at room temperature and was monitored by TLC.  Once the 
reaction was judged to be complete, the reaction mixture was filtered through a pad of silica 
(eluting with EtOAc).  The crude reaction mixture was then concentrated under reduced 
pressure.  CDCl3 (2 ml) was added to dissolve the crude reaction mixture, and the diastereomeric 
ratio was determined by 1H NMR spectroscopy using dibromomethane as the internal standard.  
The crude reaction mixture was purified by flash column silica gel chromatography 
(hexanes:EtOAc) to yield racemic pyrroloindolines exo-3a-p. 
General procedure for catalytic, enantioselective synthesis of pyrroloindolines exo-3a-p 
 
 In a nitrogen-filled dry-box, Cu(OTf)2 (7.2 mg, 0.020 mmol, 0.10 equiv), R-Difluorphos 
(15.3 mg, 0.0200 mmol, 0.100 equiv), and the appropriate indole 1a or 1b (0.200 mmol, 1.00 
equiv) were added to a 1-dram vial.  In a second 1-dram vial, a 0.48 M solution of the 
appropriate imino ester rac-2a-2o in THF was prepared. Both vials were sealed with a 
PTFE/silicone-lined septum cap and removed from the dry-box.  The mixture of Cu(OTf)2, R-
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BINAP, and the indole was suspended in THF (0.5 mL) and allowed to stir  for 1 h at room 
temperature.  DBU (40 L of a 1 M solution in THF, 0.040 mmol, 0.20 equiv) and the 
appropriate iminoester (0.50 mL of a 0.48M solution in THF, 0.24 mmol, 1.2 equiv) were then 
added to the vial containing the mixture of Lewis acid and dipolarophile.  The reaction mixture 
was allowed to stir overnight at room temperature and was monitored by TLC.  Once the 
reaction was judged to be complete, the reaction mixture was filtered through a pad of silica 
(eluting with EtOAc).  The crude reaction mixture was then concentrated under reduced 
pressure.  CDCl3 (2 ml) was added to dissolve the crude reaction mixture, and the diastereomeric 
ratio was determined by 1H NMR spectroscopy using dibromomethane as the internal standard.  
The crude reaction mixture was purified by flash column silica gel chromatography 
(hexanes:EtOAc) to yield pyrroloindolines exo-3a-p. 
 
Methyl (1S,3R,3aS,8bS)-3-methyl-8b-nitro-1-phenyl-4-tosyl 
1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate (exo-3a): 
Prepared according to the general procedure from 1a (63.2 mg, 0.200 
mmol) and 2a (45.9 mg, 0.240 mmol) to yield a 93:3:4 mixture of 
exo:exo:endo diastereomers.   The mixture was purified by flash column chromatography (90:10 
hexanes:EtOAc) to yield exo-3a (76.0 mg, 0.150 mmol, 75%) as a white foam with >95:5 
diastereomeric ratio. The enantiomeric excess was determined by HPLC analysis (254 nm, 25 
°C) tR 5.9 min (major); tR 11.5 min (minor) [Chiracel AD-H (0.46 cm x 25 cm)(from Daicel 
Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] to be 89% ee. [α]D24 = -55.8° (c 0.50, 
CHCl3).1H NMR (CDCl3, 600 MHz)  δ 1.73 (s, 3H), 2.31 (s, 3H), 2.45-2.91 (br s, 1H), 3.96 (s, 
3H), 4.76 (s, 1H), 5.82 (dd, J = 7.8, 0.8 Hz, 1H), 5.88 (s, 1H), 6.72 (ddd, J = 8.4, 7.8, 0.8 Hz, 
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1H), 7.01 (d, J = 7.2 Hz, 2H), 7.10 (d, J = 8.1 Hz, 2H), 7.22 (appt, J = 7.6 Hz, 2H), 7.29-7.38 (m, 
2H), 7.45 (d, J = 8.1 Hz, 2H) , 7.77 (d, J = 8.4 Hz, 1H)  13C NMR (CDCl3, 151 MHz) δ 21.8, 
22.2, 53.6, 69.0, 69.1, 74.5, 101.5, 117.0, 124.1, 124.4, 127.7, 128.2, 128.7, 129.0, 129.3, 129.88, 
131.6, 132.8, 135.2, 144.7, 145.1, 175.8.  HRMS (ESI) calcd. for C26H26N3O6S+ [M+H]+ 
508.1537, found 508.1538. 
 
Methyl (1S,3R,3aS,8bS)-3-methyl-8b-nitro-4-tosyl-1-(4- 
(trifluoromethyl)phenyl)-1,2,3,3a,4,8b-hexahydropyrrolo[3,4-
b]indole-3-carboxylate (exo-3b): Prepared according to the general 
procedure from 1a (63.2 mg, 0.200 mmol) and 2b (62.2 mg, 0.240 mmol) 
to yield a >98:1:1 mixture of exo:exo:endo diastereomers.  The mixture 
was purified by flash column chromatography (100:0 to 80:20 hexanes:EtOAc) to yield exo-3b 
(96.0 mg, 0.167 mmol, 83%) as a white foam with >95:5 diastereomeric ratio.  The enantiomeric 
excess was determined by HPLC analysis (254 nm, 25 °C) tR 6.3 min (major); tR 34.1 min 
(minor) [Chiracel AD-H (0.46 cm x 25 cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 
80:20, 1.0 mL/min] to be 81% ee. [α]D25 = -69.3° (c 0.55, CHCl3).1H NMR (CDCl3, 600 MHz) δ 
1.75 (s, 1H), 2.31 (s, 3H), 2.48-2.94 (br s, 1H), 3.96 (s, 3H), 4.81 (s, 1H), 5.82 (d, J = 8.0 Hz, 
1H), 5.89 (s, 1H), 6.73 (dd, 8.2, 7.6 Hz, 1H), 7.11 (d, J = 7.6 Hz, 2H), 7.17 (d, J = 6.6 Hz, 2H), 
7.36 (dd, J = 8.0, 7.6 Hz, 1H), 7.43-7.54 (m, 4H), 7.79 (d, J = 8.2 Hz, 1H). 13C NMR 13C NMR 
(CDCl3, 151 MHz) δ 21.7, 22.0, 53.6, 68.2, 68.9, 74.2, 101.2, 117.0, 124.06 (q, J = 272.3 Hz), 
124.07, 124.1, 124.9 (q, J = 3.7 Hz), 127.8, 128.1, 129.4, 129.8, 131.4 (q, J = 32.5 Hz), 131.9, 
132.6, 139.5, 144.7, 145.2, 175.5. 19F NMR (CDCl3, 565 MHz) δ -63.27.  HRMS (ESI) calcd. 
for C27H25F3N3O6S+ [M+H]+ 576.1411, found 576.1415. 
58 
 
 
Methyl (1S,3R,3aS,8bS)-1-(4-chlorophenyl)-3-methyl-8b-nitro-4-
tosyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate 
(exo-3c): Prepared according to the general procedure from 1a (63.2 mg, 
0.200 mmol) and 2c (54.2 mg, 0.240 mmol) to yield a 78:5:17 mixture of 
exo:exo:endo diastereomers.  The mixture was purified by flash column 
chromatography (100:0 to 80:20 hexanes:EtOAc) to yield exo-3c (76.0 mg, 0.140 mmol, 70%) 
as a white foam with >95:5 diastereomeric ratio. The enantiomeric excess was determined by 
HPLC analysis (254 nm, 25 °C) tR 7.1 min (major); tR 25.8 min (minor) [Chiracel AD-H (0.46 
cm x 25 cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] to be 88% ee. 
[α]D23 = -39.5° (c 0.51, CHCl3). 1H NMR (CDCl3, 400 MHz) δ 1.72 (s, 3H), 2.30 (s, 3H), 2.62-
2.73 (br s, 1H), 3.95 (s, 3H), 4.71 (d, J = 3.5 Hz, 1H) 5.87 (d, J = 1.2 Hz, 1H), 5.91 (dd, J = 7.6, 
0.8 Hz, 1H), 6.77 (dd, J = 8.0, 7.6 Hz, 1H), 6.96 (d, J = 8.0 Hz, 2H), 7.10 (d, J = 8.2 Hz, 2H) 
7.20 (d, J = 8.0 Hz, 2H), 7.36 (dd, J = 8.0, 7.6 Hz, 1H), 7.46 (d, J = 8.2 Hz, 2H), 7.78 (d, J = 8.0 
Hz, 1H) 13C NMR (CDCl3, 101 MHz) δ 21.8, 22.1, 53.6, 68.2, 68.9, 74.2, 101.2, 117.0, 124.2, 
127.8, 128.3, 128.5, 129.9 (2C), 130.2, 131.8, 132.7, 133.8, 135.1, 144.7, 145.2, 175.7.  HRMS 
(ESI) calcd. for C26H25ClN3O6S+ [M+H]+ 542.1147, found 542.1152.  
Methyl (1S,3R,3aS,8bS)-1-(4-bromophenyl)-3-methyl-8b-nitro-4-
tosyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate 
(exo-3d): Prepared according to the general procedure from 1a (63.2 
mg, 0.200 mmol) and 2d (64.8 mg, 0.240 mmol) to yield a 95:4:1 
mixture of exo:exo:endo diastereomers.  The mixture was purified by 
flash column chromatography (100:0 to 80:20 hexanes:EtOAc) to yield exo-3d (92.0 mg, 0.157 
mmol, 78%) as a white foam with >95:5 diastereomeric ratio.  The enantiomeric excess was 
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determined by HPLC analysis (254 nm, 25 °C) tR 7.7 min (major); tR 31.4 min (minor) [Chiracel 
AD-H (0.46 cm x 25 cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] 
to be 90% ee. [α]D23 = -252.1° (c 0.48, CHCl3). 1H NMR ((CD3)2CO, 400 MHz) δ 1.70 (s, 3H), 
2.32 (s, 3H), 3.47-3.57 (br s, 1H), 3.89 (s, 3H), 4.86 (d, J = 3.6 Hz), 5.89-6.01 (m, 2H), 6.83 
(ddd, J = 8.2, 7.4, 0.7 Hz, 1H), 7.02 (d, J = 7.8 Hz, 2H), 7.25 (d, J = 8.0 Hz, 2H), 7.40-7.49 (m, 
3H), 7.54 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 8.2 Hz, 1H) 13C NMR ((CD3)2CO, 101 MHz) δ 21.4, 
21.9, 53.4, 68.6, 69.2, 75.2, 102.0, 117.2, 123.2, 124.7, 125.4, 128.6, 128.8, 130.6, 131.6, 131.7, 
132.6, 133.8, 136.1, 145.5, 146.0, 175.5. HRMS (ESI) calcd. for C26H25BrN3O6S+ [M+H]+ 
586.0642, found 586.0643. 
Methyl (1S,3S,3aS,8bS)-1-(4-bromophenyl)-3-methyl-8b-nitro-4-
tosyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate 
(exo-3d): An analytical sample of exo-3d was isolated from the reaction 
of 1a and 2d.  The relative stereochemistry was assigned by NOE 
analysis. 1H NMR ((CD3)2CO, 400 MHz) δ  1.87 (s, 3H), 2.29 (s, 3H), 
3.32 (d, J = 12.0 Hz, 1H), 3.87 (s, 3H), 5.23 (d, J = 12.0 Hz, 1H), 5.39 (s, 1H), 5.96 (dd, J = 7.9, 
0.6 Hz, 1H), 6.93 (dd, J = 8.0, 7.6 Hz, 1H), 6.97 (d, J = 8.4 Hz, 2H), 7.17 (d, J = 8.4 Hz, 2H), 
7.38 (d, J = 8.4 Hz, 2H), 7.47 (dd, J = 7.9, 7.6 Hz, 1H), 7.56 (d, J = 8.4 Hz, 2H), 7.62 (d, J = 8.0 
Hz, 1H). HRMS (ESI) calcd. for C26H25BrN3O6S+ [M+H]+ 586.0642, found 586.0655. 
Methyl (1S,3R,3aS,8bS)-3-methyl-8b-nitro-1-(p-tolyl)-4-tosyl-
1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate (exo-3e): 
Prepared according to the general procedure from 1a (63.2 mg, 0.200 
mmol) and 2e (49.3 mg, 0.240 mmol) to yield a 90:7:3 mixture of 
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exo:exo:endo diastereomers.  The mixture was purified by flash column chromatography (100:0 
to 80:20 hexanes:EtOAc) to yield exo-3e (79.0 mg, 0.151 mmol, 76%) as a white foam with 
>95:5 diastereomeric ratio.  The enantiomeric excess was determined by HPLC analysis (254 
nm, 25 °C) tR 6.6 min (major); tR 22.4 min (minor) [Chiracel AD-H (0.46 cm x 25 cm)(from 
Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] to be 91% ee. [α]D25 = -312.5° (c 
0.51, CHCl3).  1H NMR (CDCl3, 400 MHz) δ 1.72 (s, 3H), 2.30 (s, 3H), 2.33 (s, 3H), 2.55-2.78 
(br s, 1H), 3.95 (s, 3H), 4.72 (s, 1H), 5.83-5.94 (m, 2H), 6.75 (dd, J = 8.2, 7.8 Hz, 1H), 6.88 (d, J 
= 7.6 Hz, 2H), 7.03 (d, J = 7.6 Hz, 2H), 7.10 (d, J = 8.0 Hz, 2H), 7.34 (appt, J = 7.8 Hz, 1H), 
7.45 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 8.2 Hz, 1H) 13C NMR (CDCl3, 101 MHz) δ 21.4, 21.8, 
22.2, 53.6, 68.9, 69.0, 74.4, 101.4, 116.9, 124.1, 124.4, 127.7, 128.5, 128.8, 129.1, 129.9, 131.6, 
132.0, 132.8, 139.1, 144.6, 145.1, 175.9.  HRMS (ESI) calcd. for C27H28N3O6S+ [M+H]+ 
522.1693, found 522.1695.   
 
Methyl (1S,3R,3aS,8bS)-1-(4-methoxyphenyl)-3-methyl-8b-nitro-4-
tosyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate 
(exo-3f): Prepared according to the general procedure from 1a (64.4 
mg, 0.204 mmol) and 2f (53.1 mg, 0.240 mmol) to yield a 95:4:1 
mixture of exo:exo:endo diastereomers.  The mixture was purified by 
flash column chromatography (100:0 to 70:30 hexanes:EtOAc) to yield exo-3f (78.0 mg, 0.145 
mmol, 71%) as a white foam with >95:5 diastereomeric ratio.  The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 9.2 min (major); tR 37.6 min (minor) [Chiracel 
AD-H (0.46 cm x 25 cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] 
to be 96% ee. [α]D25 = -141.2° (c 0.51, CHCl3). 1H NMR (CDCl3, 400 MHz) δ 1.72 (s, 3H), 2.30 
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(s, 3H), 2.59-2.73 (bs, 1H), 3.79 (s, 3H), 3.95 (s, 3H), 4.69 (s, 1H), 5.88 (s, 1H), 5.93 (d, J = 7.8 
Hz, 1H), 6.69-6.82 (m, 3H), 6.91 (d, J = 8.0 Hz, 2H), 7.10 (d, J = 8.0 Hz, 2H), 7.35 (t, J = 7.8 
Hz, 1H), 7.45 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 8.0 Hz, 1H)  13C NMR (CDCl3, 101 MHz) δ 21.8, 
22.2, 53.6, 55.5, 68.79, 68.84, 74.3, 101.4, 113.4, 116.9, 124.1, 124.4, 127.1, 127.7, 129.1, 
129.86, 129.90, 131.6, 132.7, 144.6, 145.1, 160.3, 175.9  HRMS (ESI) calcd. for C27H28N3O7S+ 
[M+H]+ 538.1642, found 538.1642. 
 
Methyl (1S,3R,3aS,8bS)-3-methyl-8b-nitro-4-tosyl-1-(3,4,5-
trimethoxyphenyl)-1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-
carboxylate (exo-3g): Prepared according to the general procedure 
from 1a (63.2 mg, 0.200 mmol) and 2g (67.5 mg, 0.240 mmol) to yield a 
65:13:22 mixture of exo:exo:endo diastereomers.  The mixture was 
purified by flash column chromatography (100:0 to 60:40 hexanes:EtOAc) to yield exo-3g (47.0 
mg, 0.078 mmol, 39%) as a yellow foam with >95:5 diastereomeric ratio.  The enantiomeric 
excess was determined by HPLC analysis (254 nm, 25 °C) tR 44.4 min (major); tR 51.2 min 
(minor) [Chiracel AD-H (0.46 cm x 25 cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 
95:5, 1.0 mL/min] to be 32% ee. [α]D24 = +18.4° (c .434, CHCl3).  1H NMR (CDCl3, 400 MHz) 
δ 1.73 (s, 3H), 2.30 (s, 3H), 2.69 (s, 1H), 3.63 (s, 6H), 3.82 (s, 3H), 3.96 (s, 3H), 4.67 (s, 1H), 
5.83 (s, 1H), 5.97 (d, J = 7.8 Hz, 1H), 6.20 (s, 2H), 6.78 (dd, J = 8.2, 7.6 Hz, 1H), 7.09 (d, J = 
8.0 Hz, 2H), 7.35 (dd, J = 7.8, 7.6 Hz, 1H), 7.43 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 8.2 Hz, 1H).  
13C NMR (CDCl3, 101 MHz) δ 21.8, 22.2, 53.6, 56.2, 61.2, 68.9, 69.3, 74.3, 101.4, 110.2, 117.0, 
124.0, 124.4, 127.7, 129.1, 129.9, 130.7, 131.6, 132.6, 138.6, 144.6, 145.2, 152.9, 175.8.  HRMS 
(ESI) calcd. for C29H32N3O9S+ [M+H]+ 598.1854, found 598.1855. 
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Methyl (1S,3R,3aS,8bS)-1-(3-methoxyphenyl)-3-methyl-8b-nitro-4-
tosyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate 
(exo-3h): Prepared according to the general procedure from 1a (63.2 
mg, 0.200 mmol) and 2h (53.1 mg, 0.240 mmol) to yield a 89:8:3 
mixture of exo:exo:endo diastereomers.  The mixture was purified by 
flash column chromatography (100:0 to 70:30 hexanes:EtOAc) to yield exo-3h (77.0 mg, 0.143 
mmol, 72%) as a white foam with >95:5 diastereomeric ratio.  The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 7.7 min (major); tR 12.7 min (minor) [Chiracel 
AD-H (0.46 cm x 25 cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] 
to be 89% ee. [α]D25 = -69.1° (c 0.55, CHCl3).  1H NMR (CDCl3, 600 MHz) δ 1.73 (s, 3H), 2.30 
(s, 3H), 2.41-2.93 (bs, 1H), 3.63 (s, 3H), 3.96 (s, 3H), 4.76 (s, 1H), 5.86 (s, 1H), 5.91 (d, J = 7.6 
Hz, 1H), 6.51 (s, 1H), 6.62 (d, J = 6.4 Hz, 1H), 6.75 (dd, J = 8.2, 7.8 Hz, 1H), 6.86 (dd, J = 8.2, 
2.2 Hz, 1H), 7.10 (d, J = 8.2 Hz, 2H), 7.14 (dd, J = 8.2, 6.4 Hz, 1H), 7.34 (ddd, J = 7.8, 7.6, 0.8 
Hz, 1H), 7.44 (d, J = 8.2 Hz, 2H), 7.77 (d, J = 8.2 Hz, 1H)  13C NMR (CDCl3, 151 MHz) δ 21.7, 
22.1, 53.5, 55.4, 68.92, 68.99, 74.5, 101.4, 113.5, 115.5, 116.9, 120.96, 120.99, 124.0, 124.3, 
127.7, 129.0, 129.2, 129.8, 131.6, 132.7, 144.6, 145.1, 159.4, 175.8.  HRMS (ESI) calcd. for 
C27H28N3O7S+ [M+H]+ 538.1642, found 538.1646. 
 
Methyl (1S,3R,3aS,8bS)-1-(3-bromophenyl)-3-methyl-8b-nitro-4-
tosyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate 
(exo-3i): Prepared according to the general procedure from 1a (63.2 mg, 
0.200 mmol) and 2i (64.8 mg, 0.240 mmol) to yield a 69:8:23 mixture of 
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exo:exo:endo diastereomers.  The mixture was purified by flash column chromatography (100:0 
to 80:20 hexanes:EtOAc) to yield exo-3i (47.0 mg, 0.080 mmol, 40%) as a white foam with 
>95:5 diastereomeric ratio.  The enantiomeric excess was determined by HPLC analysis (254 
nm, 25 °C) tR 7.6 min (major); tR 12.3 min (minor) [Chiracel AD-H (0.46 cm x 25 cm)(from 
Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] to be 80% ee. [α]D24 = -846.2° (c 
0.56, CHCl3).  1H NMR (CDCl3, 400 MHz) δ 1.73 (s, 3H), 2.31 (s, 3H), 2.64-2.74 (br s, 1H), 
3.95 (s, 3H), 4.72(s, 1H), 5.82-5.92 (m, 2H), 6.79 (dd, J = 8.0, 7.6 Hz, 1H), 6.98 (d, J = 6.6 Hz, 
1H), 7.06-7.17 (m, 4H), 7.37 (dd, J = 8.0, 7.6 Hz, 1H), 7.42-7.50 (m, 3H), 7.79 (d, J = 8.0 Hz, 
1H)  13C NMR (CDCl3, 101 MHz) δ 21.8, 22.1, 53.7, 68.2, 69.0, 74.2, 101.3, 117.1, 122.3, 
124.10, 124.11, 127.6, 127.8, 128.5, 129.7, 129.9, 131.85, 131.91, 132.4, 132.6, 137.7, 144.7, 
145.2, 175.6.  HRMS (ESI) calcd. for C26H25BrN3O6S+ [M+H]+ 586.0642, found 586.0646. 
 
Methyl (1S,3R,3aS,8bS)-1-(2-methoxyphenyl)-3-methyl-8b-nitro-4-
tosyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-
carboxylate(exo-3j): Prepared according to the general procedure from 
1a (63.2 mg, 0.200 mmol) and 2j (53.1 mg, 0.240 mmol) to yield a 
74:7:19 mixture of exo:exo:endo diastereomers.  The mixture was purified by flash column 
chromatography (100:0 to 80:20 hexanes:EtOAc) to yield exo-3j (42.0 mg, 0.078 mmol, 39%) 
as a white foam with >95:5 diastereomeric ratio.  The enantiomeric excess was determined by 
HPLC analysis (254 nm, 25 °C) tR 7.0 min (major); tR 16.5 min (minor) [Chiracel AD-H (0.46 
cm x 25 cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] to be 82% ee. 
[α]D25 = +42.4° (c 0.24, CHCl3).  1H NMR (CDCl3, 600 MHz) δ 1.71 (s, 3H), 2.30 (s, 3H), 2.55-
2.81 (br s, 1H), 3.60 (s, 3H), 4.00 (s, 3H), 5.24 (s, 1H), 5.76 (s, 1H), 5.93 (d, J = 8.0 Hz, 1H), 
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6.72-6.78 (m, 2H), 6.80 (d, J = 8.0 Hz, 1H),  6.92 (d, J = 7.4 Hz, 1H), 7.07 (d, J = 8.0 Hz, 2H), 
7.20-7.43 (m, 4H), 7.76 (d, J = 8.0 Hz, 1H) 13C NMR (CDCl3, 101 MHz) δ 21.8, 22.4, 53.6, 
54.9, 64.3, 69.1, 76.1, 100.4, 109.8, 117.3, 120.4, 123.9, 124.2, 124.4, 127.4, 128.6, 129.5, 129.8, 
129.9, 131.2, 132.5, 144.6, 145.1, 157.5, 176.1.  HRMS (ESI) calcd. for C27H28N3O7S+ [M+H]+ 
538.1642, found 538.1646.  
 
Methyl (1S,3R,3aS,8bS)-1-(2-fluorophenyl)-3-methyl-8b-nitro-4-
tosyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate 
(exo-3k): Prepared according to the general procedure from 1a (64.8 
mg, 0.205 mmol) and 2k (50.2 mg, 0.240 mmol) to yield a 67:5:27 
mixture of exo:exo:endo diastereomers.  The mixture was purified by flash column 
chromatography (100:0 to 80:20 hexanes:EtOAc) to yield exo-3k (55.0 mg, 0.104 mmol, 51%) 
as a white foam with >95:5 diastereomeric ratio.  The enantiomeric excess was determined by 
HPLC analysis (254 nm, 25 °C) tR 5.9 min (major); tR 15.3 min (minor) [Chiracel AD-H (0.46 
cm x 25 cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] to be 87% ee. 
[α]D25 = -24.3° (c 0.41, CHCl3).  1H NMR (CDCl3, 600 MHz) δ 1.71 (s, 3H), 2.29 (s, 3H), 2.43-
2.94 (br s, 1H), 3.98 (s, 3H) 5.14 (s, 1H), 5.85 (s, 1H), 6.01 (d, J = 7.8 Hz, 1H), 6.78 (dd, J = 8.0, 
7.6 Hz, 1H), 6.88-6.98 (m, 2H), 7.02 (appt, J = 9.0 Hz, 1H), 7.08 (d, J = 8.0 Hz, 2H), 7.27-7.43 
(m, 4H), 7.78 (d, J = 8.0 Hz, 1H) 13C NMR (CDCl3, 151 MHz) δ 21.7, 22.3, 53.7, 62.9, 69.1, 
74.9, 100.6, 115.3 (d, J = 21.4 Hz), 117.2, 122.5 (d, J = 12.2 Hz), 123.8 (d, J = 3.3 Hz), 123.9, 
124.3, 127.5, 129.2, 129.88, 129.92 (d, J = 3.5 Hz), 130.6 (d, J = 8.5 Hz) 131.6, 132.4, 144.7, 
145.2, 161.1 (d, J = 248.1 Hz), 175.7.  19F NMR (CDCl3, 565 MHz) δ -117.22.  HRMS (ESI) 
calcd. for C26H25FN3O6S+ [M+H]+ 526.1443, found 526.1455. 
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Methyl (1S,3R,3aS,8bS)-1-(2-chlorophenyl)-3-methyl-8b-nitro-4-
tosyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate 
(exo-3l): Prepared according to the general procedure from 1a (63.2 mg, 
0.200 mmol) and 2l (54.2 mg, 0.240 mmol) to yield a 88:8:4 mixture of 
exo:exo:endo diastereomers.  The mixture was purified by flash column chromatography (100:0 
to 80:20 hexanes:EtOAc) to yield exo-3l (92.0 mg, 0.170 mmol, 85%) as a white foam with 
>95:5 diastereomeric ratio.  The enantiomeric excess was determined by HPLC analysis (254 
nm, 25 °C) tR 5.4 min (major); tR 7.5 min (minor) [Chiracel AD-H (0.46 cm x 25 cm)(from 
Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] to be 79% ee. [α]D25 = -35.3° (c 
0.62, CHCl3).  1H NMR (CDCl3, 400 MHz) δ 1.72 (s, 3H), 2.30 (s, 3H), 2.59-2.82 (br s, 1H), 
4.02 (s, 3H), 5.35 (s, 1H), 5.78 (s, 1H), 6.03 (d, J = 7.8 Hz, 1H), 6.78 (dd, J = 8.0, 7.6 Hz, 1H), 
6.89 (d, J = 8.0 Hz, 1H), 7.00 (dd, J = 7.6, 7.4 Hz, 1H), 7.07 (d, J = 8.0 Hz, 2H), 7.22 (ddd, J = 
8.0, 7.6, 1.4 Hz, 1H), 7.32-7.41 (m, 4H), 7.79 (d, J = 8.0 Hz, 1H) 13C NMR (CDCl3, 151 MHz) δ 
21.7, 22.4, 53.7, 65.5, 68.9, 75.4, 100.3, 117.3, 123.8, 124.1, 126.3, 127.5, 129.6, 129.9, 130.0, 
130.1, 131.0, 131.6, 132.2, 133.3, 134.5, 144.7, 145.3, 175.9.  HRMS (ESI) calcd. for 
C26H25ClN3O6S+ [M+H]+ 542.1147, found 542.1152. 
 
Isopropyl (1S,3R,3aS,8bS)-3-methyl-8b-nitro-1-phenyl-4-tosyl-
1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate (exo-
3m): Prepared according to the general procedure from 1a (63.2 mg, 
0.200 mmol) and 2m (52.6 mg, 0.240 mmol) to yield a 93:7 mixture of 
exo:exo diastereomers.  The mixture was purified by flash column chromatography (100:0 to 
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80:20 hexanes:EtOAc) to yield exo-3m (76.0 mg, 0.142 mmol, 71%) as a white foam with >95:5 
diastereomeric ratio.  The enantiomeric excess was determined by HPLC analysis (254 nm, 25 
°C) tR 4.6 min (major); tR 6.7 min (minor) [Chiracel AD-H (0.46 cm x 25 cm)(from Daicel 
Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] to be 94% ee. [α]D25 = -45.3° (c 0.53, 
CHCl3).   1H NMR (CDCl3, 600 MHz) δ 1.41 (d, J = 6.0 Hz, 3H), 1.46 (d, J = 6.0 Hz, 3H), 1.71 
(s, 3H), 2.31 (s, 3H), 2.43-3.12 (br s, 1H), 4.76 (s, 1H), 5.24 (septet, J = 6.0 Hz, 1H), 5.74-5.93 
(m, 2H), 6.73 (dd, J = 8.2, 7.6 Hz, 1H), 7.00 (d, J = 7.2 Hz, 2H), 7.10 (d, J = 8.0 Hz, 2H), 7.22 
(appt, J = 7.2 Hz, 2H), 7.29-7.38 (m, 2H), 7.41 (d, J = 8.0 Hz, 2H), 7.80 (d, J = 8.2 Hz, 1H)  13C 
NMR (CDCl3, 151 MHz) δ 21.7, 21.95, 22.04, 22.1, 68.9, 69.3, 70.3, 74.4, 101.6, 117.1, 124.1, 
124.4, 127.7, 128.2, 128.7, 129.0, 129.3, 129.8, 131.6, 132.6, 135.4, 144.8, 145.1, 174.9. HRMS 
(ESI) calcd. for C28H30N3O6S+ [M+H]+ 536.1850, found 536.1851. 
 
Methyl (1S,3R,3aS,8bS)-3-benzyl-8b-nitro-1-phenyl-4-tosyl-
1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate (exo-
3n):  Prepared according to the general procedure from 1a (64.8 mg, 
0.205 mmol) and 2n (64.2 mg, 0.240 mmol) to yield a 48:25:27 mixture 
of exo:exo:endo diastereomers.  The mixture was purified by flash column chromatography 
(95:5 to 90:10 hexanes:EtOAc) to yield exo-3n (80.0 mg, 0.137 mmol, 68%) as a yellow foam 
with 46:24:30 exo:exo:endo diastereomeric ratio.  The enantiomeric excess was determined by 
HPLC analysis (254 nm, 25 °C) tR 57.2 min (major); tR 72.6 min (minor) [Chiracel AD-H (0.46 
cm x 25 cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 98:2, 1.0 mL/min] to be 36% ee. 
[α]D25 = -327.3° (c 0.22, CHCl3).  1H NMR and 13C NMR data are reported for the major 
diastereomer:   1H NMR (CDCl3, 600 MHz) δ 2.31 (s, 3H), 3.27 (d, J = 13.5 Hz, 1H), 3.77 (d, J 
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= 13.5 Hz, 1H), 3.89 (s, 3H), 3.95 (s, 1H), 4.74 (s, 1H), 5.84-5.88 (m, 2H), 6.78 (dd, J = 8.2 Hz, 
7.6 Hz, 1H), 7.02 (d, J = 7.4 Hz, 2H), 7.10 (d, J = 8.0 Hz, 2H), 7.15 (d, J = 6.9 Hz, 2H), 7.19-
7.23 (m, 3H), 7.27-7.35 (m, 3H), 7.40 (dd, J = 7.8, 7.6 Hz, 1H), 7.43 (d, J = 8.2 Hz, 2H), 7.83 (d, 
J = 8.2 Hz, 1H).  13C NMR (CDCl3, 151 MHz) δ 21.8, 42.3, 53.2, 69.4, 72.8, 75.5, 101.5, 117.4, 
124.3, 124.4, 127.3, 127.7, 128.2, 128.7, 129.3, 129.88, 129.91, 129.93, 130.7, 131.7, 132.5, 
135.5, 136.1, 144.6, 145.3, 174.1.  HRMS (ESI) calcd. for C32H30N3O6S+ [M+H]+ 584.1850, 
found 584.1849. 
 
Methyl (1S,3R,3aS,8bS)-3-isobutyl-8b-nitro-1-phenyl-4-tosyl-
1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate (exo-3o):  
Prepared according to the general procedure from 1a (63.2 mg, 0.200 
mmol) and 2o (60.0 mg, 0.240 mmol) to yield a 79:19:9 mixture of 
exo:exo:endo diastereomers.  The mixture was purified by flash column chromatography (95:5 
to 85:15 hexanes:EtOAc) to yield exo-3o (78.0 mg, 0.142 mmol, 71%) as a yellow foam with 
75:20:0 exo:exo:endo diastereomeric ratio.  The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 27.8 min (major); tR 59.5 min (minor) [Chiracel AD-H (0.46 cm x 25 
cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 99:1, 1.0 mL/min] to be 30% ee. [α]D25 = -
45.9° (c 0.74, CHCl3).  
1H NMR and 13C NMR data are reported for the major diastereomer:  1H 
NMR (CDCl3, 600 MHz) δ 0.95 (d, J = 6.6 Hz, 3H), 0.97 (d, J = 6.6 Hz, 3H), 1.87 (dd, J = 14.4, 
6.3 Hz, 1H), 2.29 (s, 3H), 2.39 (dd, J = 14.4, 6.3 Hz, 1H), 2.67 (bs, 1H), 3.99 (s, 3H), 4.83 (s, 
1H), 5.74 (s, 1H), 5.80 (d, J = 7.7 Hz, 1H), 6.75 (appt, J = 8.2 Hz, 1H), 6.98 (d, J = 7.6 Hz, 2H), 
7.05 (d, J = 7.6 Hz, 2H), 7.19-7.25 (m, 2H), 7.30-7.38 (m, 3H), 7.78 (d, J = 8.2 Hz, 1H).  13C 
NMR (CDCl3, 151 MHz) δ 21.7, 24.2, 24.3, 24.9, 44.1, 53.4, 70.0, 71.9, 76.4, 101.1, 117.6, 
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124.3, 124.5, 127.6, 128.2, 128.5, 129.3, 129.6, 129.8, 131.5, 132.5, 135.5, 144.7, 145.1, 175.6.  
HRMS (ESI) calcd. for C29H32N3O6S+ [M+H]+ 550.2006, found 550.2010. 
 
 
Methyl (1S,3R,3aS,8bS)-7-bromo-3-methyl-8b-nitro-1-phenyl-4-
tosyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,4-b]indole-3-carboxylate 
(exo-3p): Prepared according to the general procedure from 1b (79.0 
mg, 0.200 mmol) and 2a (45.9 mg, 0.240 mmol) to yield a >98:1:1 
mixture of exo:exo:endo diastereomers.  The mixture was purified by flash column 
chromatography (100:0 to 80:20 hexanes:EtOAc) to yield exo-3p (93.0 mg, 0.159 mmol, 79%) 
as a white foam with >95:5 diastereomeric ratio.  The enantiomeric excess was determined by 
HPLC analysis (254 nm, 25 °C) tR 6.1 min (major); tR 8.4 min (minor) [Chiracel AD-H (0.46 cm 
x 25 cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] to be 91% ee. 
[α]D25 = -312.5° (c 0.51, CHCl3).  1H NMR (CDCl3, 600 MHz) δ 1.71 (s, 3H), 2.33 (s, 3H), 2.69-
2.77 (br s, 1H), 3.96 (s, 3H), 4.73 (d, J = 3.4 Hz, 1H), 5.80 (d, J = 2.0 Hz, 1H), 5.86 (d, J = 1.2 
Hz, 1H), 7.00 (d, J = 7.6 Hz, 2H), 7.14 (d, J = 8.0 Hz, 2H), 7.28 (dd, J = 7.6, 7.4 Hz, 2H), 7.38 
(t, J = 7.4 Hz, 1H), 7.42-7.47 (m, 3H), 7.64 (d, J = 8.7 Hz, 1H)  13C NMR (CDCl3, 151 MHz) δ 
21.8, 22.1, 53.6, 69.1, 69.3, 74.7, 100.9, 116.9, 118.3, 126.1, 127.6, 128.3, 128.5, 129.7, 130.1, 
132.2, 132.4, 134.5, 134.7, 143.7, 145.5, 175.6.  HRMS (ESI) calcd. for C26H25BrN3O6S+ 
[M+H]+ 586.0642, found 586.0641. 
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Synthesis of exo´-3f.HBr 
 
Compound exo´-3f (153.0 mg, 0.284 mmol, 86% ee) was added to a 20 mL scintillation 
vial and dissolved in 6 mL of methanol.  To this solution were added 6 drops of concentrated 
HBr.  The vial was capped and the reaction was stirred overnight at room temperature.  The 
volatiles were evaporated under reduced pressure to yield exo´-3f·HBr (175.0 mg, 0.283 mmol, 
>99%).  [α]D25 = -30.7° (c 0.52, CHCl3).  A single crystal of this compound was grown from 
hexane:dichloromethane.  1H NMR (CDCl3, 400 MHz) δ 2.24 (s, 3H), 2.29 (s, 3H), 3.76 (s, 3H), 
4.03 (s, 3H), 5.54-5.61 (m, 2H), 5.89 (d, J = 7.6 Hz, 1H), 6.68 (d, J = 8.0 Hz, 2H), 6.88 (dd, J = 
8.0, 7.4 Hz, 1H), 7.08 (d, J = 8.0 Hz, 2H), 7.29-7.40 (m, 4H), 7.47 (dd, J = 7.6, 7.4 Hz, 1H), 7.83 
(d, J = 8.0 Hz, 1H), 7.87-8.17 (br s, 2H).  13C NMR (CDCl3, 101 MHz) δ 19.2, 21.7, 54.9, 55.4, 
68.9, 71.8, 74.2, 77.4, 99.7, 114.0, 118.9, 120.8, 125.3, 127.6, 129.5, 130.0, 131.2, 132.0, 133.5, 
144.9, 145.7, 161.0, 169.8.  HRMS (ESI) calcd. for C27H28N3O7S+ [M+] 538.1642, found 
538.1644. 
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Absolute stereochemistry and structure of 3f.HBr 
 
The absolute configuration of exo-3f.HBr was determined to be (1S,3R,3aS,8bS) by X-
ray crystallographic analysis. Supplementary X-ray diffraction data and structure refinement for 
exo-3f.HBr contained in CCDC 1434459. These data can be accessed free of charge from the 
Cambridge Crystallographic Data Center at https://summary.ccdc.cam.ac.uk/structure-summary-
form 
 
.  
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CHAPTER 3 
CATALYTIC, ENANTIOSELECTIVE, NITRILE IMINE CYCLOADDITIONS WITH 
METHYLENEINDOLINES 
Modified from a paper published in Organic and Biomolecular Chemistrya 
Anthony L. Gerten, Michael C. Slade, Kelsie M. Pugh, Levi M. Stanley* 
Abstract 
Catalytic, enantioselective 1,3-dipolar cycloadditions of nitrile imines with 
methyleneindolinones are reported. The spiro[pyrazolin-3,3´-oxindole] products are formed in 
good yields (up to 98%) and high enantioselectivity (up to 99% ee). 
Introduction 
1,3-Dipolar cycloadditions of nitrile imines with alkenes represent an attractive strategy 
to generate pyrazolines. Reactions of nitrile imines with a wide variety of olefinic dipolarophiles 
have been developed to provide an array of compounds containing a pyrazoline motif.1,2  Despite 
efforts to develop the utility of nitrile imine cycloadditions, controlling the enantioselectivity of 
nitrile imine cycloadditions remains difficult to achieve. The high reactivity of nitrile imines 
renders catalytic, enantioselective cycloadditions of this class of dipole challenging due to the 
high rates of uncatalyzed background cycloaddition. To date, only a select few examples of 
catalytic, enantioselective cycloadditions of nitrile imines have been reported. Sibi et al. showed 
that 1,3-dipolar cycloadditions of nitrile imines with α,β-unsaturated oxazolidinone and 
pyrazolidinone imides occur in high yields with high enantioselectivity in the presence of chiral, 
non-racemic magnesium catalysts.3  However, the scope of dipolarophiles in enantioselective 
nitrile imine cycloadditions remains narrow. 
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The prevalence of pyrazoline motifs in bioactive compounds4 and the growing 
importance of spirocyclic oxindole derivatives5,6 led our group and others to investigate synthetic 
approaches to spiro[pyrazolin-3,3′-oxindoles]. During the course of our studies, Roth et al.7 and 
Feng et al.8 reported the first cycloadditions of nitrile imines with methyleneindolinones to 
generate spiro[pyrazolin-3,3′-oxindoles]. Roth and co-workers reported the first racemic 
synthesis of spiro[pyrazolin-3,3′-oxindoles] by uncatalyzed cycloadditions of nitrile imines with 
methyleneindolinones.7  Shortly thereafter, Feng and co-workers reported the first catalytic, 
enantioselective cycloadditions of nitrile imines generated from hydrazonoyl chlorides with 
Scheme 1.  Catalytic, enantioselective cycloadditions of nitrile imines with methyleneindolinones 
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methyleneindolinones (Scheme 1a).8  These cycloadditions occur with high enantioselectivity 
(up to 99% ee) provided the β-substituent of the methyleneindolinone substrate is a bulky alkyl 
(tert-butyl) group or an ortho-substituted aryl group. Cycloadditions of nitrile imines with 
methyleneindolinones substituted with smaller β-alkyl (e.g. iso-propyl) groups or β-aryl (e.g. Ph, 
4-Cl-C6H4) groups lacking ortho-substitution occur with lower enantioselectivity. 
Herein, we report catalytic, enantioselective cycloadditions of nitrile imines generated 
from hydrazonoyl bromides with a variety of methyleneindolinones (Scheme 1b). The nitrile 
imine cycloadditions occur in the presence of a catalyst generated in situ from Mg(NTf2)2 and an 
aminoindanol-derived bisoxazoline ligand L2. The spiro[pyrazolin-3,3′-oxindole] products are 
formed in good to high yields with high enantioselectivities. Furthermore, the nitrile imine 
cycloadditions that occur with high enantioselectivity encompass methyleneindolinones 
containing β-aryl groups lacking substitution at the ortho position. This methodology expands 
the breadth of spiro[pyrazolin-3,3′-oxindoles] that can be accessed in highly enantioselective 
fashion and is complementary to the methodology reported by Feng. 
Catalytic, enantioselective, 1,3-dipolar cycloadditions of nitrile imines with 
methyleneindolindolinones: identification of reaction conditions 
Our initial studies focused on reactions of the nitrile imine generated from hydrazonoyl 
bromide 2a with methyleneindolinones 1a–e. Table 1 summarizes the effect of Lewis acid 
identity, Lewis acid loading, temperature, and substitution at the oxindole nitrogen on these 
reactions. We chose to begin our investigation by conducting cycloadditions catalyzed by 30 
mol% loading of a complex prepared in situ from Mg(NTf2)2 and bisoxazoline ligand L2. The 
cycloaddition of the nitrile imine generated at room temperature from 2a with 1a (R = Ph) 
formed spirocycle 3a in high yield but with poor enantioselectivity. While lowering the 
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temperature of the cycloaddition from room temperature to −78 °C did not significantly impact 
the yield of 3a, this modification led to a dramatic increase in enantioselectivity (entries 1–3). 
The cycloaddition of the nitrile imine generated from 2a with 1a formed 3a in 88% yield and 
90% ee when the reaction was conducted at −78 °C (entry 3). Reducing the catalyst loading from 
30 mol% to 10 mol% did not have a significant impact on the enantioselectivity of the 
cycloaddition (entries 3–5). In fact, the reaction performed with 10 mol% catalyst occurred in 
slightly higher yield (98%) and enantioselectivity (92% ee) than the reactions performed with 20 
and 30 mol% catalyst. The reaction conducted in the presence of 5 mol% catalyst formed 3a in 
high yield, but the enantioselectivity was marginally lower (89% ee, entry 6). 
Table 1.  Identification of catalyst precursors and reaction conditions 
 
 
Entry R (1) MgX2 
(mol %) 
Temp (°C) 3 Yield (%) ee (%) 
1 Ph (1a) Mg(NTf2)2 (30) rt 3a 82 29 
2 Ph (1a) Mg(NTf2)2 (30) -20 3a 88 55 
3 Ph (1a) Mg(NTf2)2 (30) -78 3a 88 90 
4 Ph (1a) Mg(NTf2)2 (20) -78 3a 91 91 
5 Ph (1a) Mg(NTf2)2 (10) -78 3a 98 92 
6 Ph (1a) Mg(NTf2)2 (5) -78 3a 96 89 
7 Ph (1a) Mg(ClO4)2 (10) -78 3a 98 44 
8 Ph (1a) MgI2 (10) -78 3a 95 64 
9 Me (1b) Mg(NTf2)2 (10) -78 3b 76 94 
10 t-Bu (1c) Mg(NTf2)2 (10) -78 3c 97 40 
11 Ot-Bu (1d) Mg(NTf2)2 (10) -78 3d 37 94 
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The identity of the Mg(II) salt and the oxindole nitrogen substituent proved important to 
the yields and/or selectivities of the cycloaddition reactions (entries 5, 7–11). Cycloadditions 
catalyzed by complexes of Mg(ClO4)2 or MgI2 and L2 occurred with low enantioselectivity 
relative to the cycloaddition catalyzed by a complex of Mg(NTf2)2 and L2 (compare entries 7 
and 8 with entry 5). Cycloadditions of N-acetyl and N-Boc arylidine 
methyleneindolinones 1b and 1d with the nitrile imine generated from 2a formed 
spiro[pyrazolin-3,3′-oxindoles] 3b and 3d in 94% and 98% ee, but the yields were substantially 
lower than the corresponding reaction with 1a (entries 9 and 11). In contrast, the reaction of N-
pivaloyl methyleneindolinone 1c generated spiro[pyrazolin-3,3′-oxindole] 3c in high yield, but 
the enantioselectivity was poor (40% ee, entry 10). 
Catalytic, enantioselective, 1,3-dipolar cycloadditions of nitrile imines with 
methyleneindolindolinones: scope of dipolarophiles 
The scope of the Mg-catalyzed cycloaddition of the nitrile imine generated from 2a with 
a variety of methyleneindolinones is summarized in Table 2.  The reactions of an electron-rich 
methyleneindolinone and halogenated methyleneindolinones generated products 3e–g in 
moderate to good yields with high enantioselectivities (entries 1–3). The absolute configuration 
of spiro[pyrazolin-3,3′-oxindole] 3h was determined to be (3S,4′S) by X-ray crystallographic 
analysis (Fig. 1). In contrast, the reaction of an electron-deficient dipolarophile 1h furnished the 
corresponding cycloadduct 3h with modest enantioselectivity (entry 4). The reaction of a meta-
substituted methyleneindolinone 1i formed spiro[pyrazolin-3,3′-oxindole] 3i in high yield with 
high enantioselectivity (entry 5). 
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Table 3. Scope of Nitrile Imine cycloadditions with various methyleneindolinones   
 
Entry 1 R 3 Yield (%) ee (%) 
1 1e 4-MeO-C6H4 3e 81 99 
2 1f 4-Cl-C6H4 3f 86 99 
3 1g 4-Br-C6H4 3g 63
a 94 
4 1h 4-CF3-C6H4 3h 81 80 
5 1i 3-MeO-C6H4 3i 90
b 94 
6 1j 3,4,5-(MeO)3-C6H2 3j 91 61 
7 1j 3,4,5-(MeO)3-C6H2 3j 88
c 91 
8 1k 2-F-C6H4 3k 84 92 
9 1l 2-Br-C6H4 3l 43 0 
10 1m (E)-tert-butyl 3m 70 99 
aIsolated as a 10:1 mixture of diastereomers and an 11:1 mixture of regioisomers. bIsolated as a 
9:1 mixture of diastereomers. cThe reaction was conducted in the presence of 100 mol % of the 
Mg catalyst. 
 
Figure 1.  Absolute stereochemistry and structure of 3g based on X-ray diffraction data 
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The reaction of a highly electron-rich dipolarophile proved more challenging. The 
reaction of methyleneindolinone 1j occurred with 61% ee in the presence of 10 mol% catalyst 
(Table 2, entry 6). The observed decrease in enantioselectivity likely results from product 
inhibition instead of poor facial selection, as product 3j was formed with 91% ee in the presence 
of 100 mol% catalyst (entry 7). 
Reactions of methyleneindolinones containing an ortho-substituted aryl group were 
sensitive to the size of the ortho substituent. The reaction of ortho-fluorinated 
dipolarophile 1k formed cycloadduct 3k in high yield with high enantioselectivity (entry 8), but 
the reactivity of ortho-brominated dipolarophile 1l was poor and the corresponding 
product 3l was generated as a racemic mixture (entry 9).   
Although aryl groups with large ortho-substituents are not well tolerated by the current 
catalyst, bulky β-alkyl substituents are well tolerated.  The reaction of (E)-methyleneindolinone 
1m (R = t-Bu) furnished cycloadduct 3m in 70% yield and 99% ee (Table 2, entry 10).  
However, the enantioselectivity of the cycloaddition is sensitive to the geometry of the alkene 
unit.  The reaction of (Z)-methyleneindolinone 1n (R = t-Bu) furnished the diastereomeric 
cycloadduct 3n with only 66% ee (eqn (1)). 
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Catalytic, enantioselective, 1,3-dipolar cycloadditions of nitrile imines with 
methyleneindolindolinones: scope of dipoles 
 The scope of the Mg-catalyzed cycloaddition of 1a with a selection of nitrile imines is 
summarized in Table 3.  As illustrated in Table 1, entry 5, the nitrile imine generated from 
benzaldehyde-derived hydrazonoyl bromide 2a furnished cycloadduct 3a in high yield with 
excellent enantioselectivity.  The reaction of a nitrile imine bearing an electron-deficient aryl 
group (Ar1 = 4-CF3-C6H4) at the C-terminus of the dipole also generated the corresponding 
spiro[pyrazolin-3,3´-oxindole] 3o in high yield with high enantioselectivity (Table 3, entry 1).  
The reaction of a nitrile imine containing a 3-bromophenyl group at the C-terminus furnished 
cycloadduct 3p in 72% yield with 84% ee (entry 2).  The reaction also appears sensitive to the 
size of the substituent at the 2-position of the C-terminal aryl ring: whereas the reaction of a 
nitrile imine containing with a smaller 2-fluoro substituent afforded product 3q in 90% yield 
with 90% ee (entry 3), the reaction to afford product 3r with a larger 2-bromo substituent 
occurred in 81% yield with 62% ee (entry 4). 
 Nitrile imines with electron-deficient aryl groups at the N-terminus of the dipole were 
also well tolerated.  Reactions of nitrile imines substituted with N-terminal 4-fluorophenyl and 4-
trifluoromethyl groups formed the corresponding cycloadducts 3s and 3t in 83% and 87% yields 
with 91% and 90% ee, respectively (entries 5 and 6). 
 The scope of cycloadditions with methyleneindolinone 1a encompasses a wide range of 
sterically and electronically distinct nitrile imines.  However, the hydrazonoyl bromide 
precursors to nitrile imines with electron-rich aryl groups at either the C- or N-terminus were too 
unstable in our hands to generate reproducible results.  In addition, attempts to utilize 
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hydrazonoyl chlorides as nitrile imine precursors resulted in either low reactivity or poor 
enantioselectivity. 
Table 4.  Scope of 1,3-dipolar cycloadditions of methyleneindolinone 1a with nitrile imines   
 
Entry 2 Ar1 Ar2 3 Yield (%) ee (%) 
1 2b 4-CF3-C6H4 4-Br-C6H4 3o 86 94 
2 2c 3-Br-C6H4 4-Br-C6H4 3p 72 84 
3 2d 2-F-C6H4 4-Br-C6H4 3q 90 90 
4 2e 2-Br-C6H4 4-Br-C6H4 3r 81 62 
5 2f Ph 4-F-C6H4 3s 83 91 
6 2g Ph 4-CF3-C6H4 3t 87 90 
 
Catalytic, enantioselective, 1,3-dipolar cycloadditions of nitrile imines with 
methyleneindolindolinones: competition reactions of dipolarophiles 
 While most of the methyleneindolinone substrates examined in our dipolarophile scope 
reacted to furnish cycloadducts with high enantioenrichment, we observed that extremely 
electron-withdrawing groups and extremely electron-donating groups on the β-aryl ring of the 
dipolarophile were detrimental to the enantioselectivity of the reaction.  Electron-poor 
dipolarophile 1h reacted with 2a to furnish 3h in 81% yield and 80% ee (Table 2, entry 4), while 
the reaction of very electron-rich 1j with 2a afforded cycloadduct 3j in 91% yield and 62% ee at 
10 mol % catalyst loading (entry 6) and 91% ee at 100 mol % catalyst loading (entry 7).  These 
data led us to the two-fold hypothesis that 1) an electron-deficient methyleneindolinone binds 
weakly to the catalyst, leading to poor facial selectivity and thus lower ee (the racemic 
background reaction is likely not competitive with the catalyzed process, vide infra), and 2) a 
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very electron-rich methyleneindolinone binds strongly to the catalyst, slowing catalyst turnover 
and allowing the racemic background reaction to become competitive with the catalyzed 
reaction. 
 In order to confirm a correlation between the electron-density of the dipolarophile and the 
strength of catalyst binding, we set up competition reactions of dipolarophiles of varying electron 
densities.  The competition reaction of electron-neutral 1a and electron-rich 1b with 2a delivered 
cycloadducts 3a and 3e in 37% and 41% yield, respectively (Scheme 2a).  The competition 
between electron-neutral 1a and electron-poor 1h with 2a generated 3a exclusively in 51% yield 
(Scheme 2b).  Electron-rich 1e was even more reactive compared to 1a in competition against 
1h: the competition reaction between 1e and 1h generated 3e as the sole product in 70% yield 
(Scheme 2c).  In the latter two cases, the dipolarophile expected to have stronger catalyst affinity 
reacts exclusively with the dipole, lending support for our hypothesis that more electron-rich 
dipolarophiles bind more strongly to the catalyst.  
 
Scheme 2.  Competition reactions of excess dipolarophile with limiting dipole under mg-
catalyzed conditions 
In order to further demonstrate that the outcomes of these competition reactions were a 
result of catalyst affinity, we subjected substrates 1e and 1h to a competition reaction in the 
absence of catalyst, as shown in Scheme 3. This reaction delivered 3h in 84% yield, while it 
furnished 3e in only 10% yield.  This was nearly a complete reversal of outcome from the 
corresponding catalyzed competition reaction where electron-rich 1e was more reactive than 
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electron poor 1h.  Notably, the uncatalyzed reaction of 1h with 2a generated 3h with  
regiochemistry opposite of that observed in the corresponding catalyzed reaction, with fusion of 
the dipole N-terminus with the β-position of the dipolarophile and fusion of the dipole C-
terminus with the α-position of the dipolarophile.  Such a reversal of regiochemistry is consistent 
with previous observations in 1,3-dipolar cycloaddition reactions of nitrile imines with electron-
deficient dipolarophiles in the absence of Lewis-acids.9  The delivery of the product with typical 
regioselectivity in the presence of Lewis-acid but with diminished enantioselectivity (Table 2, 
entry 4) suggests that substrate 1h interacts strongly enough with the catalyst in the reaction to 
deliver only the typical regioisomer, but weakly enough to reduce facial selectivity, leading to 
lower enantioselectivity.
Scheme 3.  Uncatalyzed Competition Reaction of 1e and 1h with dipole 2a 
Catalytic, enantioselective, 1,3-dipolar cycloadditions of nitrile imines with 
methyleneindolindolinones: competition reactions of dipoles 
 We conducted competition reactions of excess dipoles in the presence of limiting 
dipolarophile to determine whether or not the electronics of the dipole had an influence on 
reaction rates.  The competition reaction outcomes are shown in Scheme 4.  The competition 
reaction of 2a and 2a in the presence of the catalyst delivered a 95:5 ratio of 3a:3o (Scheme 4a), 
while the competition of 2a and 2j resulted in a 44:56 3a:3t ratio (Scheme 4b). These 
competition reactions revealed that 1) dipoles with more electron-rich C-termini greatly are far 
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more reactive under our conditions than dipoles with less electron-rich C-termini (Scheme 4a), 
and 2) dipoles with electron-poor N-termini, and thus more acidic anilinic protons, are slightly 
more reactive than dipoles with more electron-rich N-termini under our conditions (Scheme 4b).  
Despite these differences in reaction rates, there appears to be no correlation between dipole 
electronics and enantioselectivity (Table 3), thus demonstrating that resulting yields and 
enantioselectivities in the presence of the catalyst are influenced far more by dipolarophile 
electronics. 
 
 Scheme 4. Competition reactions of excess dipole with limiting dipolarophile under mg-
catalyzed conditions 
 
Catalytic, enantioselective, 1,3-dipolar cycloadditions of nitrile imines with 
methyleneindolindolinones: conclusion 
 In summary, we have developed a method for 1,3-dipolar cycloadditions of nitrile imines 
to form spiro[pyrazolin-3,3´-oxindole] in high yields with high enantioselectivity.  This process 
is complementary to extant methods, allowing for the formation of spiro[pyrazolin-3,3´-
oxindoles] that could not previously be accessed in highly enantioenriched form.  Specifically, 
spiro[pyrazolin-3,3´-oxindole] cycloadducts are formed with high enantioselectivity from 
methyleneindolinones lacking ortho-substituted aryl group at the β-position of the dipolarophile.  
Studies to develop asymmetric cycloadditions of nitrile imines with additional classes of 
dipolarophiles are ongoing in our laboratory.  
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Experimental Details 
General experimental details  
All air-sensitive procedures were conducted under inert atmosphere in a nitrogen-filled 
dry box or by standard Schlenk techniques. All reactions were performed under an atmosphere of 
nitrogen unless otherwise stated. All glassware for moisture sensitive reactions was dried at 140 
°C in an oven. THF and CH2Cl2 were degassed by purging with argon for 45 minutes and dried 
with a solvent purification system by passing through a one-meter column of activated alumina. 
Flash column chromatography was performed on Fisher brand silica gel 60 (230-400 mesh). 
Products of reactions were visualized on TLC plates under UV light or by staining with KMnO4, 
phosphomolybdic acid, or ceric ammonium molybdate.  
HRMS (ESI) analysis was performed at the Iowa State University Chemical 
Instrumentation Facility on an Agilent 6540 QTOF spectrometer. Optical rotations were 
measured on an Atago AP-300 automatic polarimeter. HPLC analyses were carried out on a 
Water Alliance HPLC system with an e2695 Separations Module and a 2489 (UV/Vis) dual 
wavelength detector. NMR spectra were acquired on Varian MR-400 and Bruker Avance III 600 
spectrometers at the Iowa State University Chemical Instrumentation Facility. 1H and 13C NMR 
chemical shifts are reported in ppm relative to residual CHCl3 in CDCl3 (7.26 ppm for 
1H and 
77.23 ppm for 13C).  19F NMR shifts are reported in ppm relative to trifluoroacetic acid as an 
external standard (F3CCO2H = -76.55 ppm).  
Materials  
Unless otherwise stated, reagents were purchased from Sigma-Aldrich and used without 
further purification. Methyleneindolinones S1a-k were synthesized according to literature 
procedures from oxindole and the appropriate aldehyde.8,10 Methyleneindolinone 1d was 
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prepared according to a previously reported procedure.8 4-Fluorophenylhydrazine and 4- 
trifluoromethylphenylhydrazine were purchased from AK Scientific. Hydrazones S2a-g were 
synthesized by stirring an equimolar mixture of the appropriate hydrazines and aldehydes in 
CH2Cl2 (0.33 M) in the presence of MgSO4 until TLC analysis indicated consumption of the 
aldehyde. Filtration and concentration under reduced pressure afforded the hydrazone which was 
used without further purification or recrystallized from EtOH if necessary. Hydrazonoyl bromide 
2a was prepared according to a literature procedure from benzaldehyde phenylhydrazone.3b 
Bisoxazoline ligand L2 was prepared according to a previously reported procedure from (1R,2S)-
(+)-cis-1-amino-2-indanol.11 (1R,2S)-(+)-cis-1-Amino-2-indanol was purchased from 
Carbosynth. Magnesium bis(trifluoromethylsulfonyl)imide was purchased from Strem Chemicals 
and used without further purification. Magnesium perchloroate was purchased from Fisher 
Scientific and used without further purification. Powdered 4Å molecular sieves were purchased 
from Sigma-Aldrich and flame-dried under vacuum prior to use. N-bromosuccinimide (NBS) 
and N-chlorosuccinimide (NCS) were purchased from Sigma Aldrich and recrystallized from 
water before use. 
General procedure for synthesis of N-acyl methyleneindolinones 1a, 1e-n 
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To a solution of the appropriate methyleneindolinone S1 (1.0 equiv) in THF (0.1 M) at  
-78 °C was added n-BuLi (1.05 equiv as a 2.5 M solution in hexanes). The reaction mixture was 
allowed to stir for 30 minutes before dropwise addition of benzoyl chloride (1.05 equiv). After 
addition of benzoyl chloride, the reaction was allowed to warm to room temperature until TLC 
analysis showed consumption of S1. After the reaction was judged to be complete by TLC 
analysis, the mixture was quenched with saturated ammonium chloride and extracted with ethyl 
acetate. The organic layer was separated and washed with water and brine. The organic layer was 
dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The resulting 
crude product was recrystallized from ethanol to give a mixture of E- and Z-methyleneindolinone 
isomers. Pure E-methyleneindolinones 1 were isolated by fractional recrystallization from 
ethanol. 
 
(E)-1-Benzoyl-3-benzylideneindolin-2-one (1a): Prepared according to the 
general procedure from S1a (5.50 g, 24.9 mmol) to give 1a (5.27 g, 16.2 mmol, 
65%) as a yellow solid. m.p. = 153-154 °C 1H NMR (CDCl3, 600 MHz) δ 7.07 
(dt, J = 7.8, 1.2 Hz 1H), 7.37 (dt, J = 1.2, 8.4 Hz 1H), 7.44-7.54 (m, 5H), 7.62 (t, 
J = 7.8 Hz, 1H), 7.64-7.69 (m, 2H), 7.76 (dd, J = 7.8, 0.6 Hz, 1H), 7.79-7.82 (m, 2H), 7.83 (s, 
1H), 7.93 (d, J = 7.8 Hz, 1H). 13C NMR (CDCl3, 151 MHz) δ 115.4, 122.3, 122.7, 124.5, 126.1, 
128.3, 129.0, 129.4, 129.6, 130.3, 130.4, 133.0, 134.6, 134.7, 139.2, 140.7, 167.8, 169.6. HRMS 
(ESI) calcd. for C22H16NO2
+ [M+H]+ 326.1181, found 326.1178. 
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 (E)-1-Benzoyl-3-(4-methoxybenzylidene)indolin-2-one (1e): Prepared 
according to the general procedure from S1b (2.50 g, 9.95 mmol) to give 1e 
(2.32g, 6.27 mmol, 63%) as a yellow solid. m.p. = 160-162 °C 1H NMR 
(CDCl3, 400 MHz) δ 3.90 (s, 3H), 7.01 (d, J = 8.4 Hz, 1H), 7.10 (t, J = 7.6 
Hz, 1H), 7.36 (t, J = 8.0 Hz, 1H), 7.49 (t, J = 8.0 Hz, 2H), 7.61 (t, J = 7.6 Hz, 
1H), 7.67 (d, J = 8.8 Hz, 2H), 7.75-7.83 (m, 3H), 7.86-7.96 (m, 2H). 13C NMR (CDCl3, 151 
MHz) δ 55.5, 114.3, 115.2, 122.2, 122.6, 123.9, 124.2, 126.8, 128.2, 129.5, 129.8, 131.6, 132.7, 
134.7, 139.3, 140.2, 161.3, 168.0, 169.6. HRMS (ESI) calcd. for C23H18NO3
+ [M+H]+ 356.1287, 
found 356.1272. 
(E)-1-Benzoyl-3-(4-chlorobenzylidene)indolin-2-one (1f): Prepared according 
to the general procedure from S1c (1.00 g, 7.82 mmol) to give 1f (0.52 g, 2.9 
mmol, 37%) as a yellow solid. m.p. = 203-205 °C 1H NMR (CDCl3, 400 MHz) 
δ 7.08 (t, J = 8.0 Hz, 1H), 7.39 (t, J = 8.0 Hz, 1H), 7.43-7.54 (m, 4H), 7.55-7.65 
(m, 3H), 7.70 (d, J = 7.6 Hz, 1H), 7.74 (s, 1H), 7.79 (d, J = 7.2 Hz, 2H), 7.91 (d, 
J = 8.4 Hz, 1H). 13C NMR (CDCl3, 101 MHz) δ 115.5, 122.1, 122.7, 124.6, 126.6, 128.4, 129.3, 
129.7, 130.7, 130.8, 133.0, 133.1, 134.6, 136.2, 137.5, 140.8, 167.6, 169.6. HRMS (ESI) calcd. 
for C22H15NO2Cl
+ [M+H]+ 360.0791, found 360.0790. 
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(E)-1-Benzoyl-3-(4-bromobenzylidene)indolin-2-one (1g): Prepared 
according to the general procedure from S1d (2.00 g, 6.66 mmol) to give 1g 
(1.28 g, 3.19 mmol, 48%) as yellow solid. m.p. = 182-186 °C 1H NMR (CDCl3, 
400 MHz ) δ 7.08 (t, J = 8.0 Hz, 1H), 7.39 (t, J = 8.0 Hz, 1H), 7.44-7.56 (m, 
4H), 7.58-7.66 (m, 3H), 7.67-7.73 (m, 2H), 7.79 (d, J = 7.6 Hz, 2H), 7.91 (d, J 
= 8.0 Hz, 1H). 13C NMR (CDCl3, 151 MHz) δ 115.6, 122.1, 122.7, 124.5, 124.6, 126.7, 128.4, 
129.7, 130.7, 130.9, 132.3, 133.1, 133.5, 134.6, 137.5, 140.9, 167.6, 169.6. HRMS (ESI) calcd. 
for C22H15NO2Br
+ [M+H]+ 404.0286, found 404.0285. 
 
(E)-1-Benzoyl-3-(4-(trifluoromethyl)benzylidene)indolin-2-one (1h): Prepared according to 
the general procedure from S1e (1.00 g, 3.46 mmol) to give 1h (0.40 g, 1.0 mmol, 29%) as a 
yellow solid. m.p. = 175-177 °C 1H NMR (CDCl3, 600 MHz) δ 7.09 (t, J = 7.8 Hz, 1H) 7.41 (t, J 
= 7.8 Hz, 1H), 7.52 (t, J = 7.8 Hz, 2H), 7.58-7.66 (m, 2H), 7.74-7.83 (m, 7H), 7.93 (d, J = 7.8 
Hz, 1H). 13C NMR (CDCl3, 151 MHz) δ 115.7, 121.8, 122.9, 124.0 (q, J = 
272.3 Hz), 124.7, 126.0 (q, J = 3.5 Hz) 128.0, 128.4, 129.5, 129.7, 131.1, 
131.8 (q, J = 31.4 Hz), 133.2, 134.5, 136.5, 138.3, 141.1, 167.4, 169.5. 19F 
NMR (CDCl3, 376 MHz): δ -63.5. HRMS (ESI) calcd. for C23H15F3NO2+ 
[M+H]+ 394.1055, found 394.1062. 
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(E)-1-Benzoyl-3-(3-methoxybenzylidene)indolin-2-one (1i): Prepared 
according to the general procedure from S1f (5.00 g, 21.6 mmol) to give 1i (4.09 
g, 12.5 mmol, 58%) as a yellow solid. m.p. = 135-137 °C 1H NMR (CDCl3, 600 
MHz) δ 3.85 (s, 3H), 7.01 (dd, J = 8.4, 2.4 Hz, 1H), 7.08 (dt, J = 1.2, 12.0 Hz, 
1H), 7.16 (s, 1H), 7.24 (d, J = 7.8 Hz, 1H), 7.34-7.44 (m, 2H), 7.50 (t, J = 7.8 
Hz, 2H), 7.61 (t, J = 7.8 Hz, 1H), 7.77-7.82 (m, 4H), 7.92 (d, J = 8.4 Hz, 1H). 
13C NMR (CDCl3, 151 MHz) δ 55.6, 114.4, 115.4, 116.2, 121.8, 122.3, 123.0, 124.5, 126.4, 
128.4, 129.6, 130.1, 130.4, 133.0, 134.7, 135.9, 139.0, 140.7, 160.0, 167.8, 169.6. HRMS (ESI) 
calcd. for C23H18NO3
+ [M+H]+ 356.1287, found 356.1283. 
 
(E)-1-Benzoyl-3-(3,4,5-trimethoxybenzylidene)indolin-2-one (1j): 
Prepared according to the general procedure from S1g (7.50 g, 24.09 mmol) 
to give 1j (2.67 g, 6.50 mmol, 27%) as a yellow solid. m.p. =191-192 °C 1H 
NMR (CDCl3, 600 MHz) δ 3.86 (s, 6H), 3.91 (s, 3H), 7.24 (t, J = 7.8 Hz, 
1H), 7.36 (t, J = 7.8 Hz, 1H), 7.45 (t, J = 7.8 Hz, 2H), 7.55 (s, 1H), 7.56-
7.60 (m, 3H), 7.63 (d, J = 7.2 Hz, 1H), 7.77-7.83 (m, 3H). 13C NMR (CDCl3, 151 MHz,) δ 56.3, 
61.0, 110.1, 114.7, 118.7, 123.5, 124.4, 125.5, 128.1, 128.9, 129.1, 129.6, 132.7, 134.6, 138.6, 
139.2, 141.0, 152.7, 165.6, 169.8. HRMS (ESI) calcd. for C25H22NO5
+ [M+H]+ 416.1498 found 
416.1493. 
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(E)-1-Benzoyl-3-(2-fluorobenzylidene)indolin-2-one (1k): Prepared according 
to the general procedure from S1h (1.00 g, 4.18 mmol) to give 1k (0.83 g, 2.4 
mmol, 58%) as a yellow solid. m.p. = 209-211 °C 1H NMR (CDCl3, 600 MHz) 
δ 7.08 (dt, J = 1.2, 7.8 Hz, 1H), 7.21 (t, J = 9.6 Hz, 1H), 7.26 (t, J = 7.8 Hz, 1H), 
7.39 (t, J = 7.8 Hz, 1H), 7.45-7.53 (m, 3H), 7.56 (d, J = 7.8 Hz, 1H), 7.62 (t, J = 
7.8 Hz, 1H), 7.71 (dt, J = 1.2, 7.2 Hz, 1H), 7.78-7.82 (m, 3H), 7.92 (d, J = 7.8 Hz, 1H). 13C 
NMR (CDCl3, 151 MHz) δ 115.5, 116.5 (d, J = 21.1 Hz), 122.2, 122.8 (d, J = 14.7 Hz), 123.0, 
124.4 (d, J = 3.6 Hz), 124.6, 128.0, 128.4, 129.7, 130.4, 130.8, 131.4, 132.2 (d, J = 8.4 Hz), 
133.1, 134.7, 140.9, 160.7 (d, J = 252.5 Hz), 167.3, 169.6 19F NMR (CDCl3, 376 MHz): δ -
110.1 HRMS (ESI) calcd. for C22H15NO2F
+ [M+H]+ 344.1087, found 344.1087. 
 
(E)-1-Benzoyl-3-(2-bromobenzylidene)indolin-2-one (1l): Prepared according 
to the general procedure from S1i (1.20 g, 4.00 mmol) to give 1l (0.70 g, 1.7 
mmol, 43%) as a yellow solid. m.p. = 197-199 °C 1H NMR (CDCl3, 600 MHz) 
δ 7.03 (dt, J = 1.2, 8.4 Hz, 1H), 7.30-7.45 (m, 4H), 7.51 (t, J = 7.8 Hz, 2H), 7.62 
(tt, J = 7.8, 1.2 Hz, 1H), 7.69 (dd, J = 7.8, 1.2 Hz, 1H), 7.72 (dd, J = 7.8, 1.2 Hz, 
1H), 7.78-7.82 (m, 3H), 7.92 (d, J = 7.8 Hz, 1H). 13C NMR (CDCl3, 151 MHz) δ 115.5, 121.8, 
122.8, 124.2, 124.4, 127.2, 127.4, 128.2, 129.4, 130.0, 130.6, 131.2, 132.8, 133.4, 134.5, 135.1, 
137.2, 140.7, 167.1, 169.4. HRMS (ESI) calcd. for C22H15NO2Br
+ [M+H]+ 404.0286 found 
404.0280. 
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(E)-1-Benzoyl-3-(2,2-dimethylpropylidene)indolin-2-one (1m): Prepared 
according to a modified version of the general procedure from S1j (5.30 g, 26.3 
mmol) to give 1m (0.77 g, 2.63 mmol, 10%) as a light green oil. Compound 1m 
was purified by flash column chromatography (98:2 hexanes:EtOAc) instead of 
purification by recrystallization. 1H NMR (CDCl3, 400 MHz) δ 1.18 (s, 9H), 6.95- 
7.05 (m, 2H), 7.11 (t, J = 3.6 Hz, 1H), 7.22 (t, J = 4.0 Hz, 2H), 7.33 (t, J = 7.6 Hz, 
1H), 7.51-7.57 (m, 2H), 7.61 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 8.0 Hz, 1H). 13C NMR (CDCl3, 
101 MHz) δ 28.9, 32.7, 114.9, 121.4, 124.1, 125.4, 126.1, 127.9, 129.0, 129.3, 132.5, 134.5, 
140.4, 154.7, 167.8, 169.2. HRMS (ESI) calcd. for C20H20NO2
+ [M+H]+ 306.1494, found 
306.1496. 
(Z)-1-Benzoyl-3-(2,2-dimethylpropylidene)indolin-2-one (1n): Prepared 
according to a modified version of the general procedure from S1k (5.30 g, 
26.3 mmol) to give 1n (0.21 g, 0.68 mmol, 3%) as a light green oil. Compound 
1n was purified by flash column chromatography (98:2 hexanes:EtOAc) 
instead of purification by recrystallization. 1H NMR (CDCl3, 400 MHz) δ 1.36 (s, 9H), 7.07 (s, 
1H) 7.16 (dt, J = 0.8, 7.6 Hz 1H), 7.31 (dt, J = 1.2, 8.0 Hz 1H), 7.41-7.50 (m, 3H), 7.58 (t, J = 
7.6 Hz, 1H), 7.72-7.78 (m, 2H), 7.81 (d, J = 8.4 Hz, 1H). 13C NMR (CDCl3, 101 MHz) δ 29.3, 
34.0, 114.9, 118.8, 124.4, 125.0, 125.9, 128.3, 129.0, 129.5, 132.8, 134.8, 138.8, 155.2, 165.0, 
169.8. HRMS (ESI) calcd. for C20H20NO2
+ [M+H]+ 306.1494, found 306.1493. 
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Synthesis of (E)-1-acetyl-3-benzylideneindolin-2-one 1b 
 
A suspension of (E)-3-benzylideneindolin-2-one S1a (13.5 g, 61 mmol) in acetic 
anhydride (300 mL) was heated to 100 ºC (bath temperature) with stirring overnight, during 
which time the suspension cleared to a deep red-brown solution. The mixture was cooled and 
poured into 1.4 L of H2O. A yellow-orange product precipitated and was dissolved by shaking 
with 300 mL of 1:1 tBuOMe:Et2O. The organic layer was separated, and the aqueous layer was 
extracted twice more with 300 mL of 1:1 tBuOMe:Et2O. The combined organic extracts were 
washed with aqueous 2M NaOH (2 x 350 mL), H2O (2 x 500 mL), and brine (1 x 300 mL), then 
dried over Na2SO4. Filtration and concentration under reduced pressure afforded a crude orange-
red solid, which was recrystallized from EtOH (~125 mL), to afford the 1b (11.2 g, 42.5 mmol, 
70%) as yellow needles. m. p. = 123-124 °C. 1H NMR (CDCl3, 400 MHz) δ 2.77 (s, 3H), 7.04 (t, 
J = 7.6 Hz, 1H), 7.33 (dt, J = 0.8, 8.0 Hz, 1H), 7.42-7.53 (m, 3H), 7.61-7.67 (m, 2H), 7.70 (d, J = 
7.6 Hz, 1H), 7.89 (s, 1H), 8.32 (d, J = 8.0 Hz, 1H). 13C NMR (CDCl3, 101 MHz) δ 27.1, 116.9, 
122.1, 122.4, 124.7, 126.3, 129.0, 129.4, 130.3, 130.5, 134.6, 138.9, 140.5, 168.8, 171.1. HRMS 
(ESI) calcd. For C17H14NO2
+ [M+H]+ 264.1025, found 264.1023. 
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Synthesis of (E)-3-benzylidene-1-pivaloylindolin-2-one 1c 
 
To a solution of S1a (0.50 g, 2.24 mmol) in THF (50 ml) at -78 °C was added n-BuLi 
(1.10 equiv as a 2.5 M solution in hexanes). The reaction mixture was allowed to stir for 30 
minutes before dropwise addition of pivaloyl chloride (1.05 equiv). After addition of pivaloyl 
chloride, the reaction was allowed to warm to room temperature until TLC analysis showed 
consumption of S1a. After the reaction was judged to be complete by TLC analysis, the mixture 
was quenched with saturated ammonium chloride and extracted with ethyl acetate. The organic 
layer was separated and washed with water and brine. The organic layer was dried over 
magnesium sulfate, filtered, and concentrated under reduced pressure. Crude mixture was 
purified by flash column chromatography to afford 1c in 75% yield (0.512 g, 1.68 mmol). 1H 
NMR (CDCl3, 600 MHz) δ 1.25 (s, 9H), 6.88 (t, J = 7.8 Hz, 1H), 6.92 (d, J = 7.8 Hz, 1H), 7.22 
(t, J = 7.8 Hz, 1H), 7.42-7.50 (m, 3H), 7.63-7.69 (m, 3H), 7.85 (s, 1H) 13C NMR (CDCl3, 151 
MHz) δ 27.3, 38.8, 110.5, 121.9, 122.2, 123.3, 127.7, 128.9, 129.6, 123.0, 130.1, 135.0, 138.1, 
141.7, 170.8, 184.1. HRMS (ESI) calcd. For C20H20NO2
+ [M+H]+ 306.1489, found 306.1492. 
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General procedure for synthesis of hydrazonoyl bromides 2b-g 
 
The following general procedure was adapted from the literature.3b To a suspension of 
NBS (3 equiv) in dry CH2Cl2 [0.2M] at 0 ºC under N2 was added Me2S (6 equiv). After stirring 
for 15 min at 0 ºC, the mixture was cooled to -78 ºC for 10 min and a solution of the appropriate 
hydrazone S2a-g (1 equiv) in CH2Cl2 [0.5M] was added. The reaction was stirred at -78 ºC for 1 
hr and then warmed to RT for 4 hr at which point the heterogeneous reaction mixture was 
filtered through a plug of silica gel, rinsing with 10 % EtOAc/hexanes, to remove the solid 
precipitates. The resulting solution was concentrated in vacuo, and the residue was purified by 
flash column chromatography on silica gel using 30% CH2Cl2/hexanes as eluent. This eluent 
system typically afforded better separation between the desired hydrazonoyl bromide and the 
hydrazone resulting from dehalogenation at the formyl position. Chromatography was 
performed as rapidly as possible due to the instability of the hydrazonoyl bromides on silica gel. 
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(Z)-Nʹ-(4-bromophenyl)-4-(trifluoromethyl)benzohydrazonoyl bromide 
(2b): Prepared according to the general procedure from (E)-1-(4 
bromophenyl)-2-(4-(trifluoromethyl)benzylidene)hydrazine S2b (1.50 g, 
5.68 mmol) and the Corey-Kim complex of NBS (3.03 g, 17.0 mmol) and 
dimethyl sulfide (2.11 g, 2.50 mL, 34.08 mmol) as the brominating agent. 
After chromatography, the title compound 2b was isolated as a pink solid in 
29% yield (0.700 g, 1.66 mmol). 1H NMR (CDCl3, 600 MHz): δ 7.07 (dd, J = 1.2, 7.8 Hz, 2H), 
7.43 (dd, J = 1.2, 7.8 Hz, 2H), 7.65 (d, J = 8.4 Hz, 2H), 7.99 (d, J = 8.4 Hz, 2H), 8.13 (s, 1H). 
13C NMR (CDCl3, 151 MHz): δ 114.2, 115.6, 118.6, 124.1 (q, J = 272.3 Hz), 125.6 (q, J = 3.8 
Hz), 127.9, 131.3 (q, J = 32.5 Hz), 132.6, 138.9 (q, J = 1.4 Hz), 141.9. 19F NMR (CDCl3, 565 
MHz): δ -63.2. HRMS (ESI) calcd. for C28H17Br2F6N4+ [nitrile imine dimer + H]+ 680.9719, 
found 680.9716. 
 
(Z)-3-bromo-N-(4-bromophenyl)benzohydrazonoyl bromide (2c): 
Prepared according to the general procedure from (E)-1-(3-
bromobenzylidene)-2-(4-bromophenyl)hydrazine S2c (0.825 g, 3.00 mmol) 
and the Corey-Kim complex of NBS (1.60 g, 9.00 mmol) and dimethyl 
sulfide (1.12 g, 1.32 mL, 18.0 mmol) as the brominating agent. After 
chromatography, the title compound 2c was isolated as a red/purple solid in 
67% yield (0.900 g, 2.00 mmol). 1H NMR (CDCl3, 600 MHz): δ 7.06 (d, J = 8.8 Hz, 2H), 7.26 
(dd, J = 9.8, 7.8 Hz, 1H), 7.42 (d, J = 8.8 Hz), 7.49 (ddd, J = 9.0, 1.8, 1.2 Hz, 1H), 7.81 (ddd J = 
7.8, 1.8, 1.2 Hz), 8.02 (t, J = 1.8 Hz, 1H), 8.05 (s, 1H). 13C NMR (CDCl3, 151 MHz): δ 113.9, 
115.5, 118.4, 122.8, 126.4, 130.1, 130.5, 132.5 (two coincident signals, as determined by 
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HSQC), 137.6, 142.0. HRMS (ESI) calcd. for C26H17Br4N4
+ [nitrile imine dimer + H]+ 
700.8181, found 700.8170. 
 
(Z)-Nʹ-(4-bromophenyl)-2-fluorobenzohydrazonoyl bromide (2e): Prepared 
according to the general procedure from (E)-1-(4-bromophenyl)-2-(2- 
fluorobenzylidene)hydrazine S2e (2.48 g, 11.58 mmol) and the Corey-Kim 
complex of NBS (6.18 g, 34.73 mmol) and dimethyl sulfide (4.31 g, 5.10 mL, 
69.5 mmol) as the brominating agent. After chromatography, the title compound 
2e was isolated as a red solid in 28% yield (1.22 g, 3.30 mmol). 1H NMR 
(CDCl3, 400 MHz): δ 7.03-7.08 (m, 2H), 7.13 (ddd, J = 10.2, 8.9, 1.2 Hz, 1H), 7.21 (dt, J = 1.2, 
7.6 Hz, 1H), 7.31-7.37 (m, 1H), 7.37-7.42 (m, 2H), 7.66 (dt, J = 1.8, 7.6 Hz, 1H), 8.07 (s, 1H). 
13C NMR (CDCl3, 101 MHz): δ 112.7 (d, J = 4.9 Hz), 113.7, 115.5, 116.7 (d, J = 22.3 Hz), 
124.2 (d, J = 3.9 Hz), 124.6 (d, J = 10.4 Hz), 131.1 (d, J = 8.6 Hz), 131.5, 132.5, 142.1, 159.7 
(d, J = 257.4 Hz). 19F NMR (CDCl3, 376 MHz): δ -112.88. HRMS (ESI) calcd. for 
C26H17Br2F2N4
+ [nitrile imine dimer + H]+ 580.9783, found 580.9773. 
 
(Z)-2-bromo-Nʹ-(4-bromophenyl)benzohydrazonoyl bromide (2e): Prepared 
according to the general procedure from (E)-1-(2-bromobenzylidene)-2-(4- 
bromophenyl)hydrazine S2e (2.00 g, 7.27 mmol) and the Corey-Kim complex of 
NBS (3.88 g, 21.81 mmol) and dimethyl sulfide (2.70 g, 3.20 mL, 43.6 mmol) as 
the brominating agent. After chromatography, the title compound 2e was isolated 
as a brown solid in 32% yield (1.00 g, 2.30 mmol). 1H NMR (CDCl3, 600 MHz): 
δ 7.06 (d, J = 7.8 Hz, 2H), 7.26 (d, J = 7.8 Hz, 1H), 7.37-7.39 (m, 3H), 7.5 (dd, J = 7.2, 1.8 Hz, 
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1H), 7.66 (d, J = 7.8 Hz, 1H), 7.99 (s, 1H). 13C NMR (CDCl3, 151 MHz): δ 113.7, 115.5, 115.6, 
122.6, 127.6, 130.9, 131.9, 132.4, 133.8, 137.8, 142.2. HRMS (ESI) for C26H17Br4N4
+ [nitrile 
imine dimer + H]+ 700.8181, found 700.8169. 
 
(Z)-N′-(4-fluorophenyl)benzohydrazonoyl bromide (2f): Prepared according to 
the general procedure using (E)-1-benzylidene-2-(4-fluorophenyl)hydrazine (2.5 g, 
11.67 mmol) and the Corey-Kim complex of NBS (6.23 g, 35.01 mmol) and 
dimethyl sulfide (4.35 g, 5.14 mL, 70.01 mmol) as the brominating agent. Upon 
chromatography, the title compound 2f was isolated as a red solid in 54% yield (1.84 
g, 6.29 mmol). 1H NMR (CDCl3, 600 MHz): δ 6.99-7.06 (m, 2H), 7.11-7.16 (m, 2H), 7.34-7.43 
(m, 3H), 7.87-7.92 (m, 2H), 7.98 (s, 1H). 13C NMR (CDCl3, 151 MHz): δ 114.9 (d, J = 7.7 Hz), 
116.2 (d, J = 22.8 Hz), 119.7, 127.9, 128.6, 129.6, 135.9, 139.7 (d, J = 2.3 Hz), 158.1 (d, J = 
239.2 Hz). 19F NMR (CDCl3, 376 MHz): δ -123.5. HRMS (ESI) calcd. for C26H19F2N4+ [nitrile 
imine dimer + H]+ 425.1572, found 425.1569. 
 
(Z)-Nʹ-(4-(trifluoromethyl)phenyl)benzohydrazonoyl bromide (2g): Prepared 
according to the general procedure from (E)-1-benzylidene-2-(4- 
(trifluoromethyl)phenyl)hydrazine S2g (0.700 g, 2.65 mmol) and the Corey-Kim 
complex of NBS (1.41 g, 7.95 mmol) and dimethyl sulfide (0.99 g, 1.17 mL, 15.9 
mmol) as the brominating agent. After chromatography, the title compound 2g was 
isolated as a red solid in 44% yield (0.400 g, 1.17 mmol). 1H NMR (CDCl3, 600 MHz): δ 7.24 
(d, J = 8.4 Hz, 2H), 7.38-7.46 (m, 3H), 7.56 (d, J = 8.4 Hz, 2H), 7.86-7.96 (m, 2H), 8.20 (s, 1H). 
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13C NMR (CDCl3, 151 MHz): δ 113.5, 121.7, 123.2 (q, J = 32.8 Hz), 124.7 (q, J = 270.9 Hz), 
127.0 (q, J = 3.8 Hz), 128.1, 128.7, 130.1, 135.6, 145.8 (q, J = 1.2 
Hz). 19F NMR (CDCl3, 376 MHz): δ -62.0. HRMS (ESI) calcd. for C28H19F6N4+ [nitrile imine 
dimer + H]+ 525.1508, found 525.1508. 
General procedure for synthesis of spiro[pyrazolin-3,3′-oxindoles] 3a-t 
 
In a nitrogen-filled dry-box, Mg(NTf2)2 (11.7 mg, 0.0200 mmol, 0.100 equiv), L2 (7.8 
mg, 0.022 mmol, 0.11 equiv), the appropriate methyleneindolinone 1 (0.200 mmol, 1.00 equiv), 
and powdered 4Å molecular sieves (100 mg) were added to a 1-dram vial. The appropriate 
hydrazonoyl bromide 2 (0.240 mmol, 1.20 equiv) was added to a second 1-dram vial. Both vials 
were sealed with a PFTE/silicone-lined septum cap and removed from the dry-box. The mixture 
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of Mg(NTf2)2, L2, methyleneindolinone 1, and 4Å molecular sieves was suspended in CH2Cl2 (1 
mL), allowed to stir for 15 minutes at room temperature, and cooled to -78 °C in a dry 
ice/acetone bath. Hydrazonoyl bromide 2 was dissolved in CH2Cl2 (1 mL) and added to the 
mixture of catalyst, dipolarophile and 4Å molecular sieves. The resulting mixture was allowed 
to stir for five minutes at -78 °C, then triethylamine (33 μL, 0.24 mmol) was added to initiate the 
cycloaddition reaction. The reaction mixture was allowed to stir for 4 h at -78 °C and monitored 
by TLC. Upon consumption of the methyleneindolinone 1, the reaction mixture was filtered 
through a pad of silica (eluting with EtOAc). The crude reaction mixture was concentrated under 
reduced pressure. CDCl3 (0.5-0.7 mL) was added to dissolve the crude reaction mixture, and the 
diastereomeric ratio was determined by 1H NMR spectroscopy. The crude reaction mixture was 
purified by flash column silica gel chromatography (hexanes:EtOAc) to yield spiro[pyrazolin- 
3,3′-oxindoles] 3a-t. 
 
(3S,4ʹS)-1-Benzoyl-2′-(4-bromophenyl)-4′,5ʹ-diphenyl-2′,4′- 
dihydrospiro[indoline-3,3′-pyrazol]-2-one (3a) (Table 1, entry 5): 
Prepared according to the general procedure at half of the typical scale 
from 1a (32.5 mg, 0.100 mmol) and 2a (42.5 mg, 0.120 mmol). The 
crude reaction mixture was purified by flash column chromatography 
(95:5 hexanes:EtOAc) to yield 3a (58.5 mg, 0.98 mmol, 98%) as a yellow foam 
with >95:5 diastereomeric and regioisomeric ratios. The enantiomeric excess was determined by 
HPLC analysis (254 nm, 25 °C) tR 7.1 min (major); tR 14.7 min (minor) [Chiracel AD-H (0.46 
cm x 25 cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 92% ee. 
[α]D25 = -495.6° (c 0.46, CHCl3). 1H NMR (CDCl3, 600 MHz) δ 5.10 (s, 1H), 6.44 (d, J = 7.2 
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Hz, 1H), 6.78-6.90 (m, 3H), 7.06 (bs, 2H), 7.18-7.42 (m, 13H), 7.54 (t, J = 7.8 Hz, 1H), 7.60- 
7.72 (m, 2H), 7.77 (d, J = 8.4 Hz, 1H). 13C NMR (CDCl3, 151 MHz) δ 63.1, 77.8, 114.9, 115.6, 
119.6, 124.7, 125.0, 126.8, 127.2, 128.5, 128.6, 128.7, 129.2, 129.5, 129.6, 130.5, 131.1, 132.2, 
133.5, 133.6, 134.0, 140.1, 144.3, 151.3, 169.3, 174.9. HRMS (ESI) calcd. for C35H25N3O2Br
+ 
[M+H]+ 598.1130, found 598.1129. 
 
(3S,4ʹS)-1-Acetyl-2′-(4-bromophenyl)-4′,5′-diphenyl-2′,4′- 
dihydrospiro[indoline-3,3′-pyrazol]-2-one (3b) (Table 1, entry 9): 
Prepared according to the general procedure from 1b (52.7 mg, 0.200 
mmol) and 2a (85.0 mg, 0.240 mmol). The crude reaction mixture was 
purified by flash column chromatography (95:5 hexanes:EtOAc) to 
yield 3b (81.3 mg, 0.152 mmol, 76%) as a yellow foam with >95:5 diastereomeric and 
regioisomeric ratios. The enantiomeric excess was determined by HPLC analysis (254 nm, 
25 °C) tR 6.7 min (major); tR 13.9 min (minor) [Chiracel AD-H (0.46 cm x 25 cm)(from Daicel 
Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 94% ee. [α]D25 = -436.8° (c 0.55, 
CHCl3). 1H NMR (CDCl3, 600 MHz) δ 2.76 (s, 3H), 5.19 (s, 1H), 6.51 (d, J = 7.2 Hz, 1H), 6.82-
6.90 (m, 3H), 7.03 (bs, 2H), 7.22-7.42 (m, 9H), 7.73-7.81 (m, 2H), 8.32 (d, J = 7.8 Hz, 1H) 13C 
NMR (CDCl3, 151 MHz) δ 26.8, 63.8, 77.2, 114.2, 116.8, 117.5, 124.2, 125.2, 126.0, 127.1, 
128.6, 128.7, 129.0, 129.3, 129.4, 130.3, 131.3, 132.1, 133.8, 139.5, 143.3, 149.5, 170.7, 176.5. 
HRMS (ESI) calcd. for C30H23BrN3O2
+ [M+H]+ 536.0974, found 536.0969. 
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(3S,4ʹS)-2ʹ-(4-bromophenyl)-4′,5′-diphenyl-1-pivaloyl-2′,4′- 
dihydrospiro[indoline-3,3ʹ-pyrazol]-2-one (3c) (Table 1, entry 10): 
Prepared according to the general procedure at half of the typical scale 
from 1c (30.5 mg, 0.100 mmol) and 2a (42.5 mg, 0.120 mmol). The 
crude reaction mixture was purified by flash column chromatography 
(95:5 hexanes:EtOAc) to yield 3c (56.0 mg, 0.97 mmol, 97%) as a yellow foam with >95:5 
diastereomeric and regioisomeric ratios. The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 7.8 min (major); tR 28.9 min (minor) [Chiracel AD-H (0.46 cm x 
25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 80:20, 1.0 mL/min] to be 40% ee. 
[α]D23 = -84.0° (c 0.88, CHCl3). 1H NMR (CDCl3, 600 MHz) δ 1.24 (s, 9H), 5.16 (s, 1H), 6.35 
(d, J = 7.2 Hz, 1H), 6.60 (t, J = 7.8 Hz, 1H), 6.77-6.82 (m, 2H), 6.96 (bs, 2H), 7.09 (t, J =7.8 Hz, 
1H), 7.12-7.21 (m, 5H), 7.27-7.30 (m, 3H), 7.64-7.69 (m, 2H), 8.57 (s, 1H) 13C NMR (CDCl3, 
151 MHz) δ 27.2, 38.7, 62.9, 77.2, 110.7, 113.7, 117.2, 122.9, 125.4, 126.7, 127.1, 128.3, 128.6, 
128.9, 129.2, 129.3, 129.9, 131.6, 132.0, 134.6, 134.0, 143.5, 149.8, 178.4, 184.1.HRMS (ESI) 
calcd. for C28H20BrN3O
+ [M-C5HO]
+ 494.0863, found 494.0861. 
 
(3S,4ʹS)-tert-Butyl 2′-(4-bromophenyl)-2-oxo-4′,5′-diphenyl-2′,4′- 
dihydrospiro[indoline-3,3′-pyrazole]-1-carboxylate (3d) (Table 1, 
entry 11): Prepared according to the general procedure from 1d (64.3 
mg, 0.200 mmol) and 2a (85.0 mg, 0.240 mmol). The crude reaction 
mixture was purified by flash column chromatography (95:5 
hexanes:EtOAc) to yield 3d (44.0 mg, 0.074 mmol, 37%) as a yellow foam with >95:5 
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diastereomeric and regioisomeric ratios. The enantiomeric excess of 3d was determined to be 
98% after cleavage of the Boc group to form S3a. [α]D24 = -345.9 (c 0.37, CHCl3). 1H NMR 
(CDCl3, 600 MHz) δ 1.64 (s, 9H), 5.13 (s, 1H), 6.38 (d, J = 3.6 Hz, 1H), 6.71 (t, J = 7.8 Hz, 1H), 
6.76 (d, J = 9.0 Hz, 2H), 6.92 (bs, 2H), 7.11-7.24 (m, 6H), 7.26-7.30 (m, 3H), 7.62-7.68 (m, 2H), 
7.87 (d, J = 8.4 Hz, 1H). 13C NMR (CDCl3, 151 MHz) δ 28.3, 63.6, 77.1, 85.4, 113.9, 115.4, 
117.4, 123.9, 124.4, 126.1, 127.1, 128.4, 128.6, 128.9, 129.2, 129.4, 130.1, 131.4, 132.0, 134.2, 
139.2, 143.2, 149.2, 149.3, 173.8. HRMS (ESI) calcd. for C33H29N3O3Br
+ [M+H]+ 594.1392, 
found 594.1384. 
 
(3S,4ʹS)-1-benzoyl-2′-(4-bromophenyl)-4′-(4-
methoxyphenyl)-5′-phenyl-2′,4′-dihydrospiro[indoline-
3,3′-pyrazol]-2-one (3e) (Table 2, entry 1):  Prepared 
according to the general procedure from 1e (71.1 mg, 0.200 
mmol) and 2a (85.0 mg, 0.240 mmol). The crude reaction 
mixture was purified by flash column chromatography (95:5 hexanes:EtOAc) to yield 3e (102 
mg, 0.162 mmol, 81%) as a yellow foam with >95:5 diastereomeric and regioisomeric ratios. 
The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 11.0 min 
(major); tR 21.9 min (minor) [Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., 
Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 99% ee. [α]D25 = -627.1° (c 0.47, CHCl3). 1H 
NMR (CDCl3, 400 MHz) δ 3.67 (s, 3H), 4.95 (s, 1H), 6.41 (d, J = 7.2 Hz, 1H), 6.68 (d, J = 8.4 
Hz, 2H), 6.72-6.83 (m, 3H), 6.87 (bs, 2H), 7.14-7.29 (m, 10H), 7.44 (t, J = 7.6 Hz, 1H), 7.49-
7.60 (m, 2H), 7.68 (d, J = 8 Hz, 1H). 13C NMR (CDCl3, 101 MHz) δ 55.5, 62.4, 77.8, 114.5, 
114.9, 115.6, 119.6, 124.8, 125.1, 126.0, 126.9, 127.2, 128.5, 128.6, 129.4, 129.5, 130.4, 130.8, 
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131.2, 132.2, 133.5, 133.6, 140.1, 144.3, 151.6, 159.8, 169.3, 174.9. HRMS (ESI) calcd. for 
C36H27N3O3Br
+ [M+H]+ 628.1236, found 628.1225. 
 
(3S,4ʹS)-1-benzoyl-2′-(4-bromophenyl)-4′-(4-chlorophenyl)-
5′-phenyl-2ʹ,4′-dihydrospiro[indoline-3,3′-pyrazol]-2-one (3f) 
(Table 2, entry 2): Prepared according to the general procedure 
from 1f (72.0 mg, 0.200 mmol) and 2a (85.0 mg, 0.240 mmol). 
The crude reaction mixture was purified by flash column 
chromatography (95:5 hexanes:EtOAc) to yield 3f (109 mg, 0.172 mmol, 86%) as a yellow foam 
with >95:5 diastereomeric and regioisomeric ratios. The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 8.4 min (major); tR 16.5 min (minor) 
[Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 
mL/min] to be 99% ee. [α]D24 = -396.1° (c 0.62, CHCl3). 1H NMR (CDCl3, 600 MHz) δ 5.09 (s, 
1H), 6.51 (d, J = 6.6 Hz, 1H), 6.87 (d, J = 9.0 Hz, 2H), 6.96 (dt, J = 0.6, 7.8 Hz, 1H), 7.01 (bs, 
2H), 7.21-7.39 (m, 13H), 7.57 (t, J = 7.8 Hz, 1H), 7.58-7.66 (m, 2H), 7.80 (d, J = 8.4 Hz, 1H) 
13C NMR (CDCl3, 151 MHz) δ 62.2, 77.7, 115.1, 115.9, 119.7, 124.4, 125.2, 126.7, 127.1, 
128.5, 128.7, 129.4, 129.6, 129.7, 130.7, 130.8, 130.9, 132.2, 132.4, 133.4, 133.6, 134.7, 140.2, 
144.1, 151.0, 169.2, 174.6. HRMS (ESI) calcd. for C35H24N3O2BrCl
+ [M+H]+ 632.0740, found 
632.0720. 
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(3S,4ʹS)-1-benzoyl-2′,4′-bis(4-bromophenyl)-5′-phenyl-2′,4ʹ-
dihydrospiro[indoline-3,3ʹ-pyrazol]-2-one (3g) (Table 2, 
entry 3): Prepared according to the general procedure from 1g 
(80.8 mg, 0.200 mmol) and 2a (85.0 mg, 0.240 mmol). The 
crude reaction mixture was purified by flash column 
chromatography (95:5 hexanes:EtOAc) to yield 3g (85.3 mg, 0.126 mmol, 63%) as a yellow 
foam with a 90:10 diastereomeric ratio and a >95:5 regioisomeric ratio. The enantiomeric excess 
was determined by HPLC analysis (254 nm, 25 °C) tR 9.0 min (major); tR 17.2 min (minor) 
[Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 
mL/min] to be 94% ee. [α]D26 = -506.8° (c 0.59, CHCl3). 1H NMR (CDCl3, 600 MHz) δ 5.12 (s, 
1H), 6.40 (dd, J = 7.8, 0.6 Hz, 1H), 6.68 (dt, J = 0.6, 7.2 Hz, 1H), 6.77-6.86 (m, 7H), 7.13 (dt, J 
= 1.2, 7.8 Hz, 2H), 7.16-7.19 (m, 2H), 7.27-7.31 (m, 6H) 7.59-7.64 (m, 3H). 13C NMR (CDCl3, 
151 MHz) δ 62.2, 77.6, 115.1, 115.9, 119.7, 122.8, 124.3, 125.2, 126.7, 127.1, 128.5, 128.7, 
129.6, 129.7, 130.7, 130.8, 131.2, 132.2, 132.4, 133.2, 133.4, 133.56, 140.7, 144.1, 151.0, 169.2, 
174.5. HRMS (ESI) calcd. for C35H24N3O2Br2
+ [M+H]+ 676.0235, found 676.0204. 
 
(3S,4ʹS)-1-benzoyl-2′-(4-bromophenyl)-5′-phenyl-4′-(4- 
(trifluoromethyl)phenyl)-2′,4′-dihydrospiro[indoline-3,3′- 
pyrazol]-2-one (3h) (Table 2, entry 4):  Prepared according to 
the general procedure from 1h (78.7 mg, 0.200 mmol) and 2a 
(85.0 mg, 0.240 mmol). The crude reaction mixture was 
purified by flash column chromatography (95:5 hexanes:EtOAc) to yield 3h (108 mg, 0.162 
mmol, 81%) as a yellow foam with >95:5 diastereomeric and regioisomeric ratios. The 
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enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 7.4 min (major); tR 
15.3 min (minor) [Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., Ltd.) hexane/i- 
PrOH, 90:10, 1.0 mL/min] to be 80% ee. [α]D24 = -433.4° (c 0.65, CHCl3). 1H NMR (CDCl3, 
400 MHz) δ 5.12 (s, 1H), 6.36 (d, J = 7.6 Hz, 1H), 6.80-6.90 (m, 3H), 7.17 (bs, 2H), 7.22-7.37 
(m, 10H), 7.46-7.55 (m, 3H), 7.55-7.63 (m, 2H), 7.75 (d, J = 8.0 Hz, 1H). 13C NMR (CDCl3, 
151 MHz) δ 62.4, 77.8, 115.1, 116.1, 119.8, 124.0 (q, J = 272.25 Hz), 124.2, 125.1, 126.1 (q, J = 
3.62 Hz), 126.5, 127.0, 128.5, 128.8, 129.6, 129.8, 130.1, 130.70, 130.74 (q, J = 32.8 Hz), 130.9, 
132.3, 133.4, 133.6, 138.3, 140.2, 144.0, 150.7, 169.2, 174.4. 19F NMR (CDCl3, 376 MHz): δ - 
63.1. HRMS (ESI) calcd. for C36H24F3N3O2Br
+ [M+H]+ 666.1004, found 666.0973. 
 
(3S,4ʹS)-1-benzoyl-2′-(4-bromophenyl)-4′-(3-methoxyphenyl)-5′-
phenyl-2′,4′-dihydrospiro[indoline-3,3ʹ-pyrazol]-2-one (3i) 
(Table 2, entry 5): Prepared according to the general procedure 
from 1i (71.1 mg, 0.200 mmol) and 2a (85.0 mg, 0.24 mmol). The 
crude reaction mixture was purified by flash column 
chromatography (95:5 hexanes:EtOAc) to yield 3i (113 mg, 0.180 
mmol, 90%) as a yellow foam with a 90:10 diastereomeric ratio and a >95:5 regioisomeric ratio. 
The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 8.2 min (major); 
tR 19.9 min (minor) [Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., Ltd.) 
hexane/i-PrOH, 90:10, 1.0 mL/min] to be 94% ee. [α]D26 = -497.4° (c 0.39, CHCl3). 1H NMR 
(CDCl3, 600 MHz) δ 3.68 (s, 3H), 5.06 (s, 1H), 6.54 (d, J = 7.8 Hz, 1H), 6.62-6.73 (m, 1H), 
6.78-6.83 (m, 1H), 6.84-6.93 (m, 3H), 7.17 (t, J = 7.8 Hz, 1H), 7.24-7.39 (m, 11H), 7.54 (t, J = 
7.2 Hz, 1H), 7.62-7.70 (m, 2H), 7.78 (d, J = 8.4 Hz, 1H). 13C NMR (CDCl3, 151 MHz) δ 55.5, 
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63.0, 77.8, 114.1, 114.9, 115.3, 115.6, 119.6, 121.9, 124.6, 125.0, 126.7, 127.1, 128.5, 128.6, 
129.48, 129.53, 130.2, 130.5, 131.2, 132.2, 133.47, 133.53, 135.4, 140.1, 144.2, 151.3, 160.2, 
169.3, 174.8. HRMS (ESI) calcd. for C36H27N3O3Br
+ [M+H]+ 628.1236, found 628.1219. 
 
(3S,4ʹS)-1-benzoyl-2′-(4-bromophenyl)-5′-phenyl-4′ (3,4,5-
trimethoxyphenyl)-2′,4′-dihydrospiro[indoline-3,3′-
pyrazol]-2-one (3j) (Table 2, entry 6): Prepared according to 
the general procedure from 1j (83.0 mg, 0.200 mmol) and 2a 
(85.0 mg, 0.240 mmol). The crude reaction mixture was 
purified by flash column chromatography (80:20 hexanes:EtOAc) to yield 3j (125 mg, 0.182 
mmol, 91%) as a yellow foam with >95:5 diastereomeric and regioisomeric ratios. The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 6.7 min (major); tR 
37.6 min (minor) [Chiracel AD-H (0.46cm x 25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-
PrOH, 80:20, 1.0 mL/min] to be 61% ee. [α]D26 = -22.2 (c 0.63, CHCl3). 1H NMR (CDCl3, 600 
MHz) δ 3.56 (s, 6H), 3.89 (s, 3H), 5.28 (s, 1H), 6.14 (s, 2H), 6.85 (d, J = 8.4 Hz, 2H), 6.94 (d, J 
= 7.8 Hz, 2H), 7.21-7.34 (m, 8H), 7.40-7.49 (m, 2H), 7.52-7.62 (m, 3H), 7.70 (d, J = 7.2 Hz, 
1H), 7.89 (d, J = 8.4 Hz, 1H). 13C NMR (CDCl3, 151 MHz) δ 56.2, 61.1, 68.3, 78.7, 107.3, 
113.8, 116.3, 116.8, 123.8, 126.5, 127.0, 128.1, 128.6, 129.2, 129.6, 130.2, 130.6, 131.1, 132.2, 
133.1, 133.3, 138.4, 139.9, 143.2, 147.6, 153.5, 168.7, 171.6. HRMS (ESI) calcd. for 
C38H31N3O5Br+ [M+H]+ 688.1447, found 688.1440. 
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(3S,4ʹS)-1-benzoyl-2ʹ-(4-bromophenyl)-4′-(2-fluorophenyl)-5′- 
phenyl-2′,4′-dihydrospiro[indoline-3,3′-pyrazol]-2-one (3k) 
(Table 2, entry 8): Prepared according to the general procedure 
from 1k (68.7 mg, 0.200 mmol) and 2a (85.0 mg, 0.24 mmol). The 
crude reaction mixture was purified by flash column 
chromatography (95:5 hexanes:EtOAc) to yield 3k (104 mg, 0.168 mmol, 84%) as a yellow 
foam with >95:5 diastereomeric and regioisomeric ratios. The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 8.1 min (major); tR 12.4 min (minor) 
[Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 
mL/min] to be 92% ee. [α]D24 = -323.0° (c 0.52, CHCl3). 1H NMR (CDCl3, 600 MHz) δ 5.55 (s, 
1H), 6.45 (d, J = 7.8 Hz, 1H), 6.78-6.91 (m, 4H), 7.08 (t, J = 7.8 Hz, 1H), 7.18 (t, J = 7.2 Hz, 
1H), 7.20-7.26 (m, 1H), 7.28-7.37 (m, 6H), 7.40 (t, J = 7.8 Hz, 2H), 7.46 (d, J = 7.2 Hz, 2H), 
7.56 (t, J = 7.2 Hz, 1H), 7.62-7.69 (m, 2H), 7.84 (d, J = 8.4 Hz, 1H). 13C NMR (CDCl3, 151 
MHz) δ 55.4, 115.2, 115.8 (d, J = 21.9 Hz), 118.7, 121.8 (d, J = 15.1 Hz), 124.5, 124.61, 124.62, 
124.8, 126.1, 126.9, 128.5, 128.7, 129.46, 129.56, 130.5, 130.6, 130.9, 132.2, 133.4, 133.7, 
140.4, 143.7, 149.1, 160.7 (d, J = 248.1Hz), 169.0, 174.9. 19F NMR (CDCl3, 376 MHz): δ 116.5. 
HRMS (ESI) calcd. for C35H24N3O2BrF
+ [M+H]+ 616.1036, found 616.1030. 
 
(3S,4ʹS)-1-benzoyl-4′-(2-bromophenyl)-2′-(4-bromophenyl)-5′- 
phenyl-2ʹ,4′-dihydrospiro[indoline-3,3ʹ-pyrazol]-2-one (3l) 
(Table 2, entry 9): Prepared according to the general procedure 
from 1l (80.8 mg, 0.200 mmol) and 2a (85.0 mg, 0.240 mmol). The 
crude reaction mixture was purified by flash column 
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chromatography (95:5 hexanes:EtOAc) to yield 3l (58.3 mg, 0.086 mmol, 43%) as a yellow foam 
with >95:5 diastereomeric and regioisomeric ratios. The enantiomeric excess was determined by 
HPLC analysis (254 nm, 25 °C) tR 7.3 min (major); tR 13.0 min (minor) [Chiracel AD-H (0.46 
cm x 25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 0% ee. 
1H NMR (CDCl3, 600 MHz): δ 5.56 (s, 1H), 6.24 (d, J = 11.4 Hz, 1H), 6.66-6.79 (m, 3H), 6.96-
7.06 (m, 1H), 7.09-7.21 (m, 8H), 7.22-7.35 (m, 6H), 7.42 (t, J = 10.8 Hz, 1H), 7.45-7.51 (m, 
2H), 7.71 (d, J = 12 Hz, 1H). 13C NMR (CDCl3, 101 MHz) δ 61.4, 77.4, 115.2, 115.6, 119.4, 
124.5, 124.8, 126.1, 126.4, 127.0, 128.1, 128.5, 128.8, 129.57, 129.61, 130.2, 130.6, 130.8, 
131.0, 132.2, 133.3, 133.4, 133.6, 133.8, 141.1, 144.0, 150.5, 169.0, 174.6. HRMS (ESI) calcd. 
for C35H24N3O2Br2
+ [M+H]+ 676.0235, found 676.0228. 
 
(3S,4ʹS)-1-benzoyl-2′-(4-bromophenyl)-4′-(tert-butyl)-5′-phenyl-
2ʹ,4ʹ-dihydrospiro[indoline-3,3′-pyrazol]-2-one (3m) (Table 2, 
entry 10): Prepared according to the general procedure from 1m (61.1 
mg, 0.200 mmol) and 2a (85.0 mg, 0.240 mmol). The crude reaction 
mixture was purified by flash column chromatography (95:5 
hexanes:EtOAc) to yield 3m (81.0 mg, 0.140 mmol, 70%) as a tan foam with >95:5 
diastereomeric and regioisomeric ratios. The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 4.8 min (major); tR 39.5 min (minor) [Chiracel AD-H (0.46 cm x 
25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 99% ee. 
[α]D25 = -258.6 (c 0.52, CHCl3). 1H NMR (CDCl3, 600 MHz) δ 0.87 (s, 9H), 4.17 (s, 1H), 6.76 
(d, J = 9 Hz, 2H), 7.19-7.26 (m, 3H), 7.36-7.43 (m, 3H), 7.43-7.50 (m, 3H), 7.51-7.57 (m, 2H), 
7.57-7.64 (m, 3H), 7.67 (d, J = 7.8 Hz, 1H), 7.81 (d, J = 7.8 Hz, 1H). 13C NMR (CDCl3, 151 
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MHz) δ 29.9, 34.8, 70.8, 78.2, 114.9, 115.7, 119.1, 125.0, 125.2, 128.2, 128.4, 128.5, 128.6, 
129.1, 129.7, 130.9, 131.9, 133.6, 133.7, 135.2, 140.5, 143.6, 153.9, 169.2, 176.5. HRMS (ESI) 
calcd. for C33H29N3O2Br
+ [M+H]+ 578.1443, found 578.1440. 
 
(3S,4ʹR)-1-benzoyl-2′-(4-bromophenyl)-4′-(tert-butyl)-5′-phenyl-
2ʹ,4ʹ-dihydrospiro[indoline-3,3′-pyrazol]-2-one (3n) (Equation 1): 
Prepared according to the general procedure from 1n (61.1 mg, 0.200 
mmol) and 2a (85.0 mg, 0.240 mmol). The crude reaction mixture was 
purified by flash column chromatography (95:5 hexanes:EtOAc) to 
yield 3n (74.0 mg, 0.128 mmol, 64%) as a tan foam with >95:5 diastereomeric and regioisomeric 
ratios. The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 6.5 min 
(minor); tR 13.8 min (major) [Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., 
Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 66% ee. [α]D26 = -194.4 (c 0.36, CHCl3). 1H 
NMR (CDCl3, 600 MHz): δ 0.97 (s, 9H), 4.01 (s, 1H), 6.86 (d, J = 9.0 Hz, 2H), 7.24 (t, J = 7.8 
Hz, 1H), 7.30 (d, J = 9.0 Hz, 2H), 7.35-7.52 (m, 9H), 7.55-7.64 (m, 3H), 7.70 (d, J = 8.4 Hz, 
1H). 13C NMR (CDCl3, 151 MHz) δ 29.7, 35.0, 73.2, 78.3, 115.4, 115.6, 120.0, 123.4, 126.2, 
128.1, 128.5, 128.6, 129.1, 129.7, 130.4, 131.0, 132.0, 133.5, 133.9, 135.2, 138.8, 143.5, 153.6, 
169.4, 172.7. HRMS (ESI) calcd. for C33H29N3O2Br
+ [M+H]+ 578.1443, found 578.1444. 
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(3S,4ʹS)-1-benzoyl-2ʹ-(4-bromophenyl)-4′-phenyl-5′-(4- 
(trifluoromethyl)phenyl)-2ʹ,4ʹ-dihydrospiro[indoline-3,3′-
pyrazol]-2-one (3o) (Table 3, entry 1): Prepared according to the 
general procedure from 1a (65 mg, 0.20 mmol) and 2b (101 mg, 0.24 
mmol). The crude reaction mixture was purified by flash column 
chromatography (95:5 hexanes:EtOAc) to give 3o (114 mg, 0.172 
mmol, 86%) as a yellow foam with >95:5 diastereomeric and regioisomeric ratios. The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 8.22 min (major); tR 
20.84 min (minor) [Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-
PrOH, 90:10, 1.0 mL/min] to be 94% ee. [α]D25= -370.5 (c 0.50, CHCl3). 1H NMR (CDCl3, 600 
MHz): δ 5.11 (s, 1H), 6.45 (dd, J = 1.2, 7.8, Hz, 1H), 6.82-6.90 (m, 3H), 6.95-7.10 (br s, 2H), 
7.23-7.30 (br s, 2H), 7.31-7.35 (m, 5H), 7.37 (t, J = 8.4 Hz, 2H), 7.49-7.53 (m, 3H), 7.55 (t, 7.2 
Hz, 1H), 7.74 (d, J = 7.8 Hz, 2H), 7.77 (d, J = 7.2 Hz, 1H). 19F NMR (CDCl3, 376 MHz): δ -
63.2. HRMS (ESI) Exact mass calcd. for C36H24BrF3N3O2
+ [M+H]+ 666.0999, found: 666.0996. 
This material was contaminated by traces of the starting alkylidene oxindole; to separate them, 
the N-benzoyl group was cleaved as described below. 
 
(3S,4ʹS)-1-benzoyl-5′-(3-bromophenyl)-2′-(4-bromophenyl)-4′-
phenyl-2ʹ,4ʹ-dihydrospiro[indoline-3,3′-pyrazol]-2-one (3p) 
(Table 3, entry 2): Prepared according to the general procedure 
from 1a (65 mg, 0.20 mmol) and 2c (104 mg, 0.24 mmol). The crude 
reaction mixture was purified by flash column chromatography (95:5 
hexanes:EtOAc) to give 3p (98.0 mg, 0.145 mmol, 72%) as a yellow 
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foam with >95:5 diastereomeric and regioisomeric ratios. The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 6.81 min (major); tR 10.90 min (minor) 
[Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 
mL/min] to be 84% ee. [α]D25= -420.0 (c 0.50, CHCl3). 1H NMR (CDCl3, 600 MHz): δ 5.04 
(s,1H), 6.42 (dd, J = 1.2, 7.8 Hz, 1H), 6.81-6.88 (m, 3H)), 6.95-7.08 (br s, 1H), 7.10 (t, J = 7.8 
Hz, 1H), 7.24-7.28 (br s, 3H), 7.29-7.34 (m, 5H), 7.36 (t, J = 7.8 Hz, 2H), 7.40 (dt, J = 1.2, 7.8 
Hz, 2H), 7.54 (tt, J = 1.2, 7.2 Hz, 1H), 7.77 (d, J = 8.4 Hz, 1H), 7.93 (t, J = 1.8 Hz, 1H). 13C 
NMR (CDCl3, 151 MHz) δ 62.7, 77.9, 115.0, 115.9, 119.6, 122.9, 124.3, 125.0, 125.6, 126.7, 
128.5, 128.9, 129.3, 129.5, 129.8, 130.1 (two coincident resonances, as determined by HSQC), 
130.6, 132.2, 132.3, 133.2, 133.47, 133.52, 133.54, 140.2, 143.8, 149.8, 169.2, 174.7. HRMS 
(ESI) Exact mass calcd. for C35H24Br2N3O2
+ [M+H]+ 676.0230, found 676.0254. 
 
(3S,4ʹS)-1-benzoyl-2′-(4-bromophenyl)-5′-(2-fluorophenyl)-4′-
phenyl-2ʹ,4′-dihydrospiro[indoline-3,3ʹ-pyrazol]-2-one (3q) (Table 
3, entry 3): Prepared according to the general procedure from 1a (65 
mg, 0.20 mmol) and 2e (89 mg, 0.24 mmol). The crude reaction 
mixture was purified by flash column chromatography (95:5 
hexanes:EtOAc) to give 3q (111 mg, 0.180 mmol, 90%) as a yellow 
foam with >95:5 diastereomeric and regioisomeric ratios. The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 6.51 min (major); tR 11.07 min (minor) 
[Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 
mL/min] to be 90% ee. [α]D25= -539.3 (c 0.51, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 5.27 (d, 
J = 2 Hz, 1H), 6.40 (d, J = 8 Hz, 1H), 6.78-6.85 (m, 3H), 6.90 (dd, J = 8.4, 11.6 Hz, 1H), 6.98-
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7.03 (m, 2H), 7.10 (t, J = 7.6 Hz, 1H), 7.16-7.25 (m, 4H), 7.25-7.38 (m, 7H), 7.51 (dt, J = 
0.8,7.2 Hz, 1H), 7.75 (d, J = 8 Hz, 1H), 8.00 (t, J = 7.6 Hz, 1H). 13C NMR (CDCl3, 101 MHz) δ 
64.4 (d, J = 6.5 Hz), 77.5 (d, J = 4.8 Hz), 114.9, 115.7, 116.6 (d, J = 22.5 Hz), 119.4 (d, J = 
11.0 Hz), 119.5, 124.4, 124.4 (d, J = 8.5 Hz), 125.0, 126.6, 128.48, 128.51, 128.9, 129.45, 
129.49, 129.54, 130.5, 131.2 (d, J = 8.6 Hz), 132.2, 133.47, 133.53, 133.9, 140.1, 144.0, 148.2 
(d, J = 3.8 Hz), 160.4 (d, J = 254.7 Hz), 169.2, 174.7. 19F NMR (CDCl3, 376 MHz) δ -112.88. 
HRMS (ESI) Exact mass calcd. for C35H24BrFN3O2
+ [M+H]+ 616.1030; found: 616.1028. 
 
(3S,4ʹS)-1-benzoyl-5-(2-bromophenyl)-2′-(4-bromophenyl)-4′-
phenyl-2ʹ,4′-dihydrospiro[indoline-3,3ʹ-pyrazol]-2-one (3r) (Table 
3, entry 4): Prepared according to the general procedure from 1a (65 
mg, 0.20 mmol) and 2e (104 mg, 0.24 mmol). The crude reaction 
mixture was purified by flash column chromatography (95:5 
hexanes:EtOAc) to give 3r (110 mg, 0.162 mmol, 81%) as a yellow 
foam with >95:5 diastereomeric and regioisomeric ratios. The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 9.38 min (major); tR 20.16 min (minor) 
[Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 
mL/min] to be 62% ee. [α]D25= -247.0 (c 0.51, CHCl3). 1H NMR (CDCl3, 600 MHz): δ 5.70 (s, 
1H), 6.61 (dd, J = 1.2, 7.8 Hz, 1H), 6.83-6.88 (m, 3H), 7.02-7.05 (m, 2H), 7.13 (dt, J = 1.2, 7.8 
Hz, 1H), 7.18-7.22 (m, 3H), 7.23-7.27 (m, 2H), 7.28-7.31 (m, 2H), 7.40 (t, J = 8.4 Hz, 2H), 7.44 
(dd, J = 1.8, 7.8 Hz, 2H), 7.55-7.59 (m, 2H), 7.60 (dd, J = 1.2, 7.8 Hz, 1H), 7.70 (d, J = 8.4 Hz, 
1H). 13C NMR (CDCl3, 151 MHz): δ 64.8, 77.9, 114.9, 115.5, 119.1, 122.0, 124.3, 124.9, 126.5, 
127.5, 128.5, 128.6, 128.9, 129.7, 129.8, 130.39, 130.44, 131.6, 132.0, 132.2, 133.2, 133.5, 
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133.6, 134.6, 139.9, 143.7, 150.5, 169.1, 174.8. HRMS (ESI) Exact mass calcd. for 
C35H24Br2N3O2
+ [M+H]+ 676.0230, found 676.0225. 
 
(3S,4ʹS)-1-benzoyl-2′-(4-fluorophenyl)-4′,5′-diphenyl-2′,4′- 
dihydrospiro[indoline-3,3′-pyrazol]-2-one (3s) (Table 3, entry 5): 
Prepared according to the general procedure from 1a (65 mg, 0.20 
mmol) and 2f (70 mg, 0.24 mmol). The crude reaction mixture was 
purified by flash column chromatography (95:5 hexanes:EtOAc) to 
give 3s (89.0 mg, 0.166 mmol, 83%) as a yellow foam with >95:5 diastereomeric and 
regioisomeric ratios. The enantiomeric excess was determined by HPLC analysis (254 nm, 25 
°C) tR 6.05 min (major); tR 10.70 min (minor) [Chiracel AD-H (0.46 cm x 25cm)(from Daicel 
Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 91% ee. [α]D24= -617.0 (c 0.56, 
CHCl3). 1H NMR (CDCl3, 400 MHz): δ 5.09 (s, 1H), 6.45 (dd, J = 8, 0.8 Hz, 1H), 6.87 (dt, J = 
0.8, 7.6 Hz 1H), 6.92-6.97 (m, 4H), 7.10 (bs, 2H), 7.21 (dd, J = 8, 1.2 Hz, 2H), 7.24-7.30 (m, 
6H), 7.31-7.37 (m, 3H), 7.52 (t, J = 7.6 Hz, 1H), 7.62-7.69 (m, 2H), 7.76 (d, J = 8.4 Hz, 1H). 13C 
NMR (CDCl3, 101 MHZ) δ 62.6, 78.4, 114.8, 115.7, 115.9, 120.8 (d, J = 7.9 Hz) 124.8, 124.9, 
126.9, 127.1, 128.4, 128.6, 129.2, 129.4, 129.5, 129.7, 130.4, 131.2, 133.4, 133.6, 134.1, 140.4, 
141.5 (d, J = 2.4 Hz) 151.7, 159.5 (d, J = 243.9 Hz) 169.3, 174.8. 19F NMR (CDCl3, 376 MHz): 
δ -120.1. HRMS (ESI) Exact mass calcd. for C35H25FN3O2+  [M+H]+ 538.1925, found 538.1925. 
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(3S,4ʹS)-1-benzoyl-4′,5′-diphenyl-2′-(4-(trifluoromethyl)phenyl)-
2ʹ,4ʹ-dihydrospiro[indoline-3,3ʹ-pyrazol]-2-one (3t) (Table 3, 
entry 6): Prepared according to the general procedure from 1a (65 
mg, 0.20 mmol) and 2g (82 mg, 0.24 mmol). The crude reaction 
mixture was purified by flash column chromatography (95:5 
hexanes:EtOAc) to give 3t (103 mg, 0.174 mmol, 87%) as a yellow foam with >95:5 
diastereomeric and regioisomeric ratios. The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 5.18 min (major); tR 8.61 min (minor) [Chiracel AD-H (0.46 cm x 
25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 90% ee. 
[α]D24= -450.9 (c 0.51, CHCl3). 1H NMR (CDCl3, 600 MHz): δ 5.16 (s, 1H), 6.47 (d, J = 7.8 
Hz, 1H), 6.83 (t, J = 7.8 Hz, 1H), 6.95-7.05 (br m, 2H), 7.05 (d, J = 7.8 Hz, 2H), 7.24-7.35 (m, 
9H), 7.36 (t, J = 7.8 Hz, 1H), 7.44-7.47 (m, 4H), 7.54 (t, J = 7.8 Hz, 1H), 7.58-7.73 (m, 2H), 
7.83 (d, J = 8.4 Hz, 1H). 13C NMR (CDCl3, 151 MHz) δ 63.6, 77.2, 115.2, 115.9, 123.7 (q, J = 
32.6 Hz), 124.5, 124.6 (q, J = 270.9), 125.1, 126.6, 126.6 (q, J = 3.5 Hz), 127.3, 128.5, 128.7, 
128.7, 129.2, 129.5, 129.6, 129.7, 130.5, 131.0, 133.5, 133.6, 134.0, 139.8, 147.5, 151.1, 169.1, 
174.9. 19F NMR (CDCl3, 376 MHz): δ -62.19. HRMS (ESI) Exact mass calcd. for 
C36H25F3N3O2
+ [M+H]+ 588.1893, found 588.1898. 
 
Synthesis of S3a from 3d 
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(3S,4ʹS)-2′-(4-bromophenyl)-4′,5′-diphenyl-2′,4′-
dihydrospiro[indoline-3,3ʹ-pyrazol]-2-one (S3a): A 1:1 mixture of 
CH2Cl2:trifluoroacetic acid (1 ml) was added to compound 3d (44 mg, 
0.074 mmol) under an atmosphere of nitrogen, and the mixture was 
stirred at room temperature until TLC showed complete consumption of 3d. The volatiles were 
evaporated under reduced pressure to yield S3a (34 mg, 0.069 mmol, 92%) as a tan powder. The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 7.6 min (major); tR 
28.3 min (minor) [Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-
PrOH, 80:20, 1.0 mL/min] to be 98% ee. [α]D24= -141.1 (c 0.68, CHCl3). 1H NMR (CDCl3, 400 
MHz) δ 5.17 (s, 1H), 6.34 (d, J = 7.2 Hz, 1H), 6.60 (t, J = 7.6 Hz, 1H), 6.72-6.83 (m, 3H), 6.91-
7.02 (m, 2H), 7.08 (dt, J = 0.8 Hz, 7.8 Hz 1H), 7.12-7.20 (m, 5H), 7.27-7.31 (m, 3H), 7.63-7.70 
(m, 2H), 8.61 (s, 1H). 13C NMR (CDCl3, 101 MHz) δ 62.9, 77.4, 110.8, 113.6, 117.0, 122.9, 
125.3, 126.7, 127.1, 128.3, 128.6, 128.9, 129.2, 129.3, 129.9, 131.5, 132.0, 134.6, 139.9, 143.4, 
149.7, 178.5. HRMS (ESI) Exact mass calcd. for C28H21BrN3O
+ [M+H]+ 494.0868, found 
494.0868. 
Synthesis of S3b from 3o 
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(3S,4ʹS)-2ʹ-(4-bromophenyl)-4′-phenyl-5′-(4-
(trifluoromethyl)phenyl)-2′,4ʹ-dihydrospiro[indoline-3,3′-
pyrazol]-2-one (S3b): To a solution of 3o (121 mg, 0.181 mmol) in 
1:1 iPrOH:EtOAc (4 mL) was added ammonium hydroxide (0.03 
mL). The reaction mixture was stirred at room temperature 
until TLC analysis indicated complete consumption of 3o, at which point brine (3 mL) was 
added and the layers were separated. The aqueous layer was extracted with EtOAc (2 x 2mL), 
and the combined organic extracts were passed through a glass Pasteur pipette packed with ~2 
cm of silica gel. The resulting solution was concentrated under reduced pressure to yield the 
crude 3o. The crude product was purified by flash column chromatography (80:20 
hexanes:EtOAc) to afford 3o (48 mg, 0.085 mmol, 73%) as a yellow. HPLC analysis confirmed 
that no racemization had occurred during the cleavage reaction, although ~5% of a minor 
diastereomer had formed.  HPLC analysis (254 nm, 25 °C) tR 5.64 min (major); tR 12.5 min 
(minor) [Chiracel AD-H (0.46 cm x 25cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 
80:20, 1.0 mL/min] to be 92% ee. [α]D25= -273.5 (c 0.49, CHCl3). 1H NMR (CDCl3, 400 MHz): 
δ 5.17 (s, 1H), 6.34 (d, J = 8.4 Hz, 1H), 6.60 (t, J = 7.6 Hz, 1H), 6.75 (d, J = 8.0 Hz, 1H), 6.81 
(d, J = 8.8 Hz, 2H), 6.94 (br s, 2H), 7.08 (t, J = 7.6 Hz, 1H), 7.13-7.23 (m, 5H), 7.53 (d, J = 
8.4Hz, 2H), 7.76 (d, J = 8.0 Hz, 2H), 8.74 (br s, 1H). 13C NMR (CDCl3, 101 MHz) δ 62.6, 77.3, 
110.9, 114.2, 117.1, 123.0, 123.7 (q, J = 273.5 Hz), 124.9, 125.6 (q, J = 3.5 Hz), 126.7, 127.1, 
128.6, 129.1, 129.2, 130.1, 130.5 (q, J = 32.4 Hz), 132.1, 134.1, 135.0 (q, J = 1.1 Hz), 139.9, 
142.9, 148.1, 178.2. 19F NMR (CDCl3, 376 MHz): δ -63.2 HRMS (ESI) Exact mass calcd. for 
C29H19BrF3N3O2
+ [M+H]+ 562.0736, found 562.0737. 
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Competition reactions of dipolarophiles under catalyzed conditions 
 
 In a nitrogen-filled dry-box, Mg(NTf2)2 (23.4 mg, 0.040 mmol, 0.400 equiv), L2 (15.6 
mg, 0.044 mmol, 0.440 equiv), the appropriate methyleneindolinones 1 (each 0.200 mmol, 2 
equiv), and powdered 4Å MS (100 mg) were added to a 1-dram vial.  Hydrazonoyl bromide 2a 
(35.4 mg, 0.100 mmol, 1 equiv) was added to a second 1-dram vial.  Both vials were sealed with 
a PTFE/silicone-lined septum cap and removed from the dry-box.  The mixture of Mg(NTf2)2, 
L2, the methyleneindolinones, and the 4Å MS was suspended in CH2Cl2 (1 mL), allowed to stir 
for 15 minutes at room temperature, and cooled to -78 °C in a dry ice/acetone bath.  Hydrazonal 
bromide 2a was dissolved in CH2Cl2 (1 mL) and added to the mix of catalyst, dipolarophiles, and 
4Å molecular sieves.  The resulting mixture was allowed to stir for five minutes at -78 °C, then 
triethylamine (14 μL, 0.100 mmol) was added to initiate the cycloaddition reaction.  The reaction 
mixture was allowed to stir for 4 h at -78 °C and was then filtered through a pad of silica (eluting 
with EtOAc).  The crude mixture was the concentrated under reduced pressure, and the nmr 
yields of the products were determined with integration against 1,3,5-trimethoxybenzene.  
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Competition reactions of dipolarophiles under uncatalyzed conditions 
 
In a nitrogen-filled dry-box, 1e (73.5 mg, 0.200 mmol, 2 equiv), 1h (78.6 mg, 0.200 
mmol, 2 equiv), 2a (35.4 mg, 0.100 mmol, 1 equiv), and 4Å MS (100 mg) were added to a 1-
dram vial.  The vial was sealed with a PTFE/silicone-lined septum cap and removed from the 
drybox.  The mixture was suspended in CH2Cl2 (2 mL) and cooled to -78 °C in a dry ice/acetone 
bath.  Triethylamine (14 μL, 0.100 mmol) was added to initiate the cycloaddition reaction.  The 
reaction mixture was allowed to stir for 4 h at -78 °C and was then filtered through a pad of silica 
(eluting with EtOAc).  The crude mixture was the concentrated under reduced pressure, and the 
nmr yields of the products were determined with integration against 1,3,5-trimethoxybenzene.  
Competition reactions of dipoles under catalyzed conditions 
 
In a nitrogen-filled dry-box, Mg(NTf2)2 (11.7 mg, 0.020 mmol, 0.2 equiv), L2 (7.8 mg, 
0.022 mol, 0.22 equiv), 4Å MS, and 1a (32.5 mg, 0.100 mmol, 1 equiv) were added to a 1-dram 
vial.  To each of two additional vials were added the appropriate hydrazonoyl halides 2 (each 
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0.200 mmol, 2 equiv).  The three vials were sealed with PTFE/silicone-lined caps and removed 
from the dry-box.  The mixture of Mg(NTf2)2, L2, 4Å MS, and 1a was suspended in CH2Cl2 (1 
mL), allowed to stir for 15 minutes at room temperature, and cooled to -78 °C in a dry 
ice/acetone bath.  To each of the vials containing hydrazonoyl bromides 2 was added CH2Cl2 
(0.5 mL each), and the solutions were added to the mixture of catalyst, dipolarophile, and the 4Å 
molecular sieves.  The resulting mixture was allowed to stir at -78 °C for 4 hours and was then 
filtered through a pad of silica (eluting with EtOAc).  The crude mixture was the concentrated 
under reduced pressure, and the ratio of products was determined by NMR spectroscopy of the 
crude reaction mixture.  Note: In the case of the competition reaction between 2a and 2b, the 
resulting product mixture was subjected to debenzoylation of the oxindole nitrogen to allow for 
better resolution of diagnostic peaks in the NMR spectrum.  See procedure for Synthesis of S3b 
from 3o. 
Absolute stereochemistry and structure of 3g 
Supplementary X-ray diffraction data and structure refinement for 3g is contained in 
CCDC 958182. These data can be accessed free of charge from the Cambridge Crystallographic 
Data Center at www.ccdc.cam.ac.uk/data_request/cif. 
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CHAPTER 4 
PALLADIUM-CATALYZED CONJUGATE ADDITION OF ARYLBORONIC ACIDS TO 2-
SUBSTITUTED CHROMONES IN AQUEOUS MEDIA 
Modified from a paper submitted to Tetrahedron Lettersa 
Anthony L. Gerten and Levi M. Stanley* 
Abstract 
Palladium-catalyzed conjugate additions of arylboronic acids to 2-alkylchromones are 
reported.  The conjugate additions occur in aqueous media in the presence of a catalyst generated 
from Pd(TFA)2 and 1,10-phenanthroline, and the flavanone derivatives containing a fully-
substituted carbon center are formed in up to 90% yield.   
Introduction 
Flavanone-containing scaffolds are present in an array of natural products, and the 
biological activity associated with many of these compounds renders them attractive synthetic 
targets.1 Conjugate additions of organometallic reagents to chromones have emerged as a 
powerful means to access these structures.1a In 2010, Huang and coworkers reported conjugate 
additions of arylboronic acids to chromones catalyzed by palladium complexes.2  Since then, 
Scheme 1.  Synthesis of flavanone derivatives by conjugate additions of arylboronic acids to 
chromones 
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numerous reports of conjugate additions of arylboronic acids to chromones catalyzed by 
palladium3 and rhodium4 complexes have been disclosed (Scheme 1a). 
However, there are currently no reports of conjugate additions of arylboronic acids to 2-
substituted chromones.  In fact, a report by the Stoltz group demonstrated that 2-
methylchromone was unreactive under their conditions as a conjugate addition acceptor in 
palladium-catalyzed conjugate additions of arylboronic acids.3a 
Recent work from our laboratory showed that conjugate additions of arylboronic acids to 
sterically demanding β-aryl cycloalkenones catalyzed by a palladium(II) complex of 2,2-
bipyridine (2,2-bpy) occur in high yields when carried out in aqueous sodium trifluoroacetate 
(NaTFA).5 This work built upon studies by Stoltz that demonstrate the presence of water in 
palladium-catalyzed conjugate additions of arylboronic acids to β-substituted cyclic enones is 
important to protonate the palladium enolate intermediate and facilitate catalyst turnover.6 We 
sought to leverage the increased reactivity toward challenging enone substrates when palladium-
catalyzed conjugate additions of arylboronic acids are carried out in aqueous media. To this end, 
palladium-catalyzed conjugate additions of arylboronic acids to 2-substituted chromones are 
disclosed herein (Scheme 1b). 
Palladium-catalyzed conjugate addition of arylboronic acids to 2-substituted chromones in 
aqueous media:  identification of reaction conditions 
We began our studies by evaluating the model conjugate addition of phenylboronic acid 
1a to 2-methylchromone 2a to form 2-methyl-2-phenylchroman-4-one 3a as the desired product 
(Table 1).  The reaction conditions and catalyst identified for conjugate additions of arylboronic 
acids to β-aryl cycloalkenones were initially evaluated in the current model reaction.5 The 
addition of 1a (4 equiv) to 2a catalyzed by a complex prepared from 2,2-bipyridine and 
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palladium trifluoroacetate (Pd(TFA)2) occurs to form 3a in low yield (29%) when the reaction is 
run at 100 °C in aqueous NaTFA. In addition to the desired product, we observed >90% 
protodeboronation of phenylboronic acid 1a to form benzene and a small amount biphenyl from 
homocoupling of 1a.   
Table 1.  Reaction profile for conjugate addition of phenylboronic acid 1a to 2-methylchromone 
2a 
 
 
Entry Time (min) Yield 3a (%) Ph-H (%) Ph-Ph (%) 
1 15 5 19 4 
2 30 11 33 5 
3 60 18 40 5 
4 120 28 69 5 
5 240 28 84 6 
6 480 29 93 6 
 
The low yield of conjugate addition product 3a and the undesired protodeboronation and 
homocoupling pathways prompted us to follow the reaction over time.  After two hours, we 
observed 28% yield of 3a with 69% protodeboronation (Table 1, entry 4).  The yield of 3a did 
0
10
20
30
40
50
60
70
80
90
100
0 100 200 300 400 500
Y
ie
ld
 (
%
)
Time (min)
Yield      (%) Ph-H (%) Ph-Ph (%)3a
128 
 
 
not increase after approximately two hours, while protodeboronation continued to occur.  After 8 
hours, the phenylboronic acid was completely consumed, and 93% protodeboronation was 
observed (Table 1, entry 6).   
In our initial efforts to mitigate the undesired protodeboronation reaction and increase the 
yield of 3a, we evaluated a variety of arylboron nucleophiles, reaction temperatures, and reaction 
concentrations, with results shown in Table 2.7  Reduction of the temperature to 60 °C in the 
reaction of phenylboronic acid with 2a in the presence of the palladium catalyst increased the 
yield slightly in comparison with the reaction conducted at 100 °C to 38%, with a decrease in 
protodeboronation to 70% (entry 2).  The reaction of phenylboronic acid with 2a at 100 °C and 
1.5 M concentration based on 2a resulted in 32% yield of 3a and only 9% protodeboronation 
(entry 3).  Attempts to optimize further at 1.5 M concentration did not lead to higher yields, and 
the reason for the greatly decreased protodeboronation at 1.5 M concentration is not clear at this 
time.  At 0.5 M concentration, protodeboronation increased to 75% (entry 4).  The employment 
Entry Conc. 
(M) 
Arylboron 
Nucleophile 
Temp 
(°C) 
Yield 3a 
(%)a 
Ph-H (%)a Ph-Ph 
(%)a 
1 3 PhB(OH)2 100 29 93 6 
2 3 PhB(OH)2 60 38 70 7 
3 1.5 PhB(OH)2 100 32 9 2 
4 0.5M PhB(OH)2 100 38 75 6 
5 3 PhBPin 100 15b ND ND 
6 3 PhB-MIDA 100 31 49 2 
7c 3 PhB(OH)2 100 <5 <5 1 
Table 2.  Initial evaluation of reaction conditions for addition of arylboron nucleophiles to 2a 
a Yields determined by GC using tridecane as internal standard.    b Yield determined by 1H 
NMR spectroscopy with CH2Br2 as internal standard.  
c Under N2 with deoxygenated 50 mM 
NaTFA. 
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of phenylBPin and PhB-MIDA in place of free phenylboronic acid did not lead to respectable 
yields of 3a (entries 5 and 6).  Notably, the reaction conducted under inert atmosphere in 
deoxygenated solvent led to complete inhibition of the reaction (entry 7) (vide infra). 
 After our early efforts to mitigate protodeboronation did not lead to an acceptable 
solution, we next examined the issue of biphenyl formation in our reactions.  The generally 
accepted mechanism for palladium-catalyzed conjugate additions of arylboronic acids to enones 
is a non-redox process involving Pd(II) intermediates.
6a The observed homocoupling of 
phenylboronic acid led us to believe that this undesired side reaction was removing the requisite 
Pd(II) from the catalytic cycle by reductive elimination from a PdAr2 species to form a Pd(0) 
species.8 Greatly diminished yields of 3a under rigorously oxygen-free conditions lent even 
greater evidence to the formation of an off-cycle Pd(0) species.  The inclusion of oxygen is 
necessary to reoxidize Pd(0) species to Pd(II) species to ensure that the desired conjugate 
addition pathway remains operative.  
The observation that the yield of product 3a does not increase after two hours led us to 
hypothesize that once the concentration of 2-methylchromone 2a was low relative to the 
concentration of phenylboronic acid 1a, the desired conjugate addition reaction ceases and 
protodeboronation becomes the dominant reaction pathway for phenylboronic acid 1a.  With this 
hypothesis in mind and further inspired by a report from Minaard,9 we examined the impact of 
increasing the concentration of chromone 2a relative to phenylboronic acid 1a in an attempt to 
mitigate protodeboronation.  
The results presented in Table 3, entries 1-3 demonstrate that the relative rate of 
protodeboration versus conjugate addition is highly dependent on the concentration of 2a.  The 
model reaction catalyzed by complex C1, prepared in situ from Pd(TFA)2 and 2,2-bpy, occurred 
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to form product 3a in 38% yield when the reaction was run at 60 °C with a 1:4 ratio of 2a:1a 
(entry 1).  However, we still observed 70% protodeboronation under these reaction conditions. 
When the reaction was run with a 1:1 ratio of 2a:1a, we observed 27% yield of product 3a, 35% 
protodeboronation, and 21% biphenyl formation (entry 2).  Encouraged by the lower relative rate 
of protodeboronation versus desired conjugate addition observed under these conditions, we ran 
the reaction with a 2:1 ratio of 2a:1a.  This reaction delivered product 3a in 56% yield and 
decreased protodeboronation and biphenyl formation to 19% and 12%, respectively (entry 3). 
Table 3.  Identification of reaction conditions to minimize protodeboronation 
 
Entry Catalyst Ratio 2a:1a Yield 3a (%)a,b Ph-H (%)a Ph-Ph (%)a 
1c C1 1:4 38 70 7 
2 C1 1:1 27 35 21 
3 C1 2:1 56 19 12 
4 C2 2:1 49 30 12 
5 C3 2:1 53 13 15 
6 C4 2:1 68 16 13 
7d C4 2:1 65 22 12 
8e C4 2:1 49 25 11 
9f C4 2:1 72 (76) 14 10 
10f C4 3:1 84 (87) 6 6 
a Yields determined by GC using tridecane as internal standard. b Isolated yields in parentheses. c 
Catalyst C1 generated in situ from Pd(TFA)2 and 2,2-bpy. d Reaction run at 80 °C. e Reaction 
run at 100 °C. f 4.5 M in 50 mM aq. NaTFA.  
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To further improve upon our reaction conditions, we examined the impact of 
electronically distinct bipyridine ligands on the activity of the palladium catalyst (entries 3-5). A 
more electron-rich palladium center proved detrimental. The reaction catalyzed by complex C2 
(R = OMe) formed 3a in slightly lower yield with 30% protodeboronation (entry 4).  The 
outcome of the reaction conducted in the presence of the electron-poor catalyst complex C3 (R = 
CF3) was essentially unchanged from that observed with complex C1 (compare entry 5 with 
entry 3). 
Notably, the complex derived from 1,10-phenanthroline (C4) led to higher yield of 
product 3a relative to the palladium complexes of bipyridine ligands. Complex C4 catalyzed the 
addition of 1a to 2a to form 3a in 68% yield with 16% protodeboronation and 13% biphenyl 
formation (entry 6).  We hypothesize that the palladium complex of 1,10-phenanthroline 
eliminates the potential for rollover C-H activation of 2,2-bipyridine ligands that may remove 
palladium from the catalytic cycle.10  
Encouraged by the results of reactions catalyzed by complex C4, we sought to identify 
reaction conditions to further increase the yield of 3a and limit protodeboronation. Increasing the 
temperature of the reaction to 80 or 100 °C led to a decrease in the yield of 3a and an increase in 
protodeboronation (entries 7 and 8). Increasing the concentration of the reaction to 4.5 M based 
on phenylboronic acid led to the formation of 3a in 76% isolated yield (entry 9). 
Protodeboronation and biphenyl formation could be further suppressed by conducting the 
reaction with a 3:1 ratio of 2a:1a (entry 10), and 2-methyl-2-phenylchroman-4-one 3a was 
isolated in 87% yield.  
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Palladium-catalyzed conjugate addition of arylboronic acids to 2-substituted chromones in 
aqueous media:  scope of arylboronic acids 
With a practical catalyst system identified, we proceeded to evaluate conjugate additions 
of a variety of arylboronic acids to 2-methylchromone 2a.  These results are summarized in 
Scheme 2.  Palladium-catalyzed conjugate additions of arylboronic acids to 2a  
 Additions of arylboronic acids containing electron-donating and electron-neutral groups 
at the para-position to 2a formed the corresponding 2-methyl-2-arylchroman-4-ones 3b-3e in 
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68-83% yield.  Moderately electron-deficient p-fluorophenyl and p-chlorophenylboronic acids 
reacted with 2a to generate 2-methyl-2-arylchroman-4-ones 3f and 3g in 51% and 57% yield, 
respectively. However, the additions of p-bromophenylboronic acid and electron-poor p-
trifluoromethylphenylboronic acid to 2a formed 3h and 3i in low yields.  Additions of m-
methoxy- and m-methylphenylboronic acid generated 3j and 3k in good yields (68-69%), while a 
m-halogenated arylboronic acid led to low yields of the corresponding 2-methyl-2-arylchroman-
4-one 3l. Additions of electron-rich 3,4- and 3,5-disbustituted arylboronic acids to 2a formed 2-
methyl-2-arylchroman-4-ones 3m-3o in good-to-excellent yields (60-90%).    
Notably, o-substituted arylboronic acids displayed decreased reactivity in conjugate 
additions to 2a. The addition of o-fluorophenylboronic acid to 2a formed 3p in <5% yield.  o-
Methoxyphenylboronic acid displayed increased reactivity toward the desired conjugate addition 
reaction relative to o-fluorophenylboronic acid and led to the formation of 3q in 35% yield.  The 
addition of 2-fluoro-4-methoxyphenylboronic acid provides further evidence to the impact of o-
substitution on the arylboronic acid.  This reaction generated the corresponding 2-methyl-2-
arylchromanone 3r in 25% yield.  In contrast, the addition of an electronically similar 
arylboronic acid, 3-fluoro-4-methoxyphenylboronic acid, led to the formation of 3o in high yield.  
Palladium-catalyzed conjugate addition of arylboronic acids to 2-substituted chromones in 
aqueous media:  scope of enones 
To further expand the scope of this reaction, we evaluated conjugate additions of 
phenylboronic acid to a variety of 2-alkylchromones (Scheme 3).  The reaction of 2-
ethylchromone 2b with phenylboronic acid formed chromanone 3s in 79% yield.  Increasing the 
steric volume of the substituent at the 2-position of the chromone resulted in decreased acceptor 
reactivity toward conjugate addition: the reaction of 2-isopropylchromone 2c occurred to give 
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chromanone 3t in 43% yield, and the reaction of 2-cyclohexylchromone 2d formed chromanone 
3u in 15% yield. 2-Phenylchromone (flavone) did not react under our reaction conditions. This 
trend of decreased acceptor reactivity with increasing steric volume at the 2-position of the 
chromone is consistent with a slower rate of turnover-limiting insertion of the enone into the 
palladium-arene bond.6a  Substitution on the 2-alkylchromone backbone is also tolerated. The 
reaction of 6-methoxy-2-methylchromone with phenylboronic acid formed chromanone 3v in 
81% yield. 
 
 
Scheme 3.  Palladium-catalyzed conjugate additions of PhB(OH)2 to chromones 2b-e 
 
Palladium-catalyzed conjugate addition of arylboronic acids to 2-substituted chromones in 
aqueous media:  conclusion 
In conclusion, we developed the first conjugate additions of arylboronic acids to 2-
substituted chromones. Additions of arylboronic acids to these challenging substrates are enabled 
by the use of a readily accessible palladium(II) catalyst in aqueous media.  This catalyst system 
overcomes the low reactivity of 2-alkylchromones and reduces undesired protodeboronation and 
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homocoupling pathways. The scope of these reactions encompasses a variety of arylboronic acids 
and 2-alkylchromones and enables the formation of an array of 2-alkyl-2-arylchromanone 
products.  Studies are ongoing in our laboratory to develop an enantioselective variant of this 
reaction and to expand these conjugate addition reactions to additional classes of acceptors.  
Experimental Details 
General experimental details 
All reactions were carried out on the benchtop under an atmosphere of air unless otherwise 
stated. All glassware for moisture sensitive reactions was dried at 140 °C in an oven. THF, diethyl 
ether, toluene and dimethylformamide were degassed by purging with argon for 45 minutes and 
dried with a solvent purification system by passing through a one-meter column of activated 
alumina. Flash column chromatography was performed on Fisher brand silica gel 60 (230-400 
mesh) or Silacycle Siala-P silica gel or on a Teledyne Isco CombiFlash Rf automated 
chromatography system with RediSep Rf Gold normal-phase silica columns. Products of reactions 
were visualized on TLC plates under UV light. 
HRMS (ESI) analysis was performed at the Iowa State University Chemical 
Instrumentation Facility on an Agilent 6540 QTOF spectrometer.  Fourier transform infrared 
(FTIR) spectra were recorded within the 4000−400 cm-1 range using a Bruker VERTEX 80 IR 
spectrometer. Samples were diluted with KBr and pellets prepared for analysis in transmission 
mode.  NMR spectra were acquired on Varian MR-400 and Bruker Avance III 600 spectrometers 
at the Iowa State University Chemical Instrumentation Facility. 1H and 13C NMR chemical shifts 
are reported in ppm relative to residual CHCl3 in CDCl3 (7.26 ppm for 
1H and 77.23 ppm for 13C) 
or to residual DMSO in DMSO-d6 (2.50 for 
1H). 19F NMR shifts are reported based on indirect 
reference to CDCl3 or DMSO-d6.
11  
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Materials  
CH2Br2 was purchased from Acros and used without further purification.  Phenylboronic 
acid, 4-methoxyphenylboronic acid, 4-fluorophenylboronic acid, 3-methoxyphenylboronic acid, 
3-chlorophenylboronic acid, 2,2´-bipyridine and 1,10-phenanthroline were purchased from AK 
Scientific and used without further purification.  3-methylphenylboronic acid was purchased 
from Arkpharm and used without further purification.  4-methylphenylboronic acid and 3,5-
dimethylphenylboronic acid were purchased from Combi-Blocks Inc. and used without further 
purification.  Acetic acid and trifluoroacetic acid were purchased from Fisher Scientific and used 
without further purification. 4-phenylboronic acid, 4-methoxymethylphenylboronic acid, 4-
bromophenylboronic acid, 4-trifluoromethylphenylboronic acid, 3-fluoro-4-
methoxyphenylboronic acid, 2-fluoro-4-methoxyphenylboronic acid, and 3,4-
methylenedioxyphenylboronic acid were purchased from Frontier Scientific and used without 
further purification.  Palladium acetate was purchased from Johnson Matthey and used without 
further purification. 4-Chlorophenylboronic acid, 2-methoxyphenylboronic acid, tridecane 
phenyl-BPin, and palladium trifluoroacetate were purchased from Sigma-Aldrich and used 
without purification. 2-methylchromone 2a, 2-ethylchromone 2b, 2-isopropylchromone 2c, 2-
cyclohexylchromone 2d, and 6-methoxy-2-methylchromone 2e were synthesized according to 
previously reported procedures.12  4,4´-Dimethoxy-2,2´-bipyridine and 4,4´-di(trifluoromethyl)-
2,2´-bipyridine were synthesized according to a known procedure.13 The spectra obtained 
matched previously reported spectra.14  Palladium trifluoroacetate complexes C1-C4 were 
synthesized by previously reported methods,15 and the characterization data for C2 and C3 are 
reported below. Phenyl-MIDA-boronate was synthesized by a known procedure16 and matched 
previously reported spectral data.17 
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Synthesis and characterization data for complexes C2 and C3 
 
 
(4,4´-methoxy-2,2´-bipyridyl)palladium(II)bis(trifluoroacetate) 
(C2):  Complex C2 was synthesized by a modification to a reported 
procedure:15a A roundbottom flask was charged with Pd(OAc)2 (187 
mg, 0.833 mmol, 1.00 equiv).  Acetone (18 ml) was added to the flask, and the mixture was 
stirred for 30 minutes at room temperature.  The solution was then filtered through fine filter 
paper. To the filtrate was added acetic acid (9.35 µL), followed by 4,4´-methoxy-2,2´-bipyridine 
(216 mg, 1.00 mmol, 1.2 equiv).  The reaction was then stirred for 30 minutes at room 
temperature.  The precipitate was collected by filtration and dried under high vacuum.  The 
precipitate was then redissolved in methanol (26 mL) and trifluoroacetic acid (3.19 mL, 18.7 
mmol, 25.0 equiv) was added.  The reaction mixture was stirred for 30 minutes at room 
temperature and the resulting precipitate was filtered and dried under high vacuum to yield C2 
(117 mg, 0.260 mmol, 26%) as a white powder.    1H NMR (DMSO-d6, 600 MHz) δ 4.06 (s, 
6H), 7.26-7.50 (m, 2H), 7.54-8.05 (m, 2H), 8.18-8.30 (m, 2H).  19F NMR (DMSO-d6, 565 MHz) 
δ -73.53.  IR: λmax 1233, 1701.   Anal. Calc. for: C, 35.07; H, 2.21; N, 5.11. Found: C, 34.75; H, 
2.01; N, 5.09. 
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(4,4´-trifluoromethyl-2,2´-bipyridyl)palladium(II)bis(trifluoroacetate 
(C3): Complex C3 was synthesized by a modification to a reported 
procedure:15a A roundbottom flask was charged with Pd(OAc)2 (187 mg, 
0.833 mmol, 1.00 equiv).  Acetone (18 ml) was added to the flask, and 
the mixture was stirred for 30 minutes at room temperature.  The solution was then filtered 
through fine filter paper. To the filtrate was added acetic acid (9.35 µL), followed by 4,4´-
trifluoromethyl-2,2´-bipyridine (292 mg, 1.00 mmol, 1.20 equiv).  The reaction was then stirred 
for 30 minutes at room temperature.  The precipitate was collected by filtration and dried under 
high vacuum.  The precipitate was then redissolved in methanol (26 mL) and trifluoroacetic acid 
(3.19 mL, 18.7 mmol, 25.0 equiv) was added.  The reaction mixture was stirred for 30 minutes at 
room temperature and the resulting precipitate was filtered and dried under high vacuum to yield 
C3 (372 mg, 0.720 mmol, 72%) as a yellow powder.    1H NMR (DMSO-d6, 600 MHz) δ 8.20-
8.54 (m, 4H), 9.28-9.39 (m, 2H).  19F NMR (DMSO-d6, 565 MHz) δ -73.42, -63.51.  IR: λmax 
1187, 1727.  Anal. Calc. for: C, 30.77; H, 0.97; N, 4.49. Found: C, 30.46; H, 0.78; N, 4.65. 
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Table S1.  Reaction profile for conjugate addition of phenylboronic acid 1a to 2-
methylchromone 2a 
 
 
Entry Time (min) Yield 3a (%) Ph-H (%) Ph-Ph (%) 
1 15 5 19 4 
2 30 11 33 5 
3 60 18 40 5 
4 120 28 69 5 
5 240 28 84 6 
6 480 29 93 6 
 
To a 1-dram vial were added Pd(TFA)2 (8.3 mg, 0.025 mmol, 0.050 equiv), 2,2´-
bipyridine (4.7 mg, 0.030 mmol, 0.060 equiv), 2-methylchromone 2a (80.1 mg, 0.500 mmol, 
1.00 equiv), and phenylboronic acid 1a (243.9 mg, 2.00 mmol, 4.00 equiv).  Sodium 
trifluoroacetate solution (167 μL of a 50 mM solution in water) was added to the 1-dram vial.  
The vial was sealed with a PTFE-silicone-lined septum cap.  The reaction mixture was stirred for 
the indicated time at 100 °C and then allowed to cool to room temperature.  A solution of 
tridecane (1 ml, 0.1M in EtOAC) was then added to the vial, followed by enough ethyl acetate to 
0
10
20
30
40
50
60
70
80
90
100
0 100 200 300 400 500
Y
ie
ld
 (
%
)
Time (min)
Yield      (%) Ph-H (%) Ph-Ph (%)3a
140 
 
 
fill the rest of the vial.  Once all solid material was dissolved, then solution was then transferred 
to a 2 mL vial and the mixture was then analyzed by GC-FID to determine the yields of 3a, 
benzene, and biphenyl. 
Table S2.  Initial evaluation of reaction conditions for addition of arylboron nucleophiles to 
2a 
 
Entry Conc. 
(M) 
Arylboron 
Nucleophile 
Temp 
(°C) 
Yield 3a 
(%)a 
Ph-H (%)a Ph-Ph 
(%)a 
1 3 PhB(OH)2 100 29 93 6 
2 3 PhB(OH)2 60 38 70 7 
3 1.5 PhB(OH)2 100 32 9 2 
4 0.5M PhB(OH)2 100 38 75 6 
5 3 PhBPin 100 15b ND ND 
6 3 PhB-MIDA 100 31 49 2 
7c 3 PhB(OH)2 100 <5 <5 1 
a Yields determined by GC using tridecane as internal standard.  b Yield determined by 1H NMR 
spectroscopy with CH2Br2 as internal standard.  
c Under N2 with deoxygenated 50 mM NaTFA. 
   
To a 1-dram vial were added Pd(TFA)2 (8.3 mg, 0.025 mmol, 0.050 equiv), 2,2´-
bipyridine (4.7 mg, 0.030 mmol, 0.060 equiv), 2-methylchromone 2a (80.1 mg, 0.500 mmol, 
1.00 equiv), and the appropriate arylboron nucleophile (2.00 mmol, 4.00 equiv).  Sodium 
trifluoroacetate as a 50 mM solution in water was added to the vial to the indicated 
concentration.  The vial was sealed with a PTFE-silicone-lined septum cap.  The reaction 
mixture was stirred for the indicated time at 100°C and then allowed to cool to room 
temperature.  A solution of tridecane (1 ml, 0.1M in EtOAC) was then added to the vial, 
followed by enough ethyl acetate to fill the rest of the vial.  Once all solid material was 
dissolved, the solution was transferred to a 2 mL vial, and the mixture was analyzed by GC-FID 
to determine the yields of 3a, benzene, and biphenyl. 
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General procedure for synthesis of 2-alkyl-2-arylchromones 3a-3v 
 
 Catalyst complex C4 (6.4 mg, 0.013 mmol, 0.050 equiv), the appropriate arylboronic acid 
(1a-1r) (0.250 mmol, 1.00 equiv), and the appropriate 2-alkylsubstituted chromone (2a-2e) 
(0.750 mmol, 3.00 equiv) were added to a 1-dram vial.  Sodium trifluoroacetate solution (56 μL, 
50 mM solution in water) was added to the vial.  The vial was sealed with a PTFE-silicone-lined 
septum cap.  The reaction mixture was stirred overnight and monitored by TLC.  Once the 
reaction was judged to be complete, the reaction mixture was diluted with ethyl acetate and 
filtered through a pad of silica (eluting with EtOAc).  The reaction mixture was then 
concentrated and purified by flash column silica gel chromatography (hexanes:EtOAc) to yield 
2-alkyl-2-arylchromones 3a-3v. 
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Characterization data for 2-alkyl-2-arylchromanones 3a-3v 
2-methyl-2-phenylchroman-4-one (3a): Prepared according to the 
general procedure from phenylboronic acid 1a (30.5 mg, 0.250 mmol) and 
2-methylchromone 2a (120 mg, 0.750 mmol).  The crude product was 
purified by flash column chromatography (100:0 to 80:20 hexanes:EtOAc) to yield 3a (51.8 mg, 
0.218 mmol, 87%) as a yellow powder.  The characterization data matched those previously 
reported in the literature.18 
 
2-(4-methoxyphenyl)-2-methylchroman-4-one (3b): Prepared 
according to the general procedure from 4-methoxyphenylboronic acid 
1b (38.0 mg, 0.250 mmol) and 2-methylchromone 2a (120 mg, 0.750 
mmol).  The crude product was purified by flash column 
chromatography (100:0 to 70:30 hexanes:EtOAc) to yield 3b (47.0 mg, 0.198 mmol, 79%) as a 
yellow oil.  1H NMR (CDCl3, 400 MHz) δ 1.74 (s, 3H), 3.06 (d, J = 16.5 Hz, 1H), 3.29 (d, J = 
16.5 Hz, 1H), 3.74 (s, 3H), 6.81 (d, J = 8.9 Hz, 2H), 6.92 (dd, J = 7.8, 7.2 Hz, 1H), 7.03 (dd, J = 
8.3, 0.5 Hz, 1H), 7.33 (d, J = 8.9 Hz, 2H), 7.45 (ddd, J = 8.3, 7.2, 1.6 Hz, 1H), 7.76 (dd, J = 7.8, 
1.6 Hz, 1H).  13C NMR (CDCl3, 101 MHz) δ 30.4, 48.2, 55.4, 82.5, 114.1, 118.5, 121.2, 121.3, 
126.7, 126.8, 135.0, 136.3, 159.1, 160.2, 192.1.  HRMS (ESI) calcd. for C17H17O3+ [M+H]+ 
269.1172, found 269.1169. 
 
2-(4-(methoxymethyl)phenyl)-2-methylchroman-4-one (3c): 
Prepared according to the general procedure from 4-
methoxymethylphenylboronic acid 1c (41.5 mg, 0.250 mmol) and 2-
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methylchromone 2a (120 mg, 0.750 mmol).  The crude product was purified by flash column 
chromatography (100:0 to 80:20 hexanes:EtOAc) to yield 3c (48.0 mg, 0.170 mmol, 68%) as a 
colorless oil.  1H NMR (CDCl3, 600 MHz) δ 1.75 (s, 3H), 3.09 (d, J = 16.5 Hz, 1H), 3.31 (d, J = 
16.5 Hz, 1H), 3.36 (s, 3H), 4.38 (s, 2H), 6.92 (dd, J = 7.7, 7.4 Hz, 1H), 7.06 (d, J = 8.3 Hz, 1H), 
7.26 (d, J = 8.1 Hz, 2H), 7.39 (d, J = 8.1 Hz, 2H), 7.46 (dd, J = 8.3, 7.4 Hz, 1H), 7.75 (d, J = 7.7 
Hz, 1H).  13C NMR (CDCl3, 151 MHz) δ 30.2, 48.2, 58.5, 74.4, 82.6, 118.5, 121.2, 121.3, 125.5, 
126.8, 128.1, 136.4, 137.9, 142.6, 160.2, 191.8.  HRMS (ESI) calcd. for C18H19O3+ [M+H]+ 
283.1329, found 283.1325. 
 
2-methyl-2-(p-tolyl)chroman-4-one (3d): Prepared according to the 
general procedure from 4-methylphenylboronic acid 1d (34.0 mg, 0.250 
mmol) and 2-methylchromone 2a (120 mg, 0.750 mmol).  The crude 
product was purified by flash column chromatography (100:0 to 80:20 
hexanes:EtOAc) to yield 3d (48.5 mg, 0.193 mmol, 77%) as a white powder.  1H NMR (CDCl3, 
400 MHz) δ 1.75 (s, 3H), 2.28 (s, 3H), 3.08 (d, J = 16.5 Hz, 1H), 3.31 (d, J = 16.5 Hz, 1H), 6.92 
(dd, J = 7.8, 7.2 Hz, 1H), 7.05 (dd, J = 8.3, 0.6 Hz, 1H), 7.10 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.0 
Hz, 2H), 7.46 (ddd, J = 8.3, 7.2, 1.7 Hz, 1H), 7.76 (d, J = 7.8, 1.7 Hz, 1H).  13C NMR (CDCl3, 
101 MHz) δ 21.2, 30.3, 48.2, 82.6, 118.5, 121.2, 121.3, 125.4, 126.8, 129.5, 136.3, 137.6, 140.1, 
160.2, 192.0. HRMS (ESI) calcd. for C17H17O2+ [M+H]+ 253.1223, found 253.1222. 
 
2-([1,1´-biphenyl]-4-yl)-2-methylchroman-4-one (3e): Prepared 
according to the general procedure from 4-biphenylboronic acid 1e 
(49.5 mg, 0.250 mmol) and 2-methylchromone 2a (120 mg, 0.750 
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mmol).  The crude product was purified by flash column chromatography (100:0 to 80:20 
hexanes:EtOAc) to yield 3e (65.0 mg, 0.208 mmol, 83%) as a white powder.  1H NMR (CDCl3, 
600 MHz) δ 1.81 (s, 3H), 3.13 (d, J = 16.5 Hz, 1H), 3.36 (d, J = 16.5 Hz, 1H), 6.96 (dd, J = 7.7, 
7.2 Hz, 1H), 7.10 (d, J = 8.3 Hz, 1H), 7.33 (t, J = 7.2 Hz, 1H), 7.41 (appt, J = 7.6 Hz, 2H), 7.46-
7.56 (m, 7H), 7.80 (d, J = 7.7 Hz, 1H).  13C NMR (CDCl3, 151 MHz) δ 30.1, 48.3, 82.6, 118.5, 
121.27, 121.28, 125.9, 126.8, 127.2, 127.5, 127.6, 128.9, 136.4, 140.5, 140.7, 142.1, 160.2, 
191.9. HRMS (ESI) calcd. for C22H19O2+ [M+H]+ 315.1380, found 315.1374. 
 
2-(4-fluorophenyl)-2-methylchroman-4-one (3f): Prepared according 
to the general procedure from 4-fluorophenylboronic acid 1f (35.0 mg, 
0.250 mmol) and 2-methylchromone 2a (120 mg, 0.750 mmol).  The 
crude product was purified by flash column chromatography (100:0 to 80:20 hexanes:EtOAc) to 
yield 3f (33.0 mg, 0.128 mmol, 51%) as a white powder.  1H NMR (CDCl3, 600 MHz) δ 1.74 (s, 
3H), 3.09 (d, J = 16.5 Hz, 1H), 3.27 (d, J = 16.5 Hz, 1H), 6.92-7.00 (m, 3H), 7.05 (d, J = 8.3 Hz, 
1H), 7.35-7.42 (m, 2H), 7.47 (dd, J = 8.3, 7.2 Hz, 1H), 7.76 (d, J = 7.7 Hz, 1H).  13C NMR 
(CDCl3, 151 MHz) δ 30.3, 48.3, 82.3, 115.7 (d, J = 21.5 Hz), 118.5, 121.2, 121.4, 126.8, 127.3 
(d, J = 8.2 Hz), 136.5, 139.0 (d, J = 3.1 Hz) 160.0, 162.3 (d, J = 246.9 Hz), 191.7.  19F NMR 
(CDCl3, 565 MHz) δ -114.61.  HRMS (ESI) calcd. for C16H14FO2+ [M+H]+ 257.0972, found 
257.0971. 
2-(4-chlorophenyl)-2-methylchroman-4-one (3g): Prepared according 
to the general procedure from 4-chlorophenylboronic acid 1g (39.1 mg, 
0.250 mmol) and 2-methylchromone 2a (120 mg, 0.750 mmol).  The 
crude product was purified by flash column chromatography (100:0 to 80:20 hexanes:EtOAc) to 
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yield 3g (38.5 mg, 0.143 mmol, 57%) as a white powder. 1H NMR (CDCl3, 600 MHz) δ 1.74 (s, 
3H), 3.08 (d, J = 16.5 Hz, 1H), 3.26 (d, J = 16.5 Hz, 1H), 6.95 (dd, J = 7.8, 7.4 Hz, 1H), 7.05 (d, 
J = 8.3 Hz, 1H), 7.26 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.4 Hz, 2H), 7.47 (dd, J = 8.3, 7.4 Hz, 1H), 
7.76 (d, J = 7.8 Hz, 1H).  13C NMR (CDCl3, 151 MHz) δ 30.2, 48.1, 82.3, 118.5, 121.2, 121.5, 
126.85, 126.92, 129.0, 133.8, 136.5, 141.8, 159.9, 191.5.  HRMS (ESI) calcd. for C16H14ClO2+ 
[M+H]+ 273.0677, found 273.0675. 
 
2-(4-bromophenyl)-2-methylchroman-4-one (3h): Prepared according 
to the general procedure from 4-bromophenylboronic acid 1h (50.2 mg, 
0.250 mmol) and 2-methylchromone 2a (120 mg, 0.750 mmol).  The 
crude product was purified by flash column chromatography (100:0 to 80:20 hexanes:EtOAc) to 
yield 3h (15.0 mg, 0.0480 mmol, 19%) as a white powder.  1H NMR (CDCl3, 600 MHz) δ 1.74 
(s, 3H), 3.08 (d, J = 16.5 Hz, 1H), 3.26 (d, J = 16.5 Hz, 1H), 6.95 (dd, J = 7.8, 7.1 Hz, 1H), 7.05 
(d, J = 8.3 Hz, 1H), 7.28 (d, J = 8.5 Hz, 2H), 7.42 (d, J = 8.5 Hz, 2H), 7.48 (ddd, J = 8.3, 7.1, 1.0 
Hz, 1H), 7.76 (dd, J = 7.8, 1.0 Hz, 1H).  13C NMR (CDCl3, 151 MHz) δ 30.1, 48.1, 82.3, 118.5, 
121.2, 121.5, 122.0, 126.9, 127.3, 132.0, 136.5, 142.3, 160.0, 191.5.  HRMS (ESI) calcd. for 
C16H14Br O2+ [M+H]+ 317.0172, found 317.0163. 
 
2-methyl-2-(4-(trifluoromethyl)phenyl)chroman-4-one (3i): 
Prepared according to the general procedure from 4-
(trifluoromethyl)phenylboronic acid 1i (47.5 mg, 0.250 mmol) and 2-
methylchromone 2a (120 mg, 0.750 mmol).  The crude product was 
purified by flash column chromatography (100:0 to 80:20 h2exanes:EtOAc) to yield 3i (6.1 mg, 
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0.020 mmol, 8%) as a yellow powder.  1H NMR (CDCl3, 600 MHz) δ 1.77 (s, 3H), 3.13 (d, J = 
16.5 Hz, 1H), 3.30 (d, J = 16.5 Hz, 1H), 6.97 (dd, J = 7.8, 7.4 Hz, 1H), 7.09 (d, J = 8.3 Hz, 1H), 
7.50 (ddd, J = 8.3, 7.4, 1.6 Hz, 1H), 7.52-7.60 (m, 4H), 7.77 (dd, J = 7.8, 1.6 Hz, 1H).  13C NMR 
(CDCl3, 151 MHz) δ 30.0, 48.2, 82.3, 118.5, 121.2, 121.7, 124.1 (q, J = 272.2 Hz), 125.85, 
125.92 (q, J = 3.7 Hz), 126.9, 130.2 (q, J = 32.3 Hz), 136.7, 147.3 (q, J = 1.0 Hz), 159.9, 191.3.  
19F NMR (CDCl3, 565 MHz) δ -62.74.  HRMS (ESI) calcd. for C17H14F3O2+ [M+H]+ 307.0940, 
found 307.0938. 
 
2-(3-methoxyphenyl)-2-methylchroman-4-one (3j): Prepared 
according to the general procedure from 3-methoxyphenylboronic acid 
1j (38.0 mg, 0.250 mmol) and 2-methylchromone 2a (120 mg, 0.750 
mmol).  The crude product was purified by flash column 
chromatography (100:0 to 70:30 hexanes:EtOAc) to yield 3j (39.0 mg, 0.170 mmol, 68%) as a 
colorless oil.  1H NMR (CDCl3, 600 MHz) δ 1.75 (s, 3H), 3.08 (d, J = 16.5 Hz, 1H), 3.29 (d, J = 
16.5 Hz, 1H), 3.75 (s, 3H), 6.73-6.78 (m, 1H), 6.93 (dd, J = 7.8, 7.2 Hz, 1H), 6.95-6.99 (m, 2H), 
7.06 (dd, J = 8.3. 0.5 Hz, 1H), 7.21 (app t, J = 8.0 Hz, 1H), 7.47 (ddd, J = 8.3, 7.2, 1.6 Hz, 1H), 
7.76 (dd, J = 7.8, 1.6 Hz, 1H).  13C NMR (CDCl3, 151 MHz) δ 30.1, 48.3, 55.4, 82.6, 111.7, 
112.9, 117.8, 118.5, 121.25, 121.27, 126.8, 129.9, 136.4, 144.9, 160.0, 160.2, 191.8.  HRMS 
(ESI) calcd. for C17H17O3+ [M+H]+ 269.1172, found 269.1177. 
 
2-methyl-2-(m-tolyl)chroman-4-one (3k): Prepared according to the 
general procedure from 3-methylphenylboronic acid 1k (34.0 mg, 0.250 
mmol) and 2-methylchromone 2a (120 mg, 0.750 mmol).  The crude 
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product was purified by flash column chromatography (100:0 to 80:20 hexanes:EtOAc) to yield 
3k (43.5 mg, 0.173 mmol, 69%) as an off-white powder.  1H NMR (CDCl3, 400 MHz) δ 1.75 (s, 
3H), 2.31 (s, 3H), 3.07 (d, J = 16.5 Hz, 1H), 3.31 (d, J = 16.5 Hz, 1H), 6.93 (dd, J = 7.8, 7.2 Hz, 
1H), 7.00-7.10 (m, 2H), 7.14-7.25 (m, 3H), 7.47 (ddd, 8.3, 7.2, 1.6 Hz, 1H), 7.77 (dd, J = 7.8, 1.6 
Hz, 1H).  13C NMR (CDCl3, 101 MHz) δ 21.8, 30.1, 48.3, 82.6, 118.5, 121.18, 121.22, 122.5, 
126.1, 126.8, 128.65, 128.68, 136.4, 138.4, 143.2, 160.2, 192.0.  HRMS (ESI) calcd. for 
C17H17O2+ [M+H]+ 253.1223, found 253.1227 
 
2-(3-chlorophenyl)-2-methylchroman-4-one (3l): Prepared according 
to the general procedure from 3-chlorophenylboronic acid 1l (39.1 mg, 
0.250 mmol) and 2-methylchromone 2a (120 mg, 0.750 mmol).  The 
crude product was purified by flash column chromatography (100:0 to 80:20 hexanes:EtOAc) to 
yield 3l (14.0 mg, 0.0530 mmol, 21%) as colorless oil.  1H NMR (CDCl3, 600 MHz) δ 1.74 (s, 
3H), 3.08 (d, J = 16.5 Hz, 1H), 3.25 (d, J = 16.5 Hz, 1H), 6.97 (dd, 7.8, 7.2 Hz, 1H), 7.08 (d, J = 
8.3 Hz, 1H), 7.18-7.31 (m, 3H), 7.43 (s, 1H), 7.49 (dd, J = 8.3, 7.2 Hz, 1H), 7.78 (d, J = 7.8 Hz, 
1H).  13C NMR (CDCl3, 151 MHz) δ 29.8, 48.2, 82.2, 118.6, 121.1, 121.6, 123.5, 125.8, 126.9, 
128.2, 130.2, 135.0, 136.6, 145.5, 159.9, 191.4.  HRMS (ESI) calcd. for C16H14ClO2+ [M+H]+ 
273.0677, found 273.0672. 
 
2-(3,5-dimethylphenyl)-2-methylchroman-4-one (3m): Prepared 
according to the general procedure from 3,5-dimethylphenylboronic acid 
1m (37.5 mg, 0.250 mmol) and 2-methylchromone 2a (120 mg, 0.750 
mmol).  The crude product was purified by flash column chromatography 
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(100:0 to 80:20 hexanes:EtOAc) to yield 3m (59.0 mg, 0.225 mmol, 90%) as a white solid.  1H 
NMR (CDCl3, 400 MHz) δ 1.73 (s, 3H), 2.27 (s, 6H), 3.05 (d, J = 16.5 Hz, 1H), 3.30 (d, J = 16.5 
Hz, 1H), 6.86 (s, 1H), 6.93 (dd, J = 7.8, 7.2 Hz, 1H), 7.03 (s, 2H), 7.07 (d, J = 8.3 Hz, 1H), 7.47 
(ddd, J = 8.3, 7.2, 1.6 Hz, 1H), 7.78 (dd, J = 7.8, 1.6 Hz, 1H).  13C NMR (CDCl3, 101 MHz) δ 
21.7, 23.0, 48.3, 82.6, 118.5, 121.1, 121.2, 123.2, 126.8, 129.5, 136.3, 138.3, 143.2, 160.3, 192.0.  
HRMS (ESI) calcd. for C18H19O2+ [M+H]+ 267.1380, found 267.1378. 
 
2-(benzo[d][1,3]dioxol-5-yl)-2-methylchroman-4-one (3n): Prepared 
according to the general procedure from 3,4-
methylenedioxyphenylboronic acid 1n (41.5 mg, 0.250 mmol) and 2-
methylchromone 2a (120 mg, 0.750 mmol).  The crude product was purified by flash column 
chromatography (100:0 to 70:30 hexanes:EtOAc) to yield 3n (42.4 mg, 0.150 mmol, 60%) as an 
off-white powder.  1H NMR (CDCl3, 400 MHz) δ 1.72 (s, 3H), 3.05 (d, J = 16.5 Hz, 1H), 3.26 
(d, J = 16.5 Hz, 1H), 5.89 (d, J = 1.4 Hz, 1H), 5.90 (d, J = 1.4 Hz, 1H), 6.69 (d, J = 8.1 Hz, 1H), 
6.82 (dd, J = 8.1, 1.9 Hz, 1H), 6.90-6.96 (m, 2H), 7.03 (dd, J = 8.3, 0.6 Hz, 1H), 7.45 (ddd, J = 
8.3, 7.2, 1.6 Hz, 1H), 7.76 (dd, J = 7.8, 1.6 Hz, 1H).  13C NMR (CDCl3, 101 MHz) δ 30.6, 48.2, 
82.5, 101.3, 106.4, 108.2, 118.5, 119.0, 121.26, 121.28, 126.8, 136.4, 137.0, 147.2, 148.2, 160.0, 
191.9.  HRMS (ESI) calcd. for C17H15O4+ [M+H]+ 283.0965, found 283.0960. 
 
2-(3-fluoro-4-methoxyphenyl)-2-methylchroman-4-one (3o): 
Prepared according to the general procedure from 3-fluoro-4-
methoxyphenylboronic acid 1o (42.5 mg, 0.250 mmol) and 2-
methylchromone 2a (120 mg, 0.750 mmol).  The crude product was 
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purified by flash column chromatography (100:0 to 70:30 hexanes:EtOAc) to yield 3o (59.4 mg, 
0.208 mmol, 83%) as a light yellow powder.  1H NMR (CDCl3, 600 MHz) δ 1.72 (s, 3H), 3.06 
(d, J = 16.5 Hz, 1H), 3.25 (d, J = 16.5 Hz, 1H), 3.82 (s, 3H), 6.84 (appt, J = 8.6 Hz, 1H), 6.94 
(dd, J = 7.7, 7.4 Hz, 1H), 7.04 (d, J = 8.3 Hz, 1H), 7.06 (d, J = 8.6 Hz, 1H), 7.17 (dd, J = 12.5, 
2.0 Hz, 1H), 7.46 (dd, J = 8.3, 7.4 Hz, 1H), 7.76 (d, J = 7.7 Hz, 1H).  13C NMR (CDCl3, 151 
MHz) δ 30.3, 48.1, 56.4, 82.0 (d, J = 1.2 Hz), 113.4 (d, J = 2.1 Hz), 113.8 (d, J = 19.8 Hz) 118.5, 
121.2, 121.3 (d, J = 3.6 Hz) 121.4, 126.8, 136.2 (d, J = 5.4 Hz) 136.5, 147.3 (d, J = 10.8 Hz), 
152.5 (d, J = 246.4 Hz), 160.0, 191.6.  19F NMR (CDCl3, 565 MHz) δ -133.93.  HRMS (ESI) 
calcd. for C17H16FO3+ [M+H]+ 287.1078, found 287.1080. 
 
2-(2-methoxyphenyl)-2-methylchroman-4-one (3q): Prepared according 
to the general procedure from 2-methoxyphenylboronic acid 1q (38.0 mg, 
0.250 mmol) and 2-methylchromone 2a (120 mg, 0.750 mmol).  The crude 
product was purified by flash column chromatography (100:0 to 70:30 hexanes:EtOAc) to yield 
3q (21.0 mg, 0.0880 mmol, 35%) as a white powder.  1H NMR (CDCl3, 600 MHz) δ 1.82 (s, 
3H), 3.23 (d, J = 16.4 Hz, 1H), 3.55 (d, J = 16.4 Hz, 1H), 3.86 (s, 3H), 6.86 (dd, J = 7.8, 7.2 Hz, 
1H), 6.89 (d, J = 7.9 Hz, 1H), 6.96 (dd, J = 7.8, 7.6 Hz, 1H), 7.12 (d, J = 8.3 Hz, 1H), 7.21 (ddd, 
J = 7.9, 7.6, 1.6 Hz, 1H), 7.45 (dd, J = 7.8, 1.6 Hz, 1H), 7.51 (ddd, J = 8.3, 7.2, 1.6 Hz, 1H), 7.77 
(dd, J = 7.8, 1.6 Hz, 1H).  13C NMR (CDCl3, 151 MHz) δ 26.5, 47.1, 55.5, 83.0, 111.9, 118.4, 
120.8, 121.1, 121.2, 126.7, 127.0, 129.1, 130.6, 136.3, 156.5, 160.2, 192.8.  HRMS (ESI) calcd. 
for C17H17O3+ [M+H]+ 269.1172, found 269.1179. 
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2-(2-fluoro-4-methoxyphenyl)-2-methylchroman-4-one: Prepared 
according to the general procedure from 2-fluoro-4-
methoxyphenylboronic acid 1r (42.5 mg, 0.250 mmol) and 2-
methylchromone 2a (120 mg, 0.750 mmol).  The crude product was 
purified by flash column chromatography (100:0 to 70:30 hexanes:EtOAc) to yield 3r (17.9 mg, 
0.0630 mmol, 25%) as a colorless oil.  1H NMR (CDCl3, 600 MHz) δ 1.78 (s, 3H), 3.08 (d, J = 
16.4 Hz, 1H), 3.34 (d, J = 16.4 Hz, 1H), 3.70 (s, 3H), 6.49-6.60 (m, 2H), 6.93 (dd, J = 7.7, 7.2 
Hz, 1H), 7.05 (d, J = 8.3 Hz, 1H), 7.21-7.26 (m, 1H), 7.47 (ddd, J = 8.3, 7.4, 1.3 Hz, 1H), 7.74 
(dd, J = 7.7, 1.3 Hz, 1H).  13C NMR (CDCl3, 151 MHz) δ 27.9 (d, J = 2.7 Hz), 48.0 (d, J = 5.3 
Hz), 55.7, 81.6 (d, J = 3.9 Hz), 103.0 (d, J = 27.1 Hz), 109.9 (d, J = 2.8 Hz), 118.4, 121.1, 121.4, 
121.6 (d, J = 11.9 Hz), 126.8, 128.2 (d, J = 5.7 Hz), 136.5, 159.9 (d, J = 17.7 Hz), 160.7 (d, J = 
11.5 Hz), 161.5, 191.9.  19F NMR (CDCl3, 565 MHz) δ -110.42.  HRMS (ESI) calcd. for 
C17H16FO3+ [M+H]+ 287.1078, found 287.1078. 
 
 
 
2-ethyl-2-phenylchroman-4-one (3s): Prepared according to the general 
procedure from phenylboronic acid 1a (30.5 mg, 0.250 mmol) and 2-
ethylchromone 2b (130 mg, 0.750 mmol).  The crude product was purified 
by flash column chromatography (100:0 to 90:10 hexanes:EtOAc) to yield 
3s (50.0 mg, 0.198 mmol, 79%) as an off-white powder.  1H NMR (CDCl3, 400 MHz) δ 0.86 (t, 
J = 7.4 Hz, 3H), 1.96-2.16 (m, 2H), 3.11 (d, J = 16.5 Hz, 1H), 3.27 (d, J = 16.5 Hz, 1H), 6.92 
(dd, J = 7.8, 7.2 Hz, 1H), 7.08 (dd, J = 8.4, 0.6 Hz, 1H), 7.18-7.23 (m, 1H), 7.25-7.31 (m, 2H), 
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7.32-7.38 (m, 2H), 7.46 (ddd, J = 8.4, 7.2, 1.7 Hz, 1H), 7.74 (dd, J = 7.8, 1.7 Hz, 1H).  13C NMR 
(CDCl3, 101 MHz) δ 8.1, 35.4, 46.3, 85.3, 118.5, 121.1, 121.5, 126.1, 126.7, 127.7, 128.6, 136.3, 
141.4, 160.2, 192.1.  HRMS (ESI) calcd. for C17H17O2+ [M+H]+ 253.1223, found 253.1225. 
 
2-isopropyl-2-phenylchroman-4-one (3t): Prepared according to the 
general procedure from phenylboronic acid 1a (30.5 mg, 0.250 mmol) and 
2-isopropylchromone 2c (141 mg, 0.750 mmol).  The crude product was 
purified by flash column chromatography (100:0 to 90:10 hexanes:EtOAc) 
to yield 3t (28.6 mg, 0.108 mmol, 43%) as a light yellow oil.  1H NMR (CDCl3, 600 MHz) δ 
0.87 (d, J = 6.8 Hz, 3H), 1.05 (d, J = 6.8 Hz, 3H), 2.27 (sept, J = 6.8 Hz, 1H), 3.22 (d, J = 16.4 
Hz, 1H), 3.29 (d, J = 16.4 Hz, 1H), 6.87 (dd, J = 7.8, 7.2 Hz, 1H), 7.05 (d, J = 8.3 Hz, 1H), 7.17 
(t, J = 7.3 Hz, 1H), 7.23 (dd, J = 8.0, 7.3 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 7.43 (ddd, J = 8.3, 
7.2, 1.6 Hz, 1H), 7.67 (dd, J = 7.8, 1.6 Hz, 1H).  13C NMR (CDCl3, 151 MHz) δ 17.2, 17.6, 39.1, 
42.6, 87.8, 118.5, 121.0, 121.7, 126.7, 127.3, 127.8, 128.3, 136.2, 140.1, 160.5, 192.5.  HRMS 
(ESI) calcd. for C18H19O2+ [M+H]+ 267.1380, found 267.1385. 
 
2-cyclohexyl-2-phenylchroman-4-one (3u): Prepared according to the 
general procedure from phenylboronic acid 1a (30.5 mg, 0.250 mmol) and 
2-cyclohexylchromone 2d (171 mg, 0.750 mmol).  The crude product was 
purified by flash column chromatography (100:0 to 90:10 hexanes:EtOAc) 
to yield 3u (11.5 mg, 0.0380 mmol, 15%) as a light yellow oil.  1H NMR (CDCl3, 600 MHz) δ 
1.02-1.31 (m, 5H), 1.62-2.00 (m, 6H), 3.17 (d, J = 16.3 Hz, 1H), 3.28 (d, J = 16.3 Hz, 1H), 6.86 
(dd, J = 7.6, 7.4 Hz, 1H), 7.04 (d, J = 8.3 Hz, 1H), 7.17 (t, J = 7.0 Hz, 1H), 7.23 (dd, J = 7.7, 7.0 
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Hz, 2H), 7.28 (d, J = 7.7 Hz, 2H), 7.42 (dd, J = 8.3, 7.4 Hz, 1H), 7.66 (d, J = 7.6 Hz, 1H).  13C 
NMR (CDCl3, 151 MHz) δ 26.5, 26.6, 26.7, 27.2, 27.7, 43.1, 49.2, 87.6, 118.5, 121.0, 121.7, 
126.7, 127.3, 127.7, 128.3, 136.2, 140.4, 160.4, 192.6.  HRMS (ESI) calcd. for C21H23O2+ 
[M+H]+ 307.1693, found 307.1690. 
 
6-methoxy-2-methyl-2-phenylchroman-4-one (3v): Prepared 
according to the general procedure from phenylboronic acid 1a (30.5 
mg, 0.250 mmol) and 6-methoxy-2-methylchromone 2e (142 mg, 
0.750 mmol).  The crude product was purified by flash column chromatography (100:0 to 70:30 
hexanes:EtOAc) to yield 3v (54.4 mg, 0.203 mmol, 81%) as a tan powder.  1H NMR (CDCl3, 
400 MHz) δ 1.74 (s, 3H), 3.08 (d, J = 16.6 Hz, 1H), 3.31 (d, J = 16.6 Hz, 1H), 3.73 (s, 3H), 6.99 
(d, J = 9.0 Hz, 1H), 7.07 (dd, J = 9.0, 3.2 Hz, 1H), 7.19 (d, J = 3.2 Hz, 1H), 7.22 (t, J = 7.3 Hz, 
1H), 7.30 (dd, J = 7.3, 7.2 Hz, 2H), 7.40 (d, J = 7.2 Hz, 2H).  13C NMR (CDCl3, 101 MHz) δ 
30.3, 48.1, 55.9, 82.6, 107.3, 119.8, 121.0, 125.4, 125.5, 127.8, 128.8, 143.2, 153.9, 154.8, 192.0.  
HRMS (ESI) calcd. for C17H17O3+ [M+H]+ 269.1172, found 269.1177. 
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CHAPTER 5 
CONCLUSIONS 
 We have shown that cycloadditions of α-substituted azomethine ylides with 3-
nitroindoles occur in the presence of a catalyst derived from Cu(OTf)2 and (R)-Difluorphos to 
deliver pyrrolo[3, 4b]indoles in moderate-to-good yields (39-85%) with up to 98 : 1 : 1 
exo´:exo:endo selectivity and up to 96% yield.  A portion of this work demonstrates that the 
copper-catalyst is involved in an endoexo´ epimerization process that allows for high exo´-
selectivity.  We obtained data that suggests that D-configured imino esters move through the 
catalyzed cycloaddition pathway at a rate faster than L-configured imino esters.  These reactions 
set four contiguous stereocenters, two of which are fully substituted. 
 We have designed a catalyst system that smoothly catalyzes reactions of highly reactive 
nitrile imines with methyleneindolinones to afford spiro[pyrazolin-3,3´-oxindoles] in up to 98% 
yield and up to 99% ee.  This methodology, which is applicable to a diverse scope of dipoles and 
dipolarophiles, compliments extant methods which require steric bulk at the β-aryl ring of the 
methyleneindoline and less reactive hydrazonoyl chlorides in order to achieve high yields and 
enantioselectivities.   Data obtained in competition reactions of dipolarophiles suggests that 
strength of dipolarophile-catalyst binding plays a role in enantioselectivity in these reactions. 
 We have demonstrated that conjugate additions of arylboronic acids with 2-substituted 
chromones occur in aqueous medium in the presence of a catalyst generated from Pd(TFA)2 and 
1,10-phenanthroline to deliver 2-alkyl-2-arylchromanones in up to 90% yield.  The scope of 
these reactions includes a variety of arylboronic acids and 2-alkylchromones.  These reactions 
overcome the problems of undesired protodeboronation and arylboronic acid homocoupling and 
provide a new means to generate a fully substituted carbon center.  
